小児内科　Vol.47　2015年増刊号　小児疾患診療のための病態生理　2　改訂第5版

I. 総論

P.13 掲載の参考文献

1) Nishiyama M, Sawai H, Kosugi S : The current state of genetic counseling before and after amniocentesis for fetal karyotyping in Japan : a survey of obstetric hospital clients of a prenatal testing laboratory. J Genet Couns 22 : 795-804, 2013

PubMed

2) 坂井律子 : いのちを選ぶ社会-出生前診断のいま. NHK出版, 東京, 2013

 

3) 日本医学会 : 医療における遺伝学的検査・診断に関するガイドライン http://jams.med.or.jp/guideline/genetics-diagnosis.pdf (2015年7月24日アクセス)

 

4) 日本産科婦人科学会 : 出生前に行われる遺伝学的検査および診断に関する見解 http://www.jsog.or.jp/ethic/H25_6_shusseimae-idengakutekikensa.html (2015年7月24日アクセス)

 

5) 日本産科婦人科学会, 日本産婦人科医会 (編) : CQI06-1～5. 産婦人科診療ガイドライン-産科編 2014, 日本産科婦人科学会, 東京, pp81-102, 2014

 

6) 厚生科学審議会先端医療技術評価部会・出生前診断に関する専門委員会 : 「母体血清マーカー検査に関する見解」 1999年 (平成11年) 6月23日

 

7) 日本産科婦人科学会 : 母体血を用いた新しい出生前遺伝学的検査に関する指針 http://www.jsog.or.jp/news/pdf/guidelineForNIPT_20130309.pdf (2015年7月24日アクセス)

 

8) 福嶋義光 : 生命倫理とゲノム解析技術-出生前診断を考える際の論点整理. 日医師会誌 143 : 1159-1163, 2014

 

P.20 掲載の参考文献

1) Imura H : Life course health care and preemptive approach to non-communicable diseases. Proc Jpn Acad Ser B Phys Biol Sci 89 : 462-473, 2013

PubMed

2) Wood-Bradley RJ, Barrand S, Giot A, et al : Understanding the role of nlaternal diet on kidney development ; an opportunity to improve cardiovascular and renal health for future generations. Nutrients 7 : 1881-1905, 2015

PubMed

3) Jarvelin MR, Sovio U, King V, et al : Early life factors and blood pressure at age 31 years in the 1966 northern Finland birth cohort. Hypertension 44 : 838-846, 2004

PubMed

4) Mafialich R, Reyes L, Herrera M, et al : Relationship between weight at birth and the number and size of renal glomeruli in humans : a histomorphometric study. Kidney Int 58 : 770-773, 2000

PubMed

5) Brenner BM, Garcia DL, Anderson S : Glomeruli and blood pressure. Less of one, more the other? Am J Hypertens 1 : 335-347, 1988

PubMed

6) Keller G, Zimmer G, Mall G, et al : Nephron number in patients with primary hypertension. N Engl J Med 348 : 101-108, 2003

PubMed

7) Kuure S, Sainio K, Vuolteenaho R, et al : Crosstalk between Jaggedl and GDNF/Ret/GFRalphal signalling regulates ureteric budding and branching. Mech Dev 122 : 765-780, 2005

 

8) Merlet-Benichou C : Influence of fetal environment on kidney development. Int J Dev Biol 43 : 453-456, 1999

PubMed

9) Merlet-Benichou C : Regulation of c-ret expression by retinolic acid in rat metanephros. Implication in nephron mass control. Am J Physiol 47 : F938-945, 1998

 

10) Whorwood CB, Firth KM, Budge H, et al : Maternal undernutrition during early to midgestation programs tissue-specific alterations in the expression of the glucocorticoid receptor, 11beta-hydroxysteroid dehydrogenase isoforms, and type 1 angiotensin II receptor in neonatal sheep. Endocrinology 142 : 2854-2864, 2001

PubMed

11) Zhang SL, Moini B, Ingelfinger JR : Angiotensin II increases Pax-2 expression in fetal kidney cells via the AT2 receptor. J Am Soc Nephrol 15 : 1452-1465, 2004

PubMed

12) Chen Y-W, Tran S, Chenier I, et al : Deficiency of intrarenalangiotensin II type 2 receptor impairs paired Homeobox-2 and N-myc expression during nephrogenesis. Pediatr Nephrol 23 : 1769-1777, 2008

 

13) Bertram C, Trowern AR, Copin N, et al : The maternal diet during Pregnancy programs altered expression of the glucocorticoid receptor and type 2 11beta-hydroxysteroid dehydrogenase : potential molecular mechanisms underlying the programming of hypertension in utero. Endocrinology 142 : 2841-2853, 2001

PubMed

14) Lindsay RS, Lindsay RM, Edwards CR, et al : Inhibition of 11-beta-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring. Hypertension 27 : 1200-1204, 1996

PubMed

15) Zhao Y, Gong X, Chen L, et al : Site-specific methylation of placental HSD11B2 gene promoter is related to intrauterine growth restriction. Eur J Hum Genet 22 : 734-740, 2014

PubMed

16) Pham TD, MacLennan NK, Chiu CT, et al : Uteroplacental insufficiency increases apoptosis and alters p53 gene methylation in the full-term IUGR rat kidney. Am J Physiol Regul Integr Comp Physiol 285 : R962-970, 2003

PubMed

P.25 掲載の参考文献

1) Karlberg J : A biologically-oriented mathematical model (ICP) for human growth. Acta Paediatr Scand 350 (Suppl) : 70-94, 1989

PubMed

2) 田中敏章 : 成長と成熟の現象学. 日成長会誌 19 : 16-28, 2013

Medical*Online

3) 田中敏章 : 成長の機構とその制御. 日本小児内分泌学会 (編) : 小児内分泌学, 診断と治療社, 東京, pp169-175, 2009

 

4) 田島敏弘 : 小児の成長・思春期発達 2) 内分泌学的側面. 横谷進 (編) : 成長障害のマネジメント改訂3版, 医薬ジャーナル社, 大阪, pp18-25, 2013

 

5) Daughaday WH, Rotwein P : Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endcr Rev 10 : 68-91, 1989

 

6) Yakar S, Liu LJ, Stannard B, et al : Normal growth and development in the absence of hepatic insulin like growth factor I. Proc Natl Acad Sci USA 96 : 7324-7329, 1999

 

7) Wu S, Yang W, Luca FD : Insulin-like growth factor independent effects of growth hormone on growth plate chondrogenesis and longitudinal bone growth. Endcrinology 156 : 2541-2551, 2015

 

8) Rochira V, Carani C : Aromatase deficiency in men : a clinical perspective. Nat Rev Endocrinol 5 : 559-568, 2009

 

9) Yasoda A, Komatsu Y, Chusho H, et al : Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat Med 10 : 80-86, 2004

PubMed

10) Bartels CE Bukulmez H, Padayatti P, et al : Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia, type Maroteaux. Am J Hum Genet 75 : 27-34, 2004

 

11) Miura K, Namba N, Fujiwara M, et al : An overgrowth disorder associated with excessive production of cGMP due to a gain-of-function mutation of the natriuretic peptide receptor 2 gene. PlosOne 7 : E42180, 2012

 

12) Durand C, Rappold GA : Height matters-from monogenic disorders to normal variation. Nat Rev Endocrinol 9 : 171-177, 2013

PubMed

13) Lorget F, Kaci N, Peng J, et al : Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia. Am J Hum Genet 91 : 1108-1114, 2012

 

P.30 掲載の参考文献

1) Troy EB, Kasper DL : Beneficial effects of Bacteroides fragilis polysaccharides on the immune system. Fron Biol 15 : 25-34, 2010

 

2) Chinen T, Rudensky AY : The effects of commensal microbiota on immllne cell subsets and inflammatory responses. Immunol Rev 245 : 45-55, 2012

PubMed

3) Goto Y, Panea C, Nakato G, et al : Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation. Immunity 40 : 594-607, 2014

PubMed

4) Furusawa Y, Obata Y, FukUda S, et al : Commensal microbe-derived butyrate induces colonic regulatory T cells. Nature 504 : 446-450, 2013

PubMed

5) Chang PV, Hao L, Offermanns S, et al : The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition. Proc Natl Acad Sci USA 111 : 2247-2252, 2014

PubMed

6) Thangaraju M, Cresci GA, Liu K, et al : GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Res 69 : 2826-2832, 2009

 

7) Singh N, Gurav A, Sivaprakasam S, et al : Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 40 : 128-139, 2014

PubMed

8) Kim MH, Kang SG, Park JH, et al : Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology 145 : 396-406, 2013

PubMed

9) Maslowski KM, Vieira AT, Ng A, et al : Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461 : 1282-1286, 2009

PubMed

10) Trompette A, Gollwitzer ES, Yadava K, et al : Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 20 : 159-166, 2014

PubMed

11) Smith PM, Howitt MR, Panikov N : The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341 : 569-573, 2013

PubMed

12) Fukuda S, Toh H, Hase K, et al : Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469 : 543-547, 2011

PubMed

13) Goto Y, Obata T, Kunisawa J, et al : Innate lymphoid cells regulate intestinal epithelial cell glycosylation., Science 345 : 1254009, 2014

PubMed

P.35 掲載の参考文献

1) 原田正平 : 治療管理の進歩と小児慢性疾患の予後について. 小児内科 43 : 1434-1437, 2011

Medical*Online

2) Blum RW : Transition to adult health care : Setting the stage. J Adolesc Health 17 : 3-5, 1995

 

3) Perrin JM : Children with special health care needs and changing policy Acad Pediatr 11 : 103-104, 2011

PubMed

4) Haggerty RJ : Caring for children with special needs : Historical perspective. Acad Pediatr 11 : 107-109, 2011

PubMed

5) Van Dyck PC, McPherson M, Strickland BB, et al : The national survey of children with special health care needs. Ambul Pediatr 2 : 29-37, 2002

PubMed

6) 横谷進, 落合亮太, 小林信秋, 他 : 小児期発症疾患を有する患者の移行期医療に関する提言, 日本小児科学会ホームページ http://www.jpeds.or.jp/modules/news/index.php?content_id=83 (2015年7月24日アクセス)

 

7) 日本成人先天性心疾患学会ホームページ http://www.jsachd.org/about/ (2015年7月24日アクセス)

 

8) Oeffinger KC, Mertens AC, Sklar CA, et al : Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355 : 1572-1582, 2006

PubMed

9) Nathan PC, Ford JS, Henderson TO, et al : Health behaviors, medical care, and interventions to promote healthy living in the childhood cancer survivor study cohort. J Clin Oncol 27 : 2363-2373, 2009

PubMed

10) American Academy of Pediatrics, American Academy of Family Physicians, American College of Physicians, American Society of Internal Medicine : A consensus statement on health care transitions for young adults with special health care needs. Pediatrics 110 : 1304-1306, 2002

 

II. 新生児疾患

P.44 掲載の参考文献

1) 鮫島浩 : 胎児機能不全. 第66回日本産科婦人科学会学術講演会 専攻医教育プログラム 6 http://jsog.umin.ac.jp/66/handout/6_2Dr.sameshima.pdf (2015年7月30日アクセス)

 

2) Ikenoue T, Martin CB Jr, Murata Y, et al : Effect of acute hypoxemia and respiratory acidosis on the fetal heart rate in monkeys. Am J Obstet Gynecol 141 : 797-806, 1981

PubMed

3) Martin CB Jr, de Haan J, van der Wildt B, et al : Mechanisms of late decelerations in the fetal heart rate. A study with autonomic blocking agents in fetal lambs. Eur J Obstet Gynecol Reprod Biol 9 : 361-373, 1979

PubMed

4) Murata Y, Miyake Y, Yamamoto T, et al : Experimentally produced sinusoidal fetal heart rate pattern in the chronically instrumented fetal lamb. Am J Obstet Gynecol 153 : 693-702, 1985

 

5) Paul RH, Suidan AK, Yeh S, et al : Clinical fetal monitoring. VII. The evaluation and significance of intrapartum baseline FHR variability. Am J Obstet Gynecol 123 : 206-210, 1975

PubMed

6) Sameshima H, Ikenoue T : Predictive value of late decelerations for fetal acidemia in unselective low-risk pregnancies. Am J Perinatol 22 : 19-2 ; 3, 2005

 

7) Signore C, Freeman RK, Spong CY : Antenatal testing-a reevaluation : executive summary of a Eunice Kennedy Shriver National Institute of Child Health and Human Development workshop. Obstet Gynecol 113 : 687-701, 2009

PubMed

8) 丸山有子, 茨聡, 加藤博美 : ハイリスク症例における医療介入のタイミング「Intrauterine growth restriction (IUGR) 」. 産と婦 57 : 1853-1858. 2004

 

9) Vintzileos AM, Gaffney SE, Salinger LM, et al : The relationship between fetal biophysical profile and cord pH in patients undergoing cesarean section before the onset of labor. Obstet Gynecol 70 : 196-201, 1987

PubMed

10) 藤森敬也, 他 : 胎児子宮内環境評価の新たな展開と可能性 慢性子宮内環境悪化に伴う胎児パラメータの変化と子宮内環境評価. 日新生児会誌 39 : 708-715, 2003

 

P.49 掲載の参考文献

1) Gomez R, Romero R, Ghezzi F, et al : The fetal inflammatory response syndrome. Am J Obstet Gynecol 179 : 194-202, 1998

PubMed

2) Carlo WA, McDonald SA, Tyson JE, et al : Cytokines and neurodevelopmental outcomes in extremely low birth weight infants. J Pediatr 159 : 919-925, e913, 2011

 

3) Hofer N, Kothari R, Morris N, et al : The fetal inflammatory response syndrome is a risk factor for morbidity in preterm neonates. Am J Obstet Gynecol 209 : 542, e1-542, e11, 2013 doi : 10.1016/j. ajog. 2013. 08. 030

 

4) Combs CA, Gravett M, Fadia M, et al : Amniotic fluid infection, inflammation, and colonization in preterm labor with intact memranes. Am J Obstet Gynecol 210 : 125, e 1-5, 2014

 

5) Erison J, Laughon M : Chorioamnionitis, implicaitons for the neonate. Clin Perinatol 42 : 155-165, 2015

 

6) Nishimaki S, Sato M, An H, et al : Comparison of markers for fetal inflammatory response syndrome : fetal blood interleukin-6 and neonatal urinary beta (2) -microglobulin. J Obstet Gynaecol Res 35 : 472-476, 2009 doi : 10.1111/j. 1447-0756. 2008. 00988. x

 

7) Namba F, Kitajima H, Tabata A, et al : Anti-annexin A2 IgM antibody in preterm infants : its association with chorioamnionitis. Pediatr Res 60 : 699-704, 2006

PubMed

8) Dessardo NS, Dessardo S, Mustac E, et al : Chronic lung disease of prematurity and early childhood wheezing : is foetal inflammatory response syndrome to blame? Early Hum Dev 90 : 493-499, 2014

PubMed

9) Liu Z, Tang Z, Li J, et al : Effects of placental inflammation on neonatal outcome in preterm infants. Pediatr Neonatol 55 : 35-40, 2014 doi : 10. 1016/j. pedneo. 2013. 05. 007

 

10) Sood BG, Madan A, Saha S, et al : Perinatal systemic inflammatory response syndrome and retinopathy of prematurity. Pediatr Res 67 : 394-400, 2010 doi : 10.1203/PDR. 0b013e3181d01a36

 

11) Musilova I, Kacerovsky M, Homychova H, et al : Pulsation of the fetal splenic vein-a potential ultrasound Inarker of histological chorioamnionitis and funisitis in women with preterm prelabor rupture of membranes. Acta Obstet Gynecol Scand 91 : 1119-1123, 2012 doi : 10.1111/j. 1600-0412. 2012. 01450. x

 

12) Kobayashi A, Minami S, Tanizaki Y, et al : Adverse perinatal and neonatal outcomes in patients with chronic abruption-oligohydramnios sequence. J Obstet Gynaecol Res 40 : 1618-1624, 2014 doi : 10.1111/jog. 12395

 

13) Elliott JP, Gilpin B, Strong TH Jr, et al : Chronic abruption-oligohydramnios sequence. J Reprod Med 43 : 418-422, 1998

PubMed

P.53 掲載の参考文献

1) Itabashi K, Miura F, Uehara R, et al : New Japanese neonatal anthropometric charts for gestational age at birth. Pediatr Int 56 : 702-708, 2014

PubMed

2) 細野茂春 : 子宮内発育遅延児. 小児内科 35 (増刊) : 60-64, 2003

 

3) Cox P, Marton T : Pathological assessment of intrauterine growth restriction. Best Pract Res Clin Obstet Gynaecol 23 : 751-764, 2009

PubMed

4) Bartels DB, Kreienbrock L, Dammann O, et al : Population based study on the outcome of small for gestational age newborns. Arch Dis Child Fetal Neonatal Ed 90 : F53-59, 2005

 

5) Bozzetti V, Paterlini G, Gazzolo D, et al : Monitoring Doppler patterns and clinical parameters may predict feeding tolerance in intrauterine growth-restricted infants. Acta Paediatr 102 : e519-523, 2013

PubMed

6) Levine TA, Grunau RE, McAuliffe FM, et al : Early childhood neurodevelopment after intrauterine growth restriction : a systematic review. Pediatrics 135 : 126-141, 2015

PubMed

7) Gluckmann PD, Hanson MA, Cooper C, et al : Effects of in utero and early-life conditions on adult health and disease. N Engl J Med 359 : 61-73, 2008

 

8) Carmody JB, Charlton JR : Short-term gestation, long-terln risk : prematurity and chronic kidney disease. Pediatrics 131 : 1168-1179, 2013

PubMed

9) Modi N, Thomas EL, Harrington TA, et al : Determinant of adiposity during preweaning postnatal growth in appropriate grown and growth-restricted term infants. Pediatr Res 60 : 345-348, 2006

PubMed

P.56 掲載の参考文献

1) Lorch SA, Mollen TJ : Nonimmune hydrops. In Gleason CA, Devaskar SU (eds) : Avery's Disease of the Newborn, 9th ed, Elsevier Saunders, Philadelphia, pp 67-73, 2011

 

2) Brret KE, Barman SM, Boitano S : Ganong's Review of Medical Physiology, 24th ed, McGraw-Hill, pp555-586, 2012

 

3) 日本産婦人科学会・日本産婦人科医会 (編) : 産婦人科診療ガイドライン-産科編 2014. 日本産婦人科学会, 東京, pp38-41, 2014

 

4) 村越毅 : 多胎妊娠の短期および長期予後の検討. 日周産期・新生児会誌 41 : 750-755, 2005

 

5) 室伏航, 宮園弥生 : 胎児水腫. 周産期医学 41 (増刊) : 510-511, 2011

 

6) Volpe JJ : Bilirubin and brain injury. In Volpe JJ (ed) : Neurology of the Newborn, 4th ed, WB Saunders, Philadelphia, pp619-651, 2008

 

7) Etches P, Demianczuk N, Chari R : Non-immune hydrops fetalis. In Rennie JM (ed) : Roberton's Textbook of Neonatology, 4th ed, Elsevier, Philadelphia, pp773-782, 2005

 

8) Fukushima K, Morokuma S, Fujita Y, et al : Short-term and long-term outcomes of 214 cases of non-immune hydrops fetalis. Early Hum Dev 87 : 571-575, 2011 doi : 10.1016/j. earlhumdev. 2011. 04. 015

 

P.61 掲載の参考文献

1) 田村正徳 (監) : Consensus2010に基づく新生児低体温療法実践マニュアル, 東京医学社, 東京, 2011

 

2) Paul PD, Laura B, Alistair JG : Mechanism of hypothermic neuroprotection. Semin Fetal Neonatal Med 15 : 287-292, 2010

 

3) Sarnat HB, Samat MS : Neonatal encephalopathy following fetal distress. A clinical and electroencephalographic study. Arch Neurol 33 : 696-705, 1976

 

4) Volpe JJ : Neurology of the Newborn, 5th ed, Saunders, Philadelphia, 2008

 

5) Thompson CM, Puterman AS, Linley LL, et al : The value of a scoring system for hypoxic ischemic encephalopathy in predictingneurodevelopmental outcome. Acta Paediatr 86 : 757-761, 1997

PubMed

6) 田村正徳 (監) : 日本版救急蘇生ガイドライン2010に基づく新生児蘇生法テキスト, 改訂2版, メジカルビュー社, 東京, 2011

 

7) Shankaran S, Laptook AR, Ehrenkranz RA, et al : Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med 353 : 1574-1584, 2005

PubMed

8) Azzopardi DV, Strohm B, Edwards AD, et al : Moderate hypothermia to treat perinatal asphyxia encephalopathy. N Engl J Med 361 : 1349-1358, 2009

PubMed

9) Perlman JM, Wyllie J, Kattwinkel J, et al : Part 11 : Neonatal resuscitation : 2010 Inernational Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science with Treatment Recommendations. Circulation 122 : S516-538, 2010

 

10) Shankaran S, Laptook AR, Pappas A, et al : Effect of depth and duration of cooling on deaths in the NICU among neonates with hypoxic ischemic encephalopathy. A randomized clinical trial. JAMA 312 : 2629-2639, 2014

PubMed

P.66 掲載の参考文献

1) Volpe JJ : Neonatal Seizures. The Neurology of the Newbom, 5th ed, Saunders, pp203-243, 2008

 

2) Nabetani M, Okada Y, Takata T, et al : Neural activity and intracellular Ca2+ mobilization in the CA1 area of hippocampal slices from immature and mature rats during ischemia or glucose deprivation. Brain Res 769 : 158-162, 1997

PubMed

3) Murray DM, Boylan GB, Ali I, et al : Defining the gap between electrographic seizure burden, clinical expression and staff recognition of neonatal seizures. Arch Dis Child Fetal Neonatal Ed 93 : F187-191, 2008

PubMed

4) Malone A, Ryan CA, Fitzgerald A, et al : Interobserver agreement in neonatal seizure identification. Epilepsia 50 : 2097-2101, 2009

PubMed

5) 渡部一功 : 新生児, 乳幼児の脳波. 臨床脳波 20 : 155-163, 1978

 

6) Nagarajan L, Palumbo L, Ghosh S : Classification of clinical semiology in epileptic seizures in neonates. Eur J Paediatr Neurol 16 : 118-125, 2012

PubMed

7) Mizrahi EM, Kellaway P : Diagnosis and Management of Neonatal Seizures, Lippincott-Raven, Philadelphia, 1998

 

8) Slaughter LA, Patel AD, Slaughter JL : Pharmacological treatment of neonatal seizures : a systematic review. J Child Neurol 28 : 351-364, 2013

PubMed

9) Tulloch JK, Carr RR, Ensom MH : A systematic review of the pharmacokinetics of antiepileptic drugs in neonates with refractory seizures. J Pediatr Phanmacol Ther 17 : 31-44, 2012

 

10) 笹征史 : 新規抗てんかん薬levetiracetamのすべてLevetiracetamの薬理作用-そしててんかん原性抑制への期待. 臨床精神薬理 13 : 1671-1683, 2010

 

P.71 掲載の参考文献

1) Swarnam K, Soraisham AS, Sivanandan S : Advances in the management of meconillm aspiration syndrome. Int J Pediatr, 2012 doi : 10.1155/2012/359571

 

2) Yoder BA, Kirsch EA, Barth WH, et al : Changing obstetric practices associated with decreasing incidence of meconium aspiration syndrome. Obstet Gynecol 99 : 731-739, 2002

PubMed

3) 清水浩 : 胎便が単離肺胞II型細胞のサーファクタント・アポ蛋白遺伝子発現に及ぼす影響. 日界面学会誌 35 : 46-47, 2004

 

4) Lopez-Rodriguez E, Echaide M, Cruz A, et al : Meconium impairs pulmonary surfactant by a combined action of cholesterol and bile acids. Biophys J 100 : 646-655, 2011

PubMed

5) Zuo YY, Veldhuizen RA, Neumann AW, et al : Current perspectives in pulmonary surfactant-Inhibition, enhancement and evaluation. Biochim Biophys Acta 1778 : 1947-1977, 2008

PubMed

6) Yamada T, Minakami H, Matsubara S, et al : Meconium-stained amniotic fluid exhibits chemotactic activity for polymorphonuclear leukocytes in vitro. J Reprod Immunol 46 : 21-30, 2000

PubMed

7) Cleary GM, Wiswell TE : Meconium-stained amniotic fluid and the meconium aspiration syndrome. An update. Pediatr Clin North Am 45 : 511-529, 1998

PubMed

8) Jovanovic R, Nguyen HT : Experimental meconium aspiration in guinea pigs. Obstet Gynecol 73 : 654-656, 1989

 

9) Ghidini A, Spong CY : Severe meconium aspiration syndrome is not caused by aspiration of meconium. Am J Obstet Gynecol 185 : 931-938, 2001

 

10) Hahn S, Choi HJ, Soll R, et al : Lung lavage for meconiunl aspiration syndrome in newborn infants. Cochrane Database Syst Rev 30 ; 4 : CD003486. 2013

 

11) Fischer C, Rybakowski C, Ferdynus C, et al : A population-based study of meconium aspiration syndrome in neonates born between 37 and 43 weeks of gestation. Int J Pediatr, 2012 doi : 10.1155/2012/321545

 

P.76 掲載の参考文献

1) Travadi JN, Patole SK : Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn. Pediatr Pulmonol 36 : 529-535, 2003

PubMed

2) Hernandez-Diaz S, Van Marter LJ, Werler MM, et al : Risk factors for persistent pulmonary hypertension of the newborn. Pediatrics 120 : 272-282, 2007

 

3) Roofthooft MT, Elema A, Bergman KA, et al : Patient characteristics in persistent pulmonary hypertension of the newborn. Pulm Med 2011 ; 2011 : 858154 doi : 10.1155/2011/858154 [Epub 2011 May 24]

 

4) Walsh-Sukys MC, Tyson JE, Wright LL, et al : Persistent pulmonary hypertension of the newborn in the era before nitric oxide : prectice variation and outcomes. Pediatrics 105 (1 Pt 1) : 14-20, 2000

 

5) Henderson-Smart DJ, De Paoli AG, Clark RH, et al : High frequency oscillatory ventilation versus conventional ventilation for infants with severe pulmonary dysfunction born at or near term. Cochrane Database Syst Rev : CD002974, 2009 doi : 10.1002/14651858. CD002974. pub2

PubMed

6) Finer NN, Barrington KJ : Nitiric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev : CD000399, 2006

PubMed

7) Steinhorn RH : Neonatal pulmonary hypertension. Pediatr Crit Care Med 11 (2 Suppl) : S79-84, 2010

 

8) Dhillon R : The management of neonatal pulmonary hypertension. Arch Dis Child Fetal Neonatal Ed 97 : 223-228, 2012

 

9) LakshminrusiInha S, Porta NF, Farrow KN, et al : Mirinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newborn. Pediatr Crit Care Med 10 : 106-112, 2009

 

10) Bassler D, Kreutzer K, McNamara P, et al : Milrinone for perisitent pulmonary hypetension of the newbom. Cochrane Database Syst Rev : CD007802. 2011 doi : 10.1002/14651858. CD007802. pub2

 

P.81 掲載の参考文献

1) Avery ME, Gatewood OB, Brumley G : Transient tachypnea of newborn. Possible delayed resorption of fluid at birth. Am J Dis Child 111 : 380-385, 1966

PubMed

2) Liem JJ, et al : Transient tachypnea of the newborn may be an early clinical manifestation of wheezing symptoms. J Pediatr 151 : 29-33, 2007

PubMed

3) Levine EM, Ghai V, Barton JJ, et al : Mode of delivery and risk of respiratory diseases in newborns. Obstet Gynecol 97 : 439-442, 2001

PubMed

4) Tutdibi E, Gries K, Bucheler M, et al : Impact of labor on outcomes in transient tachypnea of the newborn : population-based study. Pediatrics 125 : e577-583, 2010

PubMed

5) Pinter E, Peyman JA, Snow K, et al : Effects of maternal diabetes on fetal rat lung ion transport. Contribution of alveolar and bronchiolar epithelial cells to Na+, K (+) -ATPase expression. J Clin Invest 87 : 821-830, 1991

 

6) Demissie K, Marcella SW, Breckenridge MB, et al : Maternal asthma and transient tachypnea of the newborn. Pediatrics 102 : 84-90, 1998

PubMed

7) Bland RD, Hansen TN, Haberkem CM, et al : Lung fluid balance in lambs before and after birth. J Appl Physiol Respir Environ Exerc Physiol 53 : 992-1004, 1982

 

8) Bancalari E, et al : The Newbom Lung, Saunders, pp 141-154, 2008

 

9) William OH, et al : Nephrology and Fluid/Electrolyte Physiology, Saunders, p 190, 2008

 

10) Aslan E, Tutdibi E, Martens S, et al : Transient tachypnea of the newbom (TTN) : a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Acta Paediatr 97 : 1346-1350, 2008

 

11) Rawlings JS, Smith FR : Transient tachypnea of the newborn. An analysis of neonatal and obstetric risk factors. Am J Dis Child 138 : 869-871, 1984

PubMed

12) Kurl S, Heinonen KM, Kiekara O : The first chest radiograph in neonates exhibiting respiratory distress at birth. Clin Pediatr (Phila) 36 : 285-289, 1997

PubMed

13) Barker PM, Walters DV, Markiewicz M, et al : Development of the lung liquid reabsortive mechanism in fetal sheep ; synergism of triodothyronine and hydrocortisone. J Physiol 433 : 435-449, 1991

 

14) Otulakowski G, Rafii B, Harris M, et al : Oxygen and glucocorticoids modulate αENaC mRNA translation in fetal distal lung epithelium. Am J Respir Cell Mol Biol 34 : 204-212, 2006

 

15) Kassab M, Khriesat WM, Bawadi H, et al : Furosemide for transient tachypnea of the newborn. Cochrane Database Syst Rev 2013 Jun 5 ; 6 : CD003064

 

16) Kao B, Stewart de Ramirez SA, Belfort MB, et al : Inhaled epinephrine for the treatment of transient tachypnea of the newborn. J Perinatol 28 : 205-210, 2008

PubMed

17) Kim MJ, Yoo JH, Jung JA, et al : The effects of inhaled albuterol in transient tachypnea of the newborn. Allergy Asthma Immunol Res 6 : 126-130, 2014

PubMed

18) Stroustrup A, Trasande L, Holzman IR : Randomized controlled trial of restrictive fluid management in transient tachypnea of the newborn. J Pediatr 160 : 38, 2012

PubMed

P.88 掲載の参考文献

1) 藤村正哲 : 呼吸管理を必要とする主な疾患 新生児肺出血と出血性肺浮腫. NICU 7 (春期増刊) : 45-56, 1994

 

2) 南野初香 : 肺水腫. 小児内科 46 (増刊) : 129-133, 2014

 

3) Ware LB, et al : Clinical practice. Acute pulmonary edema. N Engl J Med 353 : 2788-2796, 2005

PubMed

4) 小山典久 : 肺水腫, Neonatal Care 11 (秋期増刊) : 69-77, 1998

 

5) 増谷聡 : 5. 新生児・未熟児の心臓は小児や成人とどう違うの? 与田仁志 : 図解でどんどんステップアップ新生児循環管理なるほどQ&A, NeonatalCare (秋期増刊), メディカ出版. 大阪. pp24-26, 2012

 

6) Ronald IC : The role of patent ductus arteriosus and its treatments in the development of bronchopulmonary dysplasia. Semin Perinatol 37 : 102-107, 2013

 

7) 清益功浩, 他 : Massive pulmonary hemorrhage in a neonate associated with Streptococcus agalactiae (Group B streptococcus : GBS) infection. 日未熟児新生児会誌 14 : 161-165, 2002

 

8) 箕面嵜至宏 : 肺浮腫 (leaky lung syndrome, 出血性肺浮腫. 肺出血) の診断と治療は? 周産期医学 34 : 474-476, 2004

 

9) Amizuka T, et al : Surfactant therapy in neonates with respiratory failure due to haemorrhagic pulmonary oedema. Eur J Pediatr 162 : 697-702, 2003

PubMed

10) Bouissou A, et al : Hypotension in preterm infants with significant patent ductus arteriosus : effects of dopamine. J Pediatr 153 : 790-794, 2008

PubMed

P.94 掲載の参考文献

1) 平野慎也, 藤村正哲, 楠田聡, 他 : 超低出生体重児の脳室内出血および動脈管開存症の発症予防 (ランダム化比較試験). 日小児臨床薬理会誌 20 : 98-102, 2007

 

2) Jobe AH, et al : Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163 : 1723-1729, 2001

PubMed

3) Fujimura M, et al : Chorioamnionitis and serum IgM in Wilson-Mikity syndrome. Arch Dis Child 64 : 1379-1383, 1989

PubMed

4) Mintz-Hittner HA, Kennedy KA, Chuang AZ ; BEAT-ROP Cooperative Group : Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 364 : 603, 2011

PubMed

5) 人口動態調査 体重別にみた年次別妊娠満22週以後の死産-早期新生児死亡別周産期死亡数及び百分率

 

6) Ishii N, et al and for the Neonatal Research Network, Japan : Outcomes of infants bom at 22 and 23 weeks' gestation. Pediatrics 132 : 62-71, 2013

 

P.99 掲載の参考文献

1) Wert SE : Nomal and abnormal structural development of the lung. In Polin RA, Fox WW, Abman SH : Fetal and Neonatal Physiology, vol. 1, 4th ed, Elsevier Saunders, Philadelphia, pp864-877, 2011

 

2) Ikegami M, Jobe A, Jacobs H, et al : A protein from airways of premature lambs that inhibits surfactant function. J Appl Physiol 57 : 1134-1142, 1984

 

3) Chida S, Fajiwara T : Stable microbubble test for predicting the risk of respiratory distress syndrome. II. Prospective evaluation of the test on amniotic fluid and gastric aspirate. Eur J Pediatr 152 : 152-156, 1993

 

4) Bomsel F : Radiologic study of hyaline membrane disease. J Radiol Electrol Med Nucl 51 : 259-268, 1970

PubMed

5) 小西峯生 : 肺サーファクタント欠乏極小未熟児に対するサーファクタント予防投与の効果 : 前方視的無作為比較試験. 日小児会誌 98 : 1057-1066, 1994

 

6) Kanmaz H, et al : Surfactant administration via thin catheter during spontaneous breathing : Randomized controlled trial. Pediatr 131 : e502-509, 2013

 

7) Gopel W, et al : Avoidance of mechanical ventilation by surfactant treatment of spontaneously breathing preteum infants (AMV) : an open-label, randomized, controlled trial. Lancet 378 : 1627-1634, 2011

PubMed

8) Committee on fetus and newborn. American Academy of Pediatrics : Respiratory support in preterm infants at birth. Pediatr 133 : 171-174, 2014

 

P.102 掲載の参考文献

1) Clyman RI, Ballard PL, Sniderman S, et al : Prenatal administration of betamethasone for prevention of patent ductus arteriosus. J Pediatr 98 : 123-126, 1981

PubMed

2) 梶野浩樹, Clyman RI : 周産期における動脈管の制御. 日小児循環器会誌 18 : 364-371, 2004

 

3) Clyman RI : Mechanisms regulating closure of the ductus arteriosus. In Polin RA, Fox WW, Abman SH (eds) : Fetal and Neonatal Physiology, 4th ed, Elsevier, Amsterdam, pp821-827, 2011

 

4) Kajino H, Chen YQ, Chemtob S, et al : Tissue hypoxia inhibits prostaglandin and nitric oxide production and prevents ductus arteriosus reopening. Am J Physiol Regul Integr Comp Physiol 27 : R278-286, 2000

 

5) 横山詩子, 南沢亨 : 動脈管閉鎖の分子機構. 山岸敬幸. 白石公 (編) : 先天性心疾患を理解するための臨床心臓発生学, メジカルビュー社, 東京, pp175-179, 2007

 

6) Archer SL, Wu XC, Thebaud B, et al : O2 sensing in the human ductus arteriosus : redox-sensitive K+ channels are regulated by mitochondria-derived hydrogen peroxide. Biol Chem 385 : 205-216, 2004

PubMed

7) Kulkarni M, Gokulakrishnan G, Price J, et al : Diagnosing significant PDA using natriuretic peptides in preterm neonates : A systematic review. Pediatrics 135 : e510-525, 2015

PubMed

8) 日本未熟児新生児学会・標準化検討委員会J-PrePガイドライン作成チーム : 根拠と総意に基づく未熟児動脈管開存症治療ガイドライン, 2010年2月 http://jspn.gr.jp/pdf/PDA.pdf (2015年7月31日アクセス)

 

P.106 掲載の参考文献

1) 高嶋幸男, 伊藤雅之 : 脳室上衣下胚層の意義. 周産期医学 31 : 443-447, 2001

 

2) 周産期母子医療センターネットワークデータベース解析報告, Analysis results on infants born in 2012, I-1/16 http://plaza.umin.ac.jp/nrndata/reports/nm1_2012.pdf (2015年7月31日アクセス)

 

3) Volpe JJ : Intracranial hemorrhage : germinal matrix intraventricular hemorrhage. In Volpe JJ (ed) : Neurology ofthe Newborn, 5th ed, WB Saunders, Philadelphia, pp517-588, 2008

 

4) Lazzara A, Ahmann P, Dykes F, et al : Clinical predictability of intraventricular hemorrhage in preterm infants. Pediatrics 65 : 30-34, 1980

PubMed

5) Papile LA, Burstein J, Burstein R. et al : Incidence and evolution of subependymal and intraventricular hemorrhage : a study of infants with birth weights less than 1,500gm. J Pediatr 92 : 529-534, 1978

 

6) 平野慎也 : 早産児脳室内出血の予防. 母子保健情報 62 : 23-27, 2010

 

7) Roberts D, Dalziel S : Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 19 : CD004454, 2006

 

8) Smit E, Odd D, Whitelaw A : Postnatal phenobarbital for the prevention of intraventricular hemorrhage in preterm infants. Cochrane Database Syst Rev 13 : CD001691, 2013

 

9) Fowlie PW, Davis PG : Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 7 : CD000174, 2010

PubMed

10) Whitelaw A, Kennedy CR, Brion LP : Diuretic therapy for newborn infants with posthemorrhagic ventricular dilatation. Cochrane Database Syst Rev 23 : CD002270, 2001

 

11) 宮嶋雅一, 木村孝興, 近藤聡英, 他 : 未熟児脳室内出血-出血後水頭症の周術期管理. 脳神経外科 22 : 276-282, 2013

 

12) Vassilyadi M, Tataryn Z, Shamji MF, et al : Functional outcomes among premature infants with intraventricular hemorrhage. Pediatr Neurosurg 45 : 247-255, 2009

PubMed

13) Futagi Y, Toribe Y, Ogawa K, et al : Neurodevelopmental outcome in children with intraventricular hemorrhage. Pediatr Neurol 34 : 219-224, 2006

PubMed

14) Beaino G, Khoshnood B, Kaminski M, et al : Predictors of cerebral palsy in very preterm infants : the EPIPAGE prospective population-based cohort study. Dev Med Child Neurol 52 : e119-125, 2010

PubMed

P.113 掲載の参考文献

1) Back SA : Cerebral white and gray matter injury in newborns : new insights into pathophysiology and managelnent. Clin Perinatol 41 : 1-24, 2014

PubMed

2) Khwaja O, Volpe JJ : Pathogenesis of cerebral white matter injury of prematurity. Arch Dis Child Fetal Neonatal Ed 93 : F153-161, 2008

PubMed

3) Volpe JJ, Kinney HC, Jensen FE, et al : The developing oligodendrocyte : key cellular target in brain injury in the premature infant. Int J Dev Neurosci 29 : 423-440, 2011

PubMed

4) Volpe JJ : Neurology of the Newborn, 5th ed, WB Saunders, Philadelphia, 2008

 

5) McChlre MM, Riddle A, Manese M, et al : Cerebral blood flow heterogeneity in preterm sheep : lack of physiologic support for vascular boundary zones in fetal cerebral white matter. J Cereb Blood Flow Metab 28 : 995-1008, 2008

PubMed

6) Riddle A, Luo nl, Manese M, et al : Spatial heterogeneity in oligodendrocyte lineage maturation and not cerebral blood flow predicts fetal ovine periventricular white matter injury. J Neurosci 26 : 3045-3055, 2006

 

7) Kitanishi R, Matsuda T, Watanabe S, et al : Cerebral ischemia or intrauterine inflammation promotes differentiation of oligodendroglial precursors in preterm ovine fetuses : possible cellular basis for white matter injury. Tohoku J Experiment Med 234 : 299-307, 2014

PubMed

8) Kwon SH, Vasung L, Ment LR, et al : The role of neuroimaging in predicting neurodevelopmental outcomes of preterm neonates. Clin Perinatol 41 : 257-283, 2014

PubMed

9) Okumura A, Hayakawa F, Kato T, et al : Abnormal sharp transients on electroencephalograms in preterm infants with periventricular leukomalacia. J Pediatr 143 : 26-30, 2003

PubMed

P.116 掲載の参考文献

1) Hannam S : Apnoea and bradycardia. In Rennie JM (ed) : Rennie and Roberton's Textbook of Neonatology, 5th ed, Churchill Livingstone, London, pp571-579, 2012

 

2) Gauda EB, Martin RJ : Control of breathing. In Gleason CA, Devaskar SU (eds) : Avery's Disease of the Newbom, 9th ed, Elsevier Saunders, Philadelphia, pp584-597, 2012

 

3) Martin RJ, Abu-Shaweesh JM, Baird TM : Patho physiologic mechanisms underlying apnea of prematurity. NeoReviews 3 : e59-65, 2002

 

4) Mesner O, Di Fiore JM, Martin RJ : Neonatal respiratory control and apnae of prematurity. In Bancalari E, Polin RA (eds) : The Newborn Lung, Elsevier Saunders, Philadelphia, pp449-460, 2008

 

5) 山崎俊夫 : 低出生体重児の無呼吸発作に対するドキサプラムの効果. 周産期医学 43 : 603-610, 2013

Medical*Online

6) Schmidt B, Roberts RS, Davis P, et al : Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 357 : 1893-1902, 2007

PubMed

P.123 掲載の参考文献

1) 南宏尚 : : 第6章 新生児慢性肺疾患の全国調査結果. 藤村正哲 (監) : 科学的根拠に基づいた新生児慢性肺疾患の診療指針, 改定2版, メデイカ出版, 大阪, pp110-127, 2010

 

2) Shaw GM, O'Brodovich HM : Progress in understanding the genetics of bronchopulmonary dysplasia. Semin Perinatol 37 : 85-93, 2013

PubMed

3) Gien J, Kinsella JP : Pathogenesis and treatment of bronchopulmonary dysplasia. Curr Opin Pediatr 23 : 305-313, 2011

PubMed

4) Northway WH Jr, Rosan RC, Porter DY : Pulmonary disease following respiratory therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med 276 : 357-368, 1967

PubMed

5) Bhandari V : The potential of non-invasive ventilation to decrease BPD. Semin Perinatol 37 : 108-114, 2013

PubMed

6) O'Reilly M, Thebaud B : The promise of stem cells in bronchopulmonary dysplasia. Semin Perinatol 37 : 79-84, 2013

PubMed

7) Fung ME, Thebaud B : Stem cell-based therapy for neonatal lung disease : it is in the juice. Pediatr Res 75 : 2-7, 2014

PubMed

8) Bhandari A, McGrath-Morrow S : Long-term pulmonary outcomes of patients with bronchopulmonary dysplasia. Semin Perinatol 37 : 132-137, 2013

PubMed

9) El Mazloum D, Moschino L, Bozzetto S, et al : Chronic lung disease of prematurity : long-term respiratory outcome. Neonatology 105 : 352-356, 2014

PubMed

10) Bates ML, Pillers DA, Palta M, et al : Ventilatory control in infants, children, and adults with bronchopulmonary dysplasia. Respir Physiol Neurobiol 189 : 329-337, 2013

PubMed

P.127 掲載の参考文献

1) 水野恵介 : 新生児に対するエリスロポエチン療法の効果と安全性. Neonatal Care 23 : 1236-1240, 2010

Medical*Online

2) Juul S : Erythropoiesis and the approach to anemia in premature infants. J Matern Fetal Neonatal Med 25 (Suppl 5) : 97-99, 2012

 

3) Kling PJ, Schmidt RL, Roberts RA, et al : Serum erythropoietin levels during infancy : associations with eryt. hropoiesis. J Pediatr 128 : 791-796, 1996

 

4) Lorenz L, Peter A, Poets CE et al : A review of cord blood concentrations of iron status parameters to define reference ranges for preterm infants. Neonatology 104 : 194-202, 2013

 

5) Neonatal Research Network : 超早産児の赤血球輸血回避に対する臍帯のミルキングの多施設ランダム化比較試験 https://nrn.shiga-med.ac.jp/milking/ (2015年8月4日アクセス)

 

6) 細野茂春 : 臍帯血ミルキング. 周産期医学 42 : 581-584, 2012

Medical*Online

7) 楠田聡, 松波聡子, 川口千春, 他 : 早産児に対する鉄剤投与のガイドライン (総説). 周産期医学 36 : 767-778, 2006

 

8) 厚生労働省医薬食品局血液対策課 : 血液製剤の使用指針 (改定版). 平成17年9月 http://www.mhlw.go.jp/new-info/kobetu/iyaku/kenketsugo/5tekisei3b.html (2015年8月4日アクセス)

 

9) Juul S : Erythropoietin in anemia of prematurity. J Matern Fetal Neonatal Med 25 (Suppl 5) : 80-84, 2012

 

10) Aher SM, Ohlsson A : Early versus late erythropoietin for preventing red blood cell transfusion in pretermand/orlowbirthweight infants. Cochrane Database Syst Rev 10 : CD004865, 2012

 

11) Whyte RK, Kirpalani H, Elizabeth V, et al : for PINTOS study group : Neurodevelomental outcome of extremely low birth weight infants randomly assigned to restrictive or liberal hemoglobin thresholds for blood transfusion. Pediatrics 123 : 207-213, 2009

PubMed

P.130 掲載の参考文献

1) Hartnett ME : Pathophysiology and mechanisms of severe retinopathy of prematurity. Ophthalmology 122 : 200-210, 2015

PubMed

2) Hellstrom A, Smith LEH, Dammann O : Retinopathy of prematurity. Lancet 382 : 1445-1447, 2013

PubMed

3) Budd S, Byfield G, Martiniuk D, et al : Reduction in endothelial tip cell filopodia corresponds to reduced intravitreous but not intraretinal vascularization in a model of ROP. Exp Eye Res 89 : 718-727, 2009

PubMed

4) Holmes JM, Duffner LA : The effect of postnatal growth retardation on abnormal neovascularization in the oxygen exposed neonatal rat. Curr Eye Res 15 : 403-409, 1996

PubMed

5) The Committee for Classification of Retinopathy of Prematurity : An interntational classification of retinopathy of prematurity revisited. Arch Opthalmol 123 : 991-999, 2005

 

6) Carlo WA, Finer NN, Walsh MC, et al : Target ranges of oxygen saturation in eXtremely preterm infants. N Engl J Med 362 : 1959-1969, 2010

PubMed

7) Azuma N, Ishikawa K, Hama Y, at al : Early vitreous surgery for aggressive posterior retinopathy of prematurity. Am J Opthalmol 142 : 636-643, 2006

 

8) 日下俊次 : 抗VEGF治療の適応と実際. 眼科グラフィック 3 : 39-43, 2014

Medical*Online

9) 平岡美依奈, 渡辺とよ子, 川上義, 他 : 超低出生体重児における未熟児網膜症 : 東京都多施設研究. 日眼会誌 108 : 600-605, 2004

 

10) 古川理子, 杉本早紀, 初川嘉一, 他 : 超未熟児の学齢期における視力予後. 大阪母子保健総合医療セ誌 12 : 35-40, 1996

 

・ 日本小児眼科学会 : 一般の皆様へ, 未熟児網膜症. http://wwwjapo-web,jp/info_ippan_page.php?id=page14

 

・ National Eye Institute : Retinopathy of Prematurity https://www.nei. nih.gov/health/rop/

 

P.135 掲載の参考文献

1) Schatz F : Eine besondere Art von einseitiger Polyhydramnie mit anderseitiger Oligohydramnie bei eineiigen Zwillingen. Archiv fur Gynakologie 19 : 329-369, 1882

 

2) Benirschke K, Kim CK : Multiple pregnancy. N Engl J Med 288 : 1276-1284, 1329-1336, 1973

 

3) Chescheir NC, Seeds JW : Polyhydramnios and oligohydramnios in twin gestations. Obstet Gynecol 71 : 882-884, 1988

PubMed

4) Simpson LL : Twin-twin transfusion syndrome. Am J Obstet Gynecol 208 : 3-18, 2013

PubMed

5) Quintero RA, Morales WJ, Allen MH, et al : Staging of twill-twill transfusion syndrome. J Perinatol 19 : 550-555, 1999

 

6) Mahieu-Caputo D, Meulemans A, Martinovic J, et al : Paradoxic activation of the renin-angiotensin system in twin-twin transfusion syndrome : an explanation for cardiovascular disturbances in the recipient. Pediatr Res 58 : 685-688, 2005

PubMed

7) Bajoria R, Ward S, ChatteIjee R : Natriuretic peptides in the pathogenesis of cardiac dysfunction in the recipient fetus of twin-twin transfusion syndrome. Am J Obstet Gynecol 186 : 121-127, 2002

PubMed

8) Luks FI, Carr SR, De Paepe ME, et al : What--and why--the pediatric surgeon should know about twin-to-twin transfusion syndrome. J Pediatr Surg 40 : 1063-1069, 2005

PubMed

9) 豊島勝昭 : 多胎児の新生児合併症とその管理-TTTS-出生直後の循環管理を中心に. 周産期医学 40 : 351-356, 2010

Medical*Online

10) Bahtiyar MO, Dulay AT, Weeks BP, et al : Prevalence of congenital heart defects in monochorionic/diamniotic twin gestations : a systematic literature review. J Ultrasound Med 26 : 1491-1498, 2007

PubMed

11) Dickinson JE, Evans SF : Obstetric and perinatal outcomes from the Australian and New Zealand twin-twin transfusion syndrome registry. Am J Obstet Gynecol 182 : 706-712, 2000

PubMed

12) Mari G, Roberts A, Detti L, et al : Perinatal morbidity and mortality rates in severe twin-twin transfusion syndrome : results of the International Amnioreduction Registry. Am J Obstet Gynecol 185 : 708-715, 2001

PubMed

13) Roberts D, Neilson JP, Kilby MD, et al : Interventions for the treatment of twin-twin transfusion syndrome. Cochrane Database Syst Rev 1 : CD002073, 2014

PubMed

14) Sago H, Hayashi S, Saito M, et al : The outcome and prognostic factors of twin-twin transfusion syndrome following fetoscopic laser surgery. Prenat Diagn 30 : 1185-1191, 2010

PubMed

15) Salomon LJ, Ortqvist L, Aegerter P, et al : Long-term developmental follow-up of infants who participated in a randomized clinical trial of amniocentesis vs laser photocoagulation for the treatment of twin-to-twin transfusion syndrome. Am J Obstet Gynecol 203 : 444, e 1-7, 2010

 

・ 日本胎児治療グループ (Japan Fetal Therapy Group) http://fetusjapan.jp/ (2015年8月4日アクセス)

 

P.139 掲載の参考文献

1) Schimmel MS, Bromiker R, Soll RF : Neonatal polycythemia : is partial exchange transfusion justified? Clin Perinatology 31 : 545-553, 2004

 

2) Sarkar S, Rosenkrantz TS : Neonatal polycythelnia and hyperviscosity. Semin Fetal Neonatal Med 13 : 248-255, 2008

PubMed

3) Gomella T, Cunningham M : Polycythemia and Hyperviscosity. In Neonatology, 7th ed, McGraw-Hill, pp826-830, 2013

 

4) OReilly D : Polycythemia. In Cloherty JP, Eichenwald EC, Hansen AR, et al (eds) : Manual of Neonatal Care, 7th ed, Lippincott, Philadelphia, pp572-577, 2012

 

5) Matthews DC, Glader B : Erythrocyte Disorders in Infancy. In Gleason, CA, Devaskar SU (eds) : Avery's Diseases of the Newborn, 9th ed, Saunders, Philadelphia, pp 1103-1105, 2012

 

6) Rosenkrantz TS : Polycythemia and hyperviscosity in the newborn. Semin Thrombosis Hemostasis 29 : 515-527, 2003

 

7) 大城誠 : 多血症. 周産期医学 41 (増刊) : 527-529, 2011

 

8) 仁志田博司 : 新生児学入門, 4版, 医学書院, 東京, pp320-321, 2012

 

9) 新生児医療連絡会 (編) : NICUマニュアル, 5版, 金原出版, 東京, pp332-335, 2014

 

10) Ozek E, Soll R, Schimmel MS : Partial exchange transfusion to prevent neurodevelopmental disability in infants with polycythemia. Cochrane Database Syst Rev 2010 Jan 20 ; (1) : CD005089. doi : 10.1002/14651858. CD005089. pub2

 

P.145 掲載の参考文献

1) Kondo M, Itoh S, Kusaka T, et al : The ability of neonatal and maternal erythrocytes to produce reactive oxygen species in response to oxidative stress. Early Hum Dev 66 : 81-88, 2002

PubMed

2) 伊藤進, 松永智幸, 原孝子, 他 : 新生児の結晶ビリルビン値と臍帯結紮時期との関係について. 周産期医学 8 : 974-978, 1978

 

3) Kawade N, Onishi S : The prenatal and postnatal development of UDP-glucuronyltransferase activity towards bilirubin and the effect of premature birth on this activity in the human liver. Biochem J 196 : 257-260, 1981

PubMed

4) Shier RW, Dilts PV, Conger WL, et al : Bilirubin transfer across the human placenta. Am J Obstet Gynecol 111 : 677-680, 1971

PubMed

5) Gartner LM, Lee KS, Moscioni AD : Effect of milk feeding on intestinal bilirubin absorption in the rat. J Pediatr 103 : 464-471, 1983

 

6) Van Praagh R : Diagnosis of kernicterus in the neonatal period. Pediatrics 28 : 870-876, 1961

PubMed

7) 大西鐘壽, 清水国樹, 山川毅 : 未熟核黄疸の特徴とその予防法としての光療法. 小児科臨床 22 : 138-150, 1969

 

8) Kuboi T, Kusaka T, Kawada K, et al : Hour-specific nomogram for transcutaneous bilirubin in Japanese neonate. Pediatr Int 55 : 608-611, 2013

PubMed

9) 今井正, 大西鐘壽 : 血清ビリルビン濃度測定の精度管理. 周産期医学 21 : 685-688, 1991

 

10) Nakamura H, Lee Y : Microdetermination of unbound bilirubin in icteric newborn sera : an enzymatic method employing peroxidase and glucose oxidase. Clin Chim Acta 79 : 411-417, 1977

 

11) Sugino M, Okada H, Kusaka T, et al : Evaluation of bilirubin displacement effect by acetaminophen in Vitro. Ann Clin Biochem 52 (Pt. 4) : 476-480, 2015

 

12) Itoh S, Kawada K, Kusaka T, et al : Influence of glucuronosyl bilirubin and (EZ) -cyclobilirubin on determination of serum unbound bilirubin by UB-analyser. Ann Clin Biochem 39 : 583-588, 2002

PubMed

13) Kimura S, Iyama S, Yamaguchi Y, et al : Enzymatic assay for coajugated bilirubin (BC) in serum using bilirubin oxidase (BOD). J Clin Lab Anal 13 : 219-223, 1999

 

14) 伊藤進, 住谷朋人, 杉原聡, 他 : Bilirubin Oxidase法の直接ビリルビン測定へのビリルビン. 異性体の影響. 日小児会誌 97 : 687-691, 1993

 

15) Nakamura H, Takada S, Shimabuku R, et al : Auditory nerve and brainstem responses in newborn infants with hyperbilirubinemia. Pediatrics 75 : 703-708, 1985

PubMed

16) Yokochi K : Magnetic resonance imaging in children with kernicterus. Acta Pediatr 84 : 937-939, 1995

 

17) Koskun A, Yikilamaz A, Karahan OI, et al : Hyperintense globus pallidus on T1-weighted MR imaging in acute kernicterus : is it common or rare? Eur Radiol 15 : 1263-1267, 2005

PubMed

18) Okumura A, Hayakawa F, Maruyama K, et al : Single photon emission computed tomography and serial MRI in preterm infants with kernicterus. Brain Dev 28 : 348-352, 2006

PubMed

19) 川瀬康浩 : 新生児高ビリルビン血症. 山口徹, 北原光夫, 福井次矢 (編) : 今日の治療指針 2006年, 医学書院, 東京, pp941-942, 2006

 

20) 神戸大学医学部小児科 (編) : 高ビリルビン血症の管理. 新版. 未熟児新生児の管理, 日本小児医事出版, 東京, pp225-240, 2000

 

21) 原寿郎, 水野由美, 石井栄一, 他 : 新生児溶血性疾患に対するγ-グロブリン療法. 日血液学会誌 50 (抄録) : 452, 1987

 

22) Onishi S, Miura I, Isobe K, et al : Structure and thermal interconversion of cyclobilirubin IXα. Biochem J 218 : 667-676, 1984

 

23) Onishi S, Isobe K, Itoh S, et al : Mechanism of bilirubin and its photoisomers in newborn infants during phototherapy. J Biochem 100 : 789-795, 1986

 

24) Itoh S, Onishi S, Isobe K, et al : Wavelength dependence of the geometric and structural photoisomerization of bilirubin bound to human serum albumin. Biol Neonate 51 : 10-17, 1987

PubMed

25) Kuboi T, Kusaka T, Yasuda S, et al : Management of phototherapy for neonatal hyperbilirubinemia : is a new radiometer application for all wavelengths and light source types? Pediatr Int 53 : 689-693, 2011

 

26) 久保井徹, 日下隆, 岡崎薫, 他 : グリーンLEDによる光療法のin vivoにおける有効性についての検討. 日新生児成育会誌 27 : 280-286, 2015

 

27) Onishi S, Itoh S, Isobe K, et al : Mechanism of development of bronze baby syndrome in neonates treated with phototherapy. Pediatrics 69 : 273-276, 1982

PubMed

28) Cohen AN, Ostrow JD : New concepts in phototherapy : photoisomerization of bilirubin IX alpha and potential toxic effects of light. Pediatrics 65 : 740-750, 1980

PubMed

29) 日本未熟児新生児学会薬事委員会 : 新生児の輸血問題小委員会からの提言, 新生児輸血に用いる院内採血した血液の適正な製造体制・順守基準 http://plaza.umin.ac.jp/~jspn/innaisaiketsu.pdf (2015年8月5日アクセス)

 

30) Cortey A, Elzaabi M, Waegemans T, et al : Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibiliry : a mata-analysis. Arch Pediatr 21 : 976-983, 2014

 

31) Louis D, More K, Oberoi S, et al : Intravenous immunoglobulin in isoimmune haemolytic disease of newborn : an updated systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 99 : F325-331, 2014

PubMed

32) Maruo Y, Nishizawa K, Sato H, et al : Association of neonatal hyperbilirubinemia with bilirubin UDP-glucuronosylt, ransferase polymorphism. Pediatrics 103 : 1224-1227, 1999

 

33) Maruo Y, Nishizawa K, Sato H, et al : Prolonged unconjugated hyperbilirubinemia associated with breast milk and mutations of the bilirubin uridine diphosphate-glucuronosyltransferase gene. Pediatrice 106 : E59, 2000

 

P.150 掲載の参考文献

1) Kelly A, Stanley CA : Pediatric Endocrinology and Inborn Errors of Metabolism, Hyperinsulium, McGraw-Hill, USA, p39, 2009

 

2) Rozance PJ, Hav WW Jr : Describing hypoglycemia-definition or operational threshold? Early Him Dev 86 : 275-280, 2010

 

3) Srinivasan G, Pildes RS, Cattamanchi G, et al : Plasma glucose values in normal neonates : A new look. J Pediatr 109 : 114-117, 1986

 

4) Moore ER, Anderson GC, Bergman N, et al : Early skin-to-skin contact formothers and their healthy newborn infant. Cochrane Database Syst Rev 16 : CD003519, 2012

 

5) Harris DL, Weston PJ, Harding JE : Incidence of neonatal hypoglycemia in babies identified as at risk. J Pediatr 161 : 787-791, 2014

 

6) 河井昌彦 : 新生児低血糖症. 小児内科 41 (増刊) : 176-179, 2009

 

7) Adamkin DH, Committee on Fetus and Newborn : Clinical report-Postnatal glucose homeostasis in late-preterm and term infants. Pediatrics 127 : 575-579, 2011

 

8) Yorifuji T, Kawakita R, Nagai S, et al : Molecular and clinical analysis of Japanese patients with persistent congenital hyperinsulinism : Predominance of paternally inherited monoallelic mutations in the KATP channel genes. J Clin Endocrinol Metab 96 : E141-145, 2011

 

9) 河井昌彦 : 血糖管理-低血糖へのアプローチ. 同産期医学 44 : 475-478, 2014

 

10) Wright N, Marinelli KA, the academy of breastfeeding medicine : ABM Clinical Protocol #1 : Guidelines for Blood Glucose Monitoring and Treatment of Hypoglycemia in Term and Late-Preterm Neonates, Reviced 2014. Breastfeeding Medicine 9 : 173-179, 2014

 

P.154 掲載の参考文献

1) Cordero L, Treuer SH, Landon MB, et al : Management of infants of diabetic mothers. Arch Pediatr Adolesc Med 152 : 249-254, 1998

PubMed

2) Demarini S, Mimouni E Tsang RC, et al : Impact of metabolic control of diabetes during pregnancy on neonatal hypocalcemia : a randomized study. Obstet Gynecol 83 : 918-922, 1994

 

3) Jain A, Aggarwal R, Jeeva Sankar M, et al : Hypoglycemia in the newborn. Indian J Pediatr 77 : 1137-1142, 2010

PubMed

4) Jain BK, Singh H, Singh D, et al : Phototherapy induced hypocalcemia. Indian Pediatr 35 : 566-567, 1998

PubMed

5) Oberleithner H, Greger R, Lang F : The effect of respiratory and metabolic acid-base changes on ionized calcium concentration : in vivo and in vitro experiments in man and rat. Eur J Clin Invest 12 : 451-455, 1982

PubMed

6) Nekvasil R, Stejskal J, Tuma A : Detection of early onset neonatal hypocalcaemia in low birth weight infants by Q-Tc and Q-oTc interval measurement. Acta Paediatr Acad Sci Hung 21 : 203-210, 1980

PubMed

P.157 掲載の参考文献

1) 仁志田博司 : カルシウムとリンのバランス-水-電解質バランス. 新生児学入門, 4版, 医学書院, 東京, pp195-201. 2012

 

2) 塚原宏一 : 未熟児骨減少症-最近の臨床治験. 小児科診療 62 : 905-910, 1999

 

3) 塚原宏一 : カルシウム代謝・骨代謝-電解質・カルシウム代謝. 河井昌彦, 楠田聡 (編) : 新生児内分泌ハンドブック. メディカ出版, 大阪, pp126-139, 2008

 

4) 仁志田博司. 楠田聡 : 経腸栄養の確立-栄養管理. 超低出生体重児新しい管理指針, 改訂3版, メジカルビュー社, 東京, pp 152-155, 2006

 

5) Moyer-Mileur, et al : Maternal-administered physical activity enhances bone mineral acquisition in premature very low birth weight infants. J Perinatol 28 : 432-437, 2008

PubMed

6) Lewis PR : Osteopathy of prematurity : disorders of calcium and phosphorus metabolism. In Gleason CA, Juul SE : Avery's Diseases of the Newborn, 9th ed, Saunders, pp 1270-1272, 2011

 

P.162 掲載の参考文献

1) Nizet V, Klein J : Bacterial sepsis and meningitis. In Wilson CB, Nizet V, Remington J, et al (eds) : Infectious Diseases of Fetus and Newborn Infant, 7th ed, Elsevir, Philadelphia, pp 222-275, 2011

 

2) Stoll BJ, Hansen NI, Sanchez PJ, et al : Early onset neonatal sepsis : The burden of group b streptococcal and E. coli disease continues. Pediatrics 127 : 817-826, 2011

 

3) 松原康策 : 早発型・遅発型b群溶連菌感染症の特徴と垂直感染予防方法の考察. 日小児会誌 114 : 1681-1691, 2011

 

4) Hornik CP, Fort P, Clark RH, et al : Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units. Early Hum Dev 88 (Suppl 2) : S69-74, 2012

 

5) 塩見正司 : エンテロウイルスとパレコウイルス. 周産期医学 44 (増刊) : 461-469, 2014

 

6) 高橋尚人 : 新生児感染症とサイトカイン. 周産期医学 44 (増刊) : 301-306, 2014

 

7) Fanaroff AA, Korones SB, Wright LL, et al : Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The national institute of child health and human development neonatal research network. Pediatr Infect Dis J 17 : 593-598, 1998

 

8) Su H, Chang SS, Han CM, et al : Inflammatory markers in cord blood or matemal serum for early detection of neonatal sepsis-a systemic review and meta-analysis. J Perinatol 34 : 268-274, 2014

PubMed

9) Stoll BJ, Hansen NI, Adams-Chapman I, et al : Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 292 : 2357-2365, 2004

PubMed

10) Kono Y, Mishina J, Yonemoto N, et al, NICU Network Jp : Neonatal correlates of adverse out-comes in very low-birthweight infants in the nicu network. Pediatr Int 53 : 930-935, 2011

 

P.171 掲載の参考文献

1) 川口千晴, 高橋幸博 : 新生児出血性疾患. 小児内科 41 (増刊) : 194-198, 2009

 

2) 東海林宏道 : 自己免疫疾患の母体から出生した児. 周産期医学 41 (増刊) : 516-518, 2011

 

3) 財団法人エイズ予防財団血液凝固異常症全国調査運営委員会 : 厚生労働省委託事業 血液凝固異常症全国調査 平成26年度報告書. 財団法人エイズ予防財団. p3, 2010

 

4) 松下正, 天野景裕. 瀧正志, 他 :日本血栓止血学会学術標準化委員会血友病部会 : インヒビターのない血友病患者の急性出血. 処置・手術における凝固因子補充療法のガイドライン. 日血栓止血会誌 19 : 510-519, 2008

 

5) 白幡聡, 伊藤進, 高橋幸博, 他 : 乳児ビタミンK欠乏性出血症全国調査成績 (1999-2004). 日産婦人科・新生児血液会誌 16 : S55-56, 2006

 

6) 白幡聡, 伊藤進, 高橋幸博, 他 : 新生児・乳児ビタミンK欠乏性出血症に対するビタミンK製剤投与の改訂ガイドライン (修正版). 日小児会誌 115 : 705-712, 2011

 

7) Shirahata A, Shirakawa Y, Murakami C : Diagnosis of DIC in very low birth weight infants. Semin Thromb Hemost 24 : 467-471, 1998

PubMed

8) 河井昌彦, 水本洋, 丹羽房子, 他 : 早期新生児期のDIC診断基準作成の試み. 日周産期・新生児会誌 43 : 10-14, 2007

 

9) 白幡聡 : 新生児DICガイドライン. Thromb Med 4 : 173-177, 2014

Medical*Online

10) 高橋大二郎 : 播種性血管内凝固症候群 (DIC). 小児内科 46 : 191-197, 2014

Medical*Online

P.176 掲載の参考文献

1) 日本小児外科学会学術・先進医療検討委員会 : 超低出生体重児における消化管穿孔の実態調査. 日小児外会誌 46 : 791-796, 2010

 

2) 日本小児外科学会学術・先進医療検討委員会 : わが国の新生児外科の現況-2003年新生児外科全国集計. 日小児外会誌 40 : 919-934, 2004

 

3) 窪田昭男 : 超低出生体重児の消化管穿孔の病因と病態. 日周産期・新生児会誌 48 : 831-834, 2013

 

4) Akihoro T, et al : Immaturity of the myentric plexus is the aetiology of meconium ileus without mucoviscidosis : a hitopathologic study. Clin Autonom Res 4 : 175-184, 1994

 

5) 向井基, 茨聡 : 新生児壊死性腸炎-病態と診断. 予防. 周産期医学 37 : 1443-1446, 2007

Medical*Online

6) Lin HC, Su BH, Chen AC, et al : Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 115 : 1-4, 2005

PubMed

7) Farrugia MK, Morgan AS, BcHugh K, et al : Neonatal gastrointestinal perforation. Arch Dis Child Fetal Neonatal Ed 88 : F75, 2003

 

8) 川嶋寛, 岩中督 : 壊死性腸炎/限局性消化管穿孔. 周産期医学 37 : 592-595. 2007

 

9) Gura KM, et al : Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver diseases. Pediatrics 121 : 678-686, 2008

 

10) Masumoto K : Cow's milk allergy in extremely short bowel syndrome : Report of two infants. Eur J Clin Nutr 3 : 217-219, 2008

 

11) 設楽佳彦, 土田晋也 : 新生児の壊死性腸炎. 小児科 56 : 3-8, 2015

 

12) Murase M, Miyazawa T, Taki M, et al : Development of fatty acid calcium stone ileus after initiation of human milk fortifier. Pediatr Int 55 : 114-116, 2013

PubMed

13) 奥山宏臣, 窪田昭男, 他 : 消化管穿孔を合併した極低出生体重児の長期予後. 日周産期・新生児会誌 42 : 779-782, 2006

 

P.181 掲載の参考文献

1) 川名尚 : 母子感染. 日本臨牀 61 (増刊 3) : 297-302, 2003

 

2) 岩澤堅太郎, 藤澤知雄 : B型肝炎ウイルス. 周産期医学 44 (増刊) : 447-451, 2014

 

3) 森内浩幸 : 先天性サイトメガロウイルス感染症. 周産期医学 44 (増刊) : 418-423, 2014

 

4) 出口雅士, 山田秀人 : 妊婦のサイトメガロウイルス感染症. 周産期医学 44 (増刊) : 158-163, 2014

 

5) 厚生労働科学研究 母子感染の実態把握及び検査・治療に関する研究班 : サイトメガロウイルス妊娠管理マニュアル. 日産婦誌 66 : 1-15, 2014

 

6) Koyano S, Inoue N, Oka A, et al : Screening for congenital cytomegalovirus infection using newborn urine samples collected on filter paper : feasibility and outcomes from a multicentre study. BMJ Open 1 : e000118, 2011

PubMed

7) Yamada H, Tairaku S, Morioka I, et al : Nationwide survey of mother-to-child infections in Japan. J Infect Chemother 21 : 161-164, 2015

PubMed

8) Morioka I, Sonoyama A, Tairaku S, et al : Awareness of and knowledge about mother-to-child infections in Japanese pregnant women. Congenit Anom 54 : 35-40, 2014

PubMed

9) Kobayashi Y, Morioka I, Koda T, et al : Low total IgM values and high cytomegalovirus loads in the blood of newborns with symptomatic congenital cytomegalovirus infection. J Perinat Med 43 : 239-243, 2015

PubMed

10) Kimberlin DW, Acosta EP, Sanchez PJ, et al : Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system : a randomized, controlled trial. J Pediatr 143 : 16-25, 2003

 

11) 森内浩幸 : 先天性CMV感染治療プロトコール. 小児感染免疫 22 : 385-389, 2010

 

12) Kimberlin DW, Jester PM, Sanchez PJ, et al : Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med 372 : 933-943, 2015

PubMed

・ 国立感染症研究所 : 母子感染 http://www.nih.go.jp/niid/ja/route/matemal.html (2015年8月5日アクセス)

 

・ 先天性サイトメガロウイルス感染症対策のための妊婦教育の効果の検討, 妊婦・新生児スクリーニング体制の構築及び感染新生児の発症リスク同定に関する研究 http://www.med.kobe-u.ac,jp/cmv/ (2015年8月5日アクセス)

 

III. 染色体異常, 先天異常

P.189 掲載の参考文献

1) 山本俊至 : 臨床遺伝に関わる人のためのマイクロアレイ染色体検査, 診断と治療社, 東京, 2012

 

2) Miller DT, Adam MP, Aradhya S, et al : Consensus statement : chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 86 : 749-764, 2010

PubMed

3) Okamoto N, Akimaru N, Matsuda K, et al : Cooccurrence of Prader-Willi and Sotos syndromes. Am J Med Genet A 152A : 2103-2109, 2010

PubMed

4) Malan V, Rajan D, Thomas S, et al : Distinct effects of allelic NFIX mutations on nonsense-mediated mRNA decay engender either a Sotos-like or a Marshall-Smith syndrome. Am J Hum Genet 87 : 189-198, 2010

PubMed

5) Shimojima K, Okamoto N, Tamasaki A, et al : An association of 19p13.2 microdeletions with Malan syndrome and Chiari malformation. Am J Med Genet A 167A : 724-730, 2015

PubMed

6) Poot M, Hochstenbach R : A three-step workflow procedure for the interpretation of array-based comparative genome hybridization results in patients with idiopathic mental retardation and congenital anomalies. Genet Med 12 : 478-485, 2010

PubMed

P.194 掲載の参考文献

1) Vega Genome Browser : Chromosome 21 : 1-46, 709, 983 http://vega.sanger.ac.uk/Homo_sapiens/Location/Chromosome?chr=21;r=21:1-46709983 (2015年8月6日アクセス)

 

2) 梶井正 : わが国の高齢出産とDown症候群増加傾向の分析. 日小児会誌 111 : 1426-1428, 2007

 

3) Vidal-Taboada JM, Sanz S, Egeo A, et al : Identification and characterization of a new gene from human chromosome 21 between markers D21S343 and D21S268 encoding a leucine-rich protein. Biochem Biophys Res Commun 250 : 547-554, 1998

PubMed

4) Hitzler JK, Cheung J, Ji Y, et al : GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome. Blood 101 : 4301-4304, 2003

 

5) Zigman WB : Atypical aging in Down syndrome. Dev Disabil Res Rev 18 : 51-67, 2013.

PubMed

6) Das D, Phillips C, Hsieh W, et al : Neurotransmitter-based strategies for the treatment of cognitive dysfunction in Down syndrome. Prog Neuropsychopharmacol Biol Psychiatry 54 : 140-148, 2014.

PubMed

7) 「ダウン症候群における社会性に関連する能力の退行様症状」の診断の手引き http://plaza.umin.ac.jp/p-genet/downloads/Down_synd_guideline.pdf (2015年8月6日アクセス)

 

8) Kitamura A, Kondoh T, Noguchi M, et al : Assessment of lower urinary tract function in children with Down syndrome. Pediatr Int 56 : 902-908, 2014.

PubMed

9) ダウン症候群児の健康管理 http://www.aichi-colonyjp/library/dsguideline.htm (2015年8月6日アクセス).

 

10) 水野誠司 : 成人期のダウン症者の健康管理 http://www.aichi-colony.jp/library/adult-dsguideline.pdf (2015年8月6日アクセス)

 

P.198 掲載の参考文献

1) 緒方勤 : ターナー症候群の遺伝学, メディカルレビュー社, 東京, 2003

 

2) Ogata T, Matsuo N : Turner syndrome and female sex chromosome aberrations : deduction of the principal factors involved in the development of clinical features. Hum Genet 95 : 607-629, 1995

PubMed

3) Kosho T, Muroya K, Nagai T, et al : Skeletal features and growth patterns in 14 patients with haploinsufficiency of SHOX : implications for the development of Turner syndrome. J Clin Endocrinol Metab 84 : 4613-4621, 1999

PubMed

4) Gonzalez L, Witchel SF : The patient with Turner syndrome : puberty and medical management concerns. Fertil Steril 98 : 780-786, 2012

PubMed

5) Davenport ML : Approach to the patient with Turner syndrome. J Clin Endocrinol Metab 95 : 1487-1495, 2010

 

6) Tfurtle EJ, Sule AA, Webb DJ, et al : Aortic dissection in children and adolescents with Tumer syndrome : risk factors and management recommendations. Arch Dis Child 100 : 662-666, 2015

 

7) Ranke MB, Lindberg A : Observed and predicted total pubertal growth during treatment with growth hormone in adolescents with idiopathic growth hormone deficiency, Turner syndrome, short stature, born small for gestational age and idiopathic short stature : KIGS analysis and review. Horm Res Paediatr 75 : 423-432, 2011

PubMed

P.202 掲載の参考文献

1) Bojesen A, Juul S, Gravholt CH, et al : Prenatal and postnatal prevalence of Klinefelter syndrome : A national registry study. J Clin Endocrinol Metab 88 : 622-626, 2003

 

2) Van Assche E, Bonduelle M, Tournaye H, et al : Cytogenetics of infertile men. Hum Reprod 11 : 1-24, 1996

PubMed

3) Lanfranco F, Kamischke A, Zitzmann M, et al : Klinefelter's syndrome. Lancet 365 : 273-283, 2004

 

4) Groth KA. , Skakkebeek A, Hφst C, et al : Clinical review : Klinefelter syndrome. J Clin Endocrinol Metab 98 : 20-20, 2013

 

5) Ottesen AM, Aksglaede L, Garn I, et al : Increased number of sex chromosomes affects height in a nonlinear fashion : a study of 305 patients with sex chromosome aneuploidy. Am J Med Genet A 152A : 1206-1212, 2010

 

6) Aksglaede L, Link K, Giwercman A, et al : 47, XYY Klinefelter syndrome : clinical characteristics and age-specific recominendations for medical man-agement. Am J Med Genet C Semin Med Genet 163C : 55-63, 2013

 

7) Hasle H, Mellemgaard A, Nielsen J, et al : Cancer incidence in men with Klinefelter syndrome. Br J Cancer 71 : 416-420, 1995

PubMed

8) Bojesen A, Juul S, Birkebaek N, et al : Increased mortality in Klinefelter syndrome. J Clin Endocrinol Metab 89 : 3830-3834, 2004

PubMed

9) Swerdlow AJ, Higgins CD, Schoemaker MJ, et al : Mortality in patients with Minefelter syndrome in Britain : a cohort study. J Clin Endocrinol Metab 90 : 6516-6522, 2005

 

10) Ramasamy R, Ricci JA, Palermo GD, et al : Successful fertility treatment for Klinefelter's syndrome. J Urol 182 : 1108-1113, 2009

PubMed

・ 難病情報センター : 難治性疾患研究班情報 (研究奨励分野), クラインフェルター症候群 (KS) (平成21年度) http://www.nanbyou.or.jp/entry/639 (2015年8月10日アクセス)

 

P.206 掲載の参考文献

1) 福嶋義光 : ゲノムコピー数異常を伴う先天奇形症候群 (ウォルフヒルシュホーン症候群を含む) の診断法の確率と患者数の把握に関する研究, 難治性疾患克服研究事業 平成22年度研究報告書, pp27-29, 2011

 

2) Zollino M, Lecce R, Fischetto R, et al : Mapping the Wolf-Hirschhorn syndrome phenotype outside the currently accepted WHS critical region and defining a new critical region, WHSCR-2. Am J Hum Genet 72 : 590-597, 2003

PubMed

3) Nimura K, Ura K, Shiratori H, et al : A histone H3 lysine 36 trimethyltransferase links Nks 2-5 to Wolf-Hirschhorn syndrome. Nature 460 : 287-291, 2009

 

4) Zhang X, Chen G, Lu Y, et al : Association of mitochondrial letm1 with epileptic seizures. Cerebral Cortex 24 : 2533-2540, 2014

 

5) Shimizu K, Wakui K, Kosho T et al : Microarray and FISH-based genotype-phenotype analysis of 22 Japanese patients with Wolf-Hirschhorn syndrome. Am J Med Genet Part A 164A : 597-609, 2014

PubMed

6) Zollino M, Orteschi D, Ruiter M, et al : Unusual 4p16.3 deletions suggest an additional chromosome region for the Wolf-Hirschhorn syndrome-associated seizures disorder. Epilepasia 55 : 849-857, 2014

PubMed

7) Andersen EF, Carey JC, Earl DL, et al : Deletions involving genes WHSC1 and LETM1 may be necessary, but are not sufficient to cause Wolf-Hirschhorn syndrome. Eur J Hum Genet 22 : 464-470, 2014

 

8) Battaglia A, Filippi T, Carey JC : Update on the clinical features and natural history of Wolf-Hirschhorn (4p-) syndrome : experience with 87 patients and recommendations for routine health supervision. Am J Med Genet Part C 148C : 246-251, 2008

PubMed

9) Battaglia A, Filipi T, South ST, et al : Spectrum of epilepsy and electroencephalogram patterns in Wolf-Hirschhorn syndrome : experience with 87 patients. Dev Med Child Neurol 51 : 373-380, 2009

 

10) Arakawa C, Fujita Y, Fuchigalni T, et al : Affinity for music in Wolf-Hirschhorn syndrome : two case reports. Pediatr Neurol 51 : 550-552, 2014

 

P.209 掲載の参考文献

1) Deletion 5p Syndrome. In Jones KL, Jones MC, Del Campo M (eds) : SMITH'S Recognizable Patterns of Human Malformation, 7th ed, Elsevier Saunders, Philadelphia, pp42-45, 2013

 

2) 鳴海洋子 : 5p-症候群. 小児科臨床 66 (増刊) : 1269-1274, 2013

Medical*Online

3) Nguyen JM, Qualmann KJ, Okashah R, et al : 5p deletions : Current Knowledge and Future Directions. Am J Med Genet Part C Semn Med Genet, 2015 doi : 10.1002/ajmg. c. 31444 [Epub ahead of print]

 

4) Mainardi PC : Cri du Chat syndrome. Orphanet J Rare Dis 1 : 33, 2006

 

・ 小児慢性疾患特定疾病恒報センター : 診断の手引き5p-症候群 http://www.shouman.jp/instructions/13_1_10/ (2015年9月4日アクセス)

 

P.211 掲載の参考文献

1) Pingault V, Ente D, Dastot-Le Moal F, et al : Review and update of mutations causing Waardenburg syndrome. Hum Mutat 4 : 391-406, 2010

PubMed

2) シェーンウォルフ GC, ブライル SB, ブラウアー PR, 他 (編著) : 仲村春和, 大谷浩 (監訳) : カラー版 ラーセン人体発生学, 4版, 西村書店, 東京, pp85-110, 2013

 

3) Arimoto Y, Namba K, Nakano A, et al : Chronic constipation recognized as a sign of a SOX10 mutation in a patient with Waardenburg syndrome. Gene 540 : 258-262, 2014

 

4) Inoue K, Shilo K, Boerkoel CE et al : Congenital hypomyelinating neuropathy, central dysmyelination, and Waardenburg-Hirschsprung disease : phenotypes linked by SOX10 mutation. Ann Neurol 52 : 836-842, 2002

 

5) Amiel J, Sproat-Emison E, Garcia-Barcelo M, et al : Hirschsprung disease, associated syndromes and genetics : a review. J Med Genet 45 : 1-14, 2008

PubMed

・ Milunsky JM : Waardenburg Syndrome Type I. Gene Reviews http://www.ncbi.nlm.nih.gov/books/NBK1531/ (2015年8月6日アクセス)

 

P.214 掲載の参考文献

1) Inage E, Suzuki M, Minowa K, et al : Phenotypic overlapping of trisomy 12p and Pallister-Killian syndrome. Eur J Med Genet 53 : 159-161, 2010

PubMed

2) Vogel I, Lyngbye T, Nielsen A, et al : Pallister-Killian syndrome in a girl with mild developmental delay and mosaicism for hexasomy 12p. Am J Med Genet A 149A : 510-514, 2009

 

3) Izumi K, Conlin LK, Berrodin D, et al : Duplication 12p and Pallister-Killian syndrome : a case report and review of the literature toward defining a Pallister-Killian syndrome minimal critical region. Am J Med Genet A 158A : 3033-3045, 2012

PubMed

4) Wilkens A, Liu H, Park K, et al : Novel clinical manifestations in Pallister-Killian syndrome : comprehellsive evaluation of 59 affected individuals and review of previously reported cases. Am J Med Genet A 158A : 3002-3017, 2012

PubMed

5) Ohashi H, Ishikiriyama S, Fuknshima Y, et al : New diagnostic method for Pallister-Killian syndrome : detection of i (12p) in interphase nuclei of buccal mucosa by fluorescence in situ hybridization. Am J Med Genet 45 : 123-128, 1993

 

6) Cobben JM, Engelen M, Polstra A. et al : Array CGH on unstimulated blood does not detect all cases of Pallister-Killian syndrome : buccal smear analysis should remain the diagnostic procedure of first choice. Am J Med Genet A 161A : 1517-1519, 2013

 

7) Tilton RK, Wilkens A, Krantz ID, et al : Cardiac manifestations of Pallister-Killian syndrome. Am J Med Genet A 164A : 1130-1135, 2014

PubMed

8) Candee MS, Carey JC, Krantz ID, et al : Seizure characterist. ics in Pallister-Killian syndrome. Am J Med Genet A 158A : 3026-3032, 2012

 

9) Kostanecka A, Cambell LB, Izumi K, et al : Developmental and behavioral characteristics of individuals with Pallister-Killian syndrome. Am J Med Genet A 158A : 3018-3025, 2012

 

・ PKS Kids (米国Palister-Killian症候群家族会) http://www.pkskids.net/ (2015年8月6日アクセス)

 

P.218 掲載の参考文献

1) Jones KL : Trisomy 13. In Jones KL (ed) : Smith's Recognizable Patterns of Human Malformation, 6th ed, Elsevier Saunders, Philadelphia, pp 18-21, 2006

 

2) Carey JC : Trisomy 18 and trisomy 13 syndromes. In Cassidy SB, Allenson JE (ed) : Management of Genetic Syndromes, 3ed ed, Wiley-Liss, New York, pp 807-823. 2010

 

3) Baty BJ, Jorde LB, Blackburn BL, et al : Natural history of trisomy 18 and trisomy 13 : I. Growth, physical assessment, medical histories, survival, and recurrence risk. Am J Med Genet 49 : 175-188, 1994

 

4) Maeda J, Yamagishi H, et al : The impact of cardiac surgery in patients with trisomy 18 and trisomy 13 in Japan. Am J Med Genet A 155A : 2641-2646, 2011

PubMed

5) 古庄和己 : 13トリソミー症候群, 18トリソミー症候群, 大関武彦, 他 (編) 小児科学, 3版, 医学書院, 東京, pp367-368, 2008

 

6) 日本新生児成育医学会 : 重篤な疾患を持つ新生児の家族と医療スタッフの話し合いのガイドライン http://jspn.gr.jp/info/INFORMATION.html (2015年8月6日アクセス)

 

7) Rasmussen SA, Wong LYC, Yang QY, et al : Population-based analysis of mortality in trisomy 13 and trisomy 18. Pediatr 111 : 777-784, 2003

 

8) Kaneko Y, Kobayashi J, Yamamoto Y, et al : Intensive cardiac management in patients with trisomy 13 or trisomy 18. Am J Med Genet 146A : 1372-1380, 2008

PubMed

9) Baty BJ, Jorde LB, Blackburn BL, et al : Natural history of trisomy 18 and trisomy 13 : II. Psychomotor development. Am J Med Genet 49 : 189-194, 1994

PubMed

10) Carey JC : Perspectives on the care and management of infants with trisomy 18 and trisomy 13 : striving for balance. Curr Opin Pediatr 24 : 672-678, 2012

PubMed

・ 13トリソミーの子供を支援する親の会 http://www.13trisomy.com/next.html (2015年8月6日アクセス)

 

・ SOFT (Support Organization for Trisomy 18, 13 and related disorders) http://trisomy.org (2015年8月6日アクセス)

 

P.223 掲載の参考文献

1) Kagami M, Sekita Y, Nishimura G, et al : Deletions and epimutations affecting the human 14q32.2 imprinted region in individuals with paternal and maternal upd (14) -like phenotypes. Nat Genet 40 : 237-242, 2008

PubMed

2) Hoffmann K, Heller R : Uniparental disomies 7 and 14. Best Pract Res Clin Endocrinol Metab 25 : 77-100, 2011

PubMed

3) Kagami M, Matsuoka K, Nagai T, et al : Paternal uniparental disomy 14 and related disorders : Placental gene expression analyses and histological examinations. Epigenetics 7 : 1142-1150, 2012

PubMed

4) Kagami M, Kurosawa K, Miyazaki O, et al : Comprehensive clinical studies in 34 patients with molecularly defined UPD (14) pat and related conditions (Kagami-Ogata syndrome). Eur J Hum Genet 2015 Feb 18 doi : 10.1038/ejhg. 2015. 13 [Epub ahead of print]

 

5) Ioannides Y, Lokulo-Sodipe K, Mackay DJ, et al : Temple syndrome : improving the recognition of an underdiagnosed chromosome 14 imprinting disorder : an analysis of 51 published cases. J Med Genet 51 : 495-501, 2014

 

6) Hosoki K, Ogata T, Kagami M, et al : Epimutation (hypomethylation) affecting the chromosome 14q32.2 imprinted region in a girl with upd (14) mat-like phenotype. Eur J Hum Genet 16 : 1019-1023, 2008

 

7) Kagami M, Mizuno S, Matsubara K, et al : Epimutations of the IG-DMR and the MEG3-DMR at the 14q32.2 imprinted region in two patients with Silver-Russell syndrome-compatible phenotype. Eur J Hum Genet 23 : 1062-1067, 2015

PubMed

P.228 掲載の参考文献

1) 古庄知己 : 18トリソミーに関する医学的エビデンス. 櫻井浩子, 橋本洋子, 古庄知己 (編) : 18トリソミー～子どもへのよりよい医療と家族支援をめざして～. メディカ出版, 大阪, pp2-32, 2014

 

2) Jones KL : Smith's Recognizable Patterns of Human Malformation, 6th ed, Elsevier Saunders, Philadelphia, pp60-63, 2006

 

3) Kosho T, Kuniba H, Tanikawa Y, et al : Natural history and parental experience of children with trisomy 18 based on a questionnaire given to a Japanese trisomy 18parental support group. Am J Med Genet A 161A : 1531-1542, 2013

PubMed

・ 18トリソミーの会 http://18trisomy.com (2015年8月6日アクセス)

 

・ 染色体起因しょうがいじの親の会 http://www.eve.ne.jp/FLC/ (2015年8月6日アクセス)

 

P.232 掲載の参考文献

1) Gardner RJ, Sutherland GR, Shaffer LG : Supernumerary marker chromosome. In Chromosome Abnormalities and Genetic Counselling, 4th ed, Oxford University Press, New York, pp304-305, 2011

 

2) 梶井正 ;日本人類遺伝学会臨床細胞遺伝学認定士制度 : 染色体異常をみつけたら, 過剰マーカー染色体 http://www.cytogen.jp/index/pdf/03-m.pdf (2015年8月6日アクセス)

 

3) Liehr T, Weise A : Frequency of small supernumerary marker chromosomes in prenatal, newborn, developmentally retarded and infertility diagnostics. Int J Mol Med 19 : 719-731, 2007

 

4) Graf MD, Christ L, Mascarello JT, et al : Redefining the risks of prenatally ascertained supernumerary marker chromosomes : a collaborative study. J Med Genet 43 : 660-664, 2006

PubMed

5) 山本俊至 : 臨床遺伝に関わる人のためのマイクロアレイ染色体検査, 診断と治療社, 東京, pp102-103, 2012

 

6) Liehr T : Small supernumerary marker chromosomes http://ssmc-tl.com/sSMC.html (2015年8月6日アクセス)

 

・ Small supernumerary marker chromosomes http://ssmc-tLcom/sSMC.html (2015年8月6日アクセス)

 

・ Online Mendelian Inheritance in Man (OMIM) http://www.ncbi.nlm,nih,gov/omim/ (2015年8月6日アクセス)

 

・ UCSC Genome Browser http://genome.ucsc.edu/cgi-bin/hgGateway (2015年8月6日アクセス)

 

・ Human Gene Mutation Database (HGMD) http://www.hgmd.cf.ac.uk/ (2015年8月6日アクセス)

 

・ Database of Chromosomal Imbalance and Phenotype in Humans using Ensembl Resources (DECIPHER) https://decipher.sanger.ac.uk/ (2015年8月6日アクセス)

 

P.235 掲載の参考文献

1) Saitoh S : Clinical, molecular, and neurophysiological features in Angelman syndrome, J Pediatr Epilepsy 4 : 17-22, 2015 doi : 10.1055/s-0035-1554787

 

2) Greer PL, et al : The Angelman syndrome protein Ube3A regulates synapse development by ubiquitinating arc. Cell 140 : 704-716, 2010

PubMed

3) Egawa K, et al : Decreased tonic inhibition in cerebellar granule cells causes motor dysfunction in amouse model of Angelman syndrome. Sci Transl Med 4 : 163ra157, 2012

 

4) Shi SQ, et al : Ube3a imprinting impairs circadian robustness in angelman syndrome models. Curr Biol 25 : 537-545, 2015

PubMed

5) Braam W, et al : Melatonin for chronic insomnia in Angelnian syndrome : arandomized placebo-controlled trial. J Child Neurol 23 : 649-654, 2008

 

・ Angelman syndrome foundation http://www.angelman.org (2015年8月6日アクセス)

 

P.239 掲載の参考文献

1) 永井敏郎 : Prader-Willi症候群. 小児内科 41 (増刊) : 252-256, 2009

 

2) Cassidy SB : Prader-Willi syndrome. In Cassidy SB, Allanson JE (eds) : Management of Genetic Syndromes, 3rd ed, John Wiley and Sons, New Jersey, pp625-650, 2010

 

3) Cassidy SB, Schwartz S, Miller JL, et al : Prader-Willi syndrome. Genet Med 14 : 10-26, 2012

PubMed

4) Sahoo T, del Gaudio D, German JR, et al : Prader-Willi phenotype caused by paternal deficiency for the HB II-85 C/D box small nucleolar RNA cluster. Nat Genet 40 : 719-721, 2008

 

5) Nagai T, Matsuo N, Kayanuma Y, et al : Standard growth curves for Japanese patients with Prader-Willi syndrome. Am J Med Genet 95 : 130-134, 2000

PubMed

6) Alan Y, Ho AY, Dimitropoulos A : Clinical management of behaVioral characteristics of Prader-Willi syndrome. Neuropsychiatr Dis Treat 6 : 107-118, 2010

 

7) Soni S, Whittington J, Holland AJ, et al : The course and outcome of psychiatric illness in people with Prader-Willi syndrome : implications for management and treatment. J Intellect Disabil Res 51 : 32-42, 2007

PubMed

8) Nakamura Y, Murakami N, Iida T, et al : The characteristics of scoliosis in Prader-Willi syndrome (PWS) : analysis of 58 scoliosis patients with PWS. J Orthop Sci 20 : 17-22, 2015

PubMed

9) Kido Y, Sakazume S, Abe Y, et al : Testosterone replacement therapy to improve secondary sexual characteristics and body composition without adverse behavioral problems in adult male patients with Prader-Willi syndrome : an observational study. Am J Med Genet A 161A : 2167-2173, 2013

PubMed

・ Driscoll DJ, Miller JL, Schwartz S, et al : Prader-Willi Syndrome. GeneReviews http://www.ncbi.nlm.nih.gov/books/NBK1330/ (2015年8月7日アクセス)

 

・ OMIM#176270, PRADER-WILLI SYNDROME ; PWS http://omim.org/entry/176270 (2015年8月7日アクセス)

 

P.243 掲載の参考文献

1) Banatvala JE, Brown DWG : Rubella. Lancet 363 : 1127-1137, 2004

PubMed

2) Best JM. : Rubella. Semin Fetal Neonatal Med 12 : 182-192, 2007

PubMed

3) Ghidini A, Lynch L : Prenatal diagnosis and significance of fetal infections. West j Med 159 : 366-373, 1993

PubMed

4) 加藤茂孝 : 風疹・CRSの歴史的背景-我々は過去から十分に学んでいたであろうか? 臨床とウイルス 42 : 26-33, 2014

Medical*Online

5) Ueda K, Nishida Y, Oshima K, et al : Congenital rubella syndrome : correlation of gestational age at time of maternal rubella with type of defect. J Pediatr 94 : 763-765, 1979

PubMed

6) 宮崎千明 : 風疹ウイルス, 日本小児感染症学会 (編) : 日常診療に役立つ小児感染症マニュアル 2007, 改訂2版, 東京医学社, 東京, pp263-270, 2007

 

7) Okuda M, Yamanaka M, Takahashi T, et al : Positive rates for rubella antibody in pregnant women and benefit of post-partum vaccination in a Japanese perinatal center. J Obstet Gynaecol Res 34 : 168-173, 2008

 

8) Katow S : Rubella virus genome diagnosis during pregnancy and mechanism of congenital rubella Intervirology 41 : 163-169, 1998

PubMed

9) 種村光代 : 風疹ウイルスの母子感染-風疹疑い妊婦の取り扱い. 周産期シンポジウム 18 : 83-91, 2000

 

・ 国立感染症研究所 http://www.nih.go.jp/niid/ja/ (2015年8月7日アクセス)

 

・ 国立感染症研究所感染症情報センター : 風疹及び先天性風疹症候群, 風しん対策の強化について http://idsc.nih.go. jp/disease/rubella/rec200408.html (2015.年8月7日アクセス)

 

P.246 掲載の参考文献

1) Jones KL, Smith DW, Ulleland CN, et al : Pattem of malformation in offspring of chronic alcoholic mothers. Lancet 1 : 1267-1271, 1973

 

2) Prevention CfDCa : Fetal Alcohol Syndrome-Alaska, Arizona, Colorado, and New York, 1995-1997. JAMA 288 : 38-40, 2002

 

3) May PA, Gossage JP, Kalberg WO, et al : Prevalence and epidemiologic characteristics of FASD from various research methods with an emphasis on recent in-school studies. Dev Disabil Res Rev 15 : 176-192, 2009

PubMed

4) 田中晴美 :日本における. 母親の飲酒による子供の異常の現状. 日本医事新報 3714 : 45-49, 1995

Medical*Online

5) 厚生労働省ホームページ ; 樋口進 : 成人の飲酒実態と関連問題の予防について http://www.mhlw.go.jp/topics/tobacco/houkoku/061122b.html (2015年8月7日アクセス).

 

6) Hoyme HE, May PA, Kalberg WO, et al : A practical clinical apProach to diagnosis of fetal alcohol spectrurn disorders : clarification of the 1996 institute of medicine criteria. Pediatrics 115 : 39-47, 2005

PubMed

7) Treit S, Lebel C, Baugh L, et al : Longitudinal MRI reveals altered trajectory of brain development during childhood and adolescence in fetal alcohol spectrum disorders. J Neurosci 33 : 10098-10109, 2013

PubMed

8) Mattson SN, Crocker N, Nguyen TT : Fetal alcohol spectrum disorders : neuropsychological and behavioral features. Neuropsychol Rev 21 : 81-101, 2011

PubMed

9) Chasnoff IJ, Wells AM, King L : Misdiagnosis and missed diagnoses in foster and adopted children with prenatal alcohol exposure. Pediatrics 135 : 264-270, 2015

PubMed

P.249 掲載の参考文献

1) Kurotaki N, Imaizumi K, Harada N, et al : Haploinsufficiency of NSD l causes Sotos syndrome. Nat Genet 30 : 365-366, 2002

 

2) Visser R, Landman E, Goeman E, et al : Sotos syndrome is associated with deregulation of the MAPK/ERK-signaling pathway. PLos One 7 : e49229, 2012

 

3) Tatton-Brown K, Cole TRP, Rahman N : Sotos Syndrome. GeneReviews http://www.ncbi.nlm.nih. gov/books/NBK1479/ (2015年9月4日アクセス)

 

4) Baujat G, Cormier-Daire V : Sotos syndrome. Orphanet J Rare Dis 2 : 36, 2007

 

5) 蒔田芳男 : Sotos症候群. 小児内科 41 (増刊) : 263-265, 2009

 

6) 黒滝直弘 : Sotos症候群. 別冊日本臨牀 新領域別シリーズ No. 29 神経症候群 (第2版) IV, 日本臨牀, 大阪, pp697-702, 2014

 

7) Cole T : Sotos syndrome. In Cassidy S, Allanson J (eds) : Management of Genetic Syndromes, 4th ed, John Wiley & Sons Inc, pp769-786, 2010

 

・ オーファンネットジャパン http://orlj.jp/about/index.html (2015年8月7日アクセス)

 

P.252 掲載の参考文献

1) Rubinstein JH, Taybi H : Broad thumbs and toes and facial abnomialities. A possible mental retardation syndrome. Am J Dis Child 105 : 588-608, 1963

PubMed

2) Petrij F, Giles RH, Dauwerse HG, et al : Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP Nature 376 (6538) : 348-351, 1995

PubMed

3) Hallam TM, Bourtchouladze R : Rubinstein-Taybi syndrome : molecular findings and therapeutic approaches to improve cognitive dysfunction. Cell Mol Life Sci 63 : 1725-1735, 2006

PubMed

4) Wang J, Weaver IC, Gauthier-Fisher A, et al : CBP histone acetyltransferase activity regulates embryonic neural differentiation in the normal and Rubinstein-Taybi syndrome brain. Dev Cell 18 : 114-125, 2010 doi : 10.1016/j. devcel. 2009. 10. 023

 

5) Hennekam RC : Rubinstein-Taybi syndrome. Eur J Hum Genet 14 : 981-985, 2006

PubMed

6) Wiley S, Swayne S, Rubinstein JH, et al : Rubinstein-Taybi syndrome medical guidelines. Am J Med Genet A 119A : 101-110, 2003

PubMed

・ ルビンシュタインテイビ症候児・者 親の会 http://2st.jp/Rcosmos/ (2015年8月7日アクセス)

 

・ GeneReviews : Rubinstein-Taybi Syndrome http://www.ncbi.nlm.nih.gov/books/NBK1526/ (2015年8月7日アクセス)

 

P.255 掲載の参考文献

1) de Lange C : Sur un type nouveau de generation (typus Ainstelodamensis). Arch Med Engant 36 : 713, 1933

 

2) Brachmann W : Ein Fall von symmetrischer Monodaktylie durch umadefekt mit symmetrischer Flughaubildung in den Ellenbeugen, sowie anderen Abnormitaten (Zwerghaftigheit, Halsrippen, Behaarung). Jahrb Kinderkeilk 84 : 224, 1916

 

3) Barisic I, Tokic V, Loane M, et al : Descriptive epidemiology of Cornelia de Lange syndrome in Europe. Am J Med Genet 146A : 51-59, 2008

PubMed

4) Krantz TZ, McCallum J, Descipio C, et al : Cornelia deLange syndrome is caused by mutations in NIPBL, the human homolog of Drosophila melanogaster Nipped-B. Nat Genet 36 : 631-635, 2004

 

5) Musio A, Selicomi A, Focarelli ML, et al : X-linked Cornelia de Lange syndrome owing to SMCIL1 mutations. Nat Genet 38 : 528-530, 2006

PubMed

6) Deardorff MA, Kaur M, Yaeger D, et al : Mutations in Cohesin complex members SMC3 and SMC1A cause a mild variant of Cornelia de Lange syndrome with predominat mental retardation. Am J Hum Genet 80 : 485-494, 2007

 

7) Deardorff MA, Wilde JJ, Albrecht M, et al : Rad21 mutations cause a human cohesinopathy. Am J Hum Genet 90 : 1014-1027, 2012

 

8) Deardorff MA, Bando M, Nakato T, et al : HDAC8 mutations in Cornelia de Lange syndrome affect the cohesion acetylation cycle. Nature 489 : 313-317, 2012

 

9) Kaiser FJ, Ansari M, Braunholz D, et al : Loss of function HDAC8 mutations cause a phenotypic spectrum of Cornelia de Lange syndrome-like features, ocular hypertelorism, large fontanelle and X-linked inheritance. Hum Mol Genet 23 : 2888-2900, 2014

 

10) Huisman SA, Redeker EJW, Maas SM, et al : High rate of mosaicism in individuals with Cornelia de Lange syndrome. J Med Genet 50 : 339-344, 2013

PubMed

P.261 掲載の参考文献

1) Aoki Y, Niihori T, Narumi Y, et al : The RAS/MAPK syndromes : novel roles of the RAS pathway in human genetic disorders. Hum Mutat 29 : 992-1006, 2008

PubMed

2) Tidyman WE, Rauen KA : The RASopathies : developmental syndromes of Ras/MAPK pathway dysregulation. Curr Opin Genet Dev 19 : 230-236, 2009

 

3) Abe Y, Aoki Y, Kuriyama S, et al : Prevalence and clinical features of Costello syndrome and cardio-facio-cutaneous syndrome in Japan : findings from a nationwide epidemiological survey. Am J Med Genet A 158A : 1083-1094, 2012

PubMed

4) Chen PC, Yin J, Yu HW, et al : Next-generation sequencing identifies rare variants associated with Noonan syndrome. Proc Natl Acad Sci USA 111 : 11473-11478, 2014

 

5) Vissers LE, Bonetti M, Paardekooper Overman J, et al : Heterozygous germline mutations in A2ML1 are associated with a disorder clinically related to Noonan syndrome. Eur J Hum Genet 23 : 317-324, 2015

PubMed

6) Yamamoto GL, Aguena M, Gos M, et al : Rare variants in SOS2 and LZTR1 are associated with Noonan syndrome. J Med Genet 52 : 413-421, 2015

PubMed

7) 分子診断に基づくヌーナン症候群の診断・治療ガイドライン作成と新規病因遺伝子探索 (研究代表者 松原洋一) : 平成23年度総括・分担研究報告書, 厚生労働科学研究費補助金難治性疾患克服研究事業, 2013

 

8) Romano AA, Allanson JE, Dahlgren J, et al : Noonan syndrome : clinical features, diagnosis, and management guidelines. Pediatrics 126 : 746-759, 2010

PubMed

9) Gripp KW, Lin AE : Costello syndrome : a Ras/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations. Genet Med 14 : 285-292, 2012

PubMed

10) Pierpont ME, Magoulas PL, Adi S, et al : Cardiofacio-cutaneous syndrome : clinical features, diagnosis, and management guidelines. Pediatrics 134 : e1149-1162, 2014

 

・ Allanson JE, Roberts AE : Noonan Syndrome. GeneReviews http://www.ncbi.nlm.nih.gov/books/NBK1124/ (2015年9月3日)

 

・ Gripp KW, Lin AE : Costello Syndrome. GeneReviews http://www.ncbi.nlm.nih.gov/books/NBK1507/ (2015年9月3日)

 

・ Rauen KA : Cardiofaciocutaneous syndrome. GeneReviews http://www.ncbi.nlm,nih.gov/books/NBK1186/ (2015年9月3日)

 

P.263 掲載の参考文献

1) Katsanis SH, Jabs EW : Treacher Collins Syndrome. GeneReviews http://www.ncbi.nlm.nih.gov/books/NBK1532/ (日本語版 http://grj.umin.jp/grj/tcs htm) (2015年7月31日アクセス)

 

2) Valdez BC, Henning D, So RB, et al : The Treacher Collins syndrome (TCOF1) gene product is involved in ribosonlal DNA gene transcription by interacting with upstream binding factor. Proc Natl Acad Sci USA 101 : 10709-10714, 2004

PubMed

3) Gonzales B, Henning D, So RB, et al : The Treacher Collins syndrome (TCOF1) gene product is involved in pre-rRNA methylation. Hum Mol Genet 14 : 2035-2043, 2005

PubMed

4) Narla A, Ebert BL : Ribosomopathies : human disorders of ribosome dysfunction. Blood 115 : 3196-3205, 2010

PubMed

5) 三浦直行, 玉越智樹 : 神経堤細胞の発生と分化. 医学のあゆみ 199 : 1025-1030, 2001

Medical*Online

6) Dixon J, Jones NC, Sandell LL, et al : Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities. Proc Natl Acad Sci USA 103 : 13403-13408, 2006

PubMed

7) Dauwerse JG, Dixon J, Seland S, et al : Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome. Nat Genet 43 : 20-22, 2011

PubMed

8) Schaefer E, Collet C, Genevieve D, et al : Autosomal recessive POLRID mutation with decrease of TCOF1 mRNA is responsible for Treacher Collins syndrome. Genet Med 16 : 720-724, 2014

 

9) Dixon J, Ellis I, Bottani A, et al : Identification of mutations in TCOF1 : use of molecular analysis in the pre-and postnatal diagnosis of Treacher Collins syndrome. Am J Med Genet A 127A : 244-248, 2004

PubMed

P.267 掲載の参考文献

1) Zechner U, Wilda M, Kehrer-Sawatzki H, et al : A high density of X-linked genes for general cognitive ability : a run-away process shaping human evolution? Trends Genet 17 : 697-701, 2001

PubMed

2) Lubs HA, Stevenson RE, Schwartz CE : Fragile X and X-linked intellectual disability : four decades of discovery. Am J Hum Genet 90 : 579-590, 2012

 

3) Boda B, Mas C, Muller D : Activity-dependent regulation of genes implicated in X-linked non-specific mental retardation. Neuroscience 144 : 13-17, 2002

 

4) Bassani S, Zapata J, Gerosa L, et al : The neurobiology of X-linked intellectual disability. Neuroscinentist 19 : 541-552, 2013

 

5) 中川栄二 : 非症候性X連鎖知的障害. 別冊日本臨牀 新領域別症候群シリーズ 29, 神経症候群 (第2版) IV-その他の神経疾患を含めて, 日本臨牀社, 大阪, pp427-433, 2014

 

6) Chelly J, Mandel JL : Monogenic causes of X-linked mental retardation. Nat Rev Genet 2 : 669-680, 2001

PubMed

7) Stevenson RE, Holden KR, Rogers RC, et al : Seizures and X-linked intellectual disability. Eur J Med Genet 55 : 307-312, 2012

 

8) Ropers HH, Hamel BC : X-linked mental retardation. Nat Rev Genet 6 : 46-57, 2005

PubMed

9) Stevenson RE, Schwartz CE, Rogers RC : Malformations among the X-linked intellectual disability syndromes. Am J Med Genet A 161A : 2741-2749, 2013

PubMed

P.271 掲載の参考文献

1) Niikawa N, et al : Kabuki make-up syndrome : a syndrome of mental retardation, unusual facies, large and protruding ears, and postnatal growth deficiency. J Pediatr 99 : 565-569, 1981

PubMed

2) Kuroki Y, et al : A new malformation syndrome of long Palpebral fissures, large ears, depressed nasal tip, and skeletal anomalies associated with postnatal dwarfism and mental retardation. J Pediatr 99 : 570-573, 1981

PubMed

3) Ng SB, et al : Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome, Nat Genet 42 : 790-793, 2010

PubMed

4) Lederer D, et al : Deletion of KDM6A, a histone demethylase interacting with MLL2, in three patients with Kabuki syndrome. Am J Hum Genet 90 : 119-124, 2012

PubMed

5) Miyake N, et al : KDM6A point mutations cause Kabuki syndrome. Hum Mutat 34 : 108-110, 2013

PubMed

6) Micale L, et al : Molecular analysis, pathogenic mechanisms, and readthrough therapy on a large cohort of Kabuki syndrome patients. Hum Mutat 35 : 841-850, 2014

 

7) Micale L, et al : Mutation spectrum of MLL2 in a cohort of Kabuki syndrome patients. Orphanet J Rare Dis 6 : 38, 2011

 

8) Hannibal MC, et al : Spectrum of MLL2 (ALR) mutations in 110 cases of Kabuki syndrome. Am J Med Genet A 155A : 1511-1516, 2011

PubMed

9) Makrythanasis P, et al : MLL2 mutation detection in 86 patients with Kabuki syndrome : a genotype-phenotype study. Clin Genet 84 : 539-545, 2013

PubMed

10) Dentici ML, et al : Kabuki syndrome : clinical and molecular diagnosis in the first year of life. Arch Dis Child 100 : 158-164, 2015

PubMed

11) 川目裕 : Kabuki make-up症候群 (新川-黒木症候群, 歌舞伎症候群). 小児科診療 72 (増刊) : 54, 2009

 

12) Dugan S, Hudgins L : Kabuki syndrome. In Cassidy SB, Allanson JE : Management of Genetic Syndromes, 3rd ed, Wiley-Blackwell, New Jersey and Canada, pp469-477, 2010

 

P.274 掲載の参考文献

1) Hannula K, Kere J, Pirinen S, et al : Do patients with maternal uniparental disomy for chromosome 7 have a distinct mild Silver-Russell phenotype? J Med Genet 38 : 273-278, 2001

PubMed

2) Price SM, Stanhope R, Garrett C, et al : The spectrum of Silver-Russell syndrome : A clinical and molecular genetic study and new diagnostic criteria. J Med Genet 36 : 837-842, 1999

PubMed

3) Kotzot D, Schmitt S, Bernasconi E et al : Uniparental disomy 7 in Silver-Russell syndrome and primordial growth retardation. Hum Mol Genet 4 : 583-587, 1995

 

4) Gicquel C, Rossignol S, Cabrol S, et al : Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome. Nat Genet 37 : 1003-1007, 2005

PubMed

5) Eggerrnann T : Russell-Silver syndrome. Am J Med Genet C Semin Med Genet 154C : 355-364, 2010

 

6) Netchine I, Rossignol S, Dufourg MN, et al : 11p15 imprinting center region 1 loss of lnethylation is a common and specific cause of typical Russell-Silver syndrome : clinical scoring system and epigenetic-phenotypic correlations. J Clin Endocrinol Metab 92 : 3148-3154, 2007

PubMed

7) Albrecht S, WahaA, KochA, et al : Variable imprinting of H19 and IGF2 in fetal cerebelhlm and medulloblastoma. Neuropathol Exp Neural 55 : 1270-1276, 1996

 

8) Fuke T, Mizuno S, Nagai T, et al : Molecular and clinical studies in 138 Japanese patients with Silver-Russell syndrome. PLoS One 8 : e60105, 2013

PubMed

P.277 掲載の参考文献

1) Boulet SL, Rasmussen SA, Honein MA : A population-based study of craniosynostosis in metropolitan Atlanta, 1989-2003. Am J Med Genet Part A 146A : 984-991, 2008

PubMed

2) Di Rocco E Arnaud E, Renier D : Evolution in the frequency of nonsyndromic craniosynostosis. J Neurosurg Pediatr 4 : 21-25, 2009

 

3) Renier D, Lajeunie E, Arnaud E, et al : Management of craniosynostosis. Child Nerv Syst 16 : 645-658, 2000

PubMed

4) Sakamoto Y, Nakajima H, Tamada I, et al : New pathogenesis and the classification in scaphocephaly. J Plast Surg Hand Surg 48 : 24-27, 2014

PubMed

5) 坂本好昭 : いびつな頭の形は治りますか. 小児科診療 75 : 2023-2026, 2012

Medical*Online

6) Nakajima H, Sakamoto Y, Tamada I, et al : Dynamic total skull remodeling by a combination of morcellation craniotomy with distraction osteogenesis : the MoD procedure. J Craniofac Surg 22 : 1240-1246, 2011

PubMed

7) Nakajima H, Sakamoto Y, Tamada I, et al : An internal distraction device for Le Fort distraction osteogenesis : the NAVID system. J Plast Reconstr Aesthet Surg 65 : 61-67, 2012

 

8) 坂本好昭 : 先天異常の治療-病態に基づく治療. 小児科臨床 66 (増刊) : 1230-1234, 2013

Medical*Online

9) Magge SN, Westerveld M, Pruzinsky T, et al : Long-tern, neuropsychological effects of sagittal craniosynostosis on child development. J Craniofac Surg 13 : 99-104, 2002

 

10) Arnaud E, Meneses P, Lajeunie E, et al : Postoperative mental and morphological outcome for nonsyndromic brachycephaly. Plast Reconstr Surg 110 : 6-12, 2002

PubMed

・ 慶應義塾大学医学部形成外科学教室 : 頭蓋顎顔面変形外来 (クラニオ外来) http://prskeiocranio.jp/ (2015年8月7日アクセス)

 

P.279 掲載の参考文献

1) Rudiger RA, Haase W, Passarge E : Association of ectrodactyly, ectodermal dysplasia, and cleft lip-palate. Am J Dis Child 120 : 160-163, 1970

PubMed

2) Celli J, Duijf P, Hamel BC, et al : Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell 99 : 143-153, 1999

PubMed

3) Roelfsema NM, Cobben JM : The EEC syndrome : a literature study. Clin Dysmorphol 5 : 115-127, 1996

PubMed

4) Jones KL : Smith's Recognizable Patterns of Human Malformation, 7th ed, Elsevier, pp390-393, 2013

 

5) Di Iorio E, Kaye SB, Ponzin D, et al : Limbal stem cell deficiency and ocular phenotype in ectrodactyly-ectodermal dysplasia-clefting syndrome caused by p63 mutations. Ophthalmology 119 : 74-83, 2012

PubMed

P.285 掲載の参考文献

1) McDonald-McGinn DM, Emanuel BS, Zackai EH : 22q11.2 deletion syndrome. GeneReviews http://www.ncbi.nlm.nih.gov/books/NBK1523/ (2015年8月10日アクセス)

 

2) Gao S, Li X, Aniendt BA : Understanding the role of Tbx1 as a candidate gene for 22q11.2 deletion syndrome. Curr Allergy Asthma Rep 13 : 613-621, 2013

 

3) Momma K : Cardiovascular anomalies associated with chromosome 22q11.2 deletion syndrome. Am J Cardiol 105 : 1617-1624, 2010

PubMed

4) McDonald-McGinn DM, Sullivan KE : Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore) 90 : 1-18, 2011

PubMed

5) Kobrynski LJ, Sullivan KE : Velocardiofacial syndrome, DiGeorge syndrome : the chromosome 22q11.2 deletion syndromes. Lancet 370 (9596) : 1443-1452, 2007

PubMed

6) Swillen A, McDonald-McGinn DM : Developmental trajectories in 22q11.2 deletion. Am J Med Genet C Semin Med Genet 169 : 172-181, 2015

 

7) Bassett AS, McDonald-McGinn DM, Vorstman J, et al ; International 22q11.2 deletion syndrome consortium : Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr 159 : 332-339, 2011

 

8) Habel A, Herriot R, Tsai-Goodman B, et al : Towards a safty net for management of 22q11.2 deletion syndrome : guidelines for our times. Eur J Pediatr 173 : 757-765, 2014

 

・ 22 Heart Club http://22hc.com/ (2015年8月10日アクセス)

 

・ Chromosome 22 Central http://www.c22c.org (2015年8月10日アクセス)

 

・ The International 22q11.2 Deletion syndrome Foundation, Inc. http://www.22q.org (2015年8月10日アクセス)

 

・ Velo-Cardio-Facial Syndrome and 22q11 Foundation http://www.vcfsfa.org,au (2015年8月10日アクセス)

 

P.288 掲載の参考文献

1) Hennekam RCM, Krantz ID, Allanson JE : Branchial arch and oral-acral disorders. In Hennekam R, Allanson J, Krantz I (eds) : Gorlin's Syndromes of the Head and Neck, 5th ed, Oxford Univ Press, New York, pp879-887, 2010

 

2) Barisic I, Odak L, Loane M, et al : Prevalence, prenatal diagnosis and clinical features of oculo-auriculo-vertebral spectrum : aregistry-based study in Europe. Eur J Hum Genet 22 : 1026-1033, 2014

 

3) Beleza-Meireles A, Clayton-Smith J, Saraiva JM, et al : Oculo-auriculo-vertebral spectrum : a review of the literature and genetic update. J Med Genet 51 : 635-645, 2014

PubMed

4) Devriendt K, de Smet L, Casteels I : Oculo-auriculo-vertebral spectrum. In Cassidy SB, Allanson JE (eds) : Management of Genetic Syndromes, 3rd ed, Wiley, pp587-596, 2010

 

P.291 掲載の参考文献

1) Schubert C : The genomic basis of the Williams-Beuren syndrome. Cell Mol Life Sci 66 : 1178-1197, 2009

PubMed

2) Bayes M, Magano LF, Rivera N, et al : Mutational mechanisms of Williams-Beuren syndrome deletions. Am J Hum Genet 73 : 131-151, 2003

PubMed

3) Morris CA : Williams Syndrome. GeneReviews(R) http://www.ncbi.nlm.nih.gov/books/NBK1249/ (2015年8月10日アクセス)

 

4) Committee on Genetics ; American Academy of Pediatrics : Health care supervision for children with Williams syndrome. Pediatrics 107 : 1192-1204, 2001

 

5) 小児慢性特定疾病情報センター : 慢性心疾患の疾患一覧 http://www.shouman.jp/search/group/list/4/ 慢性心疾患 (2015年8月10日アクセス)

 

6) 中村みほ : Williams症候群における学修のつまずきと支援の文際. 稲垣真澄, 他 (編) : 特異的発達障害診断・治療のための実践ガイドライン. 診断と治療社, 東京. pp81-89, 2010

 

7) Morris CA : 60 Williams Syndrome. In Cassidy SB, Allarson JE (eds) : Management of Genetic Syndromes, 3rd ed, Wiley-Blackwell, Chichester, pp909-924, 2010

 

8) Pober BR, Morris CA : Diagnosis and management of medical problems in adults with Williams-Beuren syndrome. Am J Med Genet Part C Semin Med Genet 145C : 280-290, 2007

PubMed

9) Horowitz PE, Akhtar S, Wulff JA, et al : Coronary artery disease and anesthesia-related death in children with Williams syndrome. J Cardiothorac Vasc Anesth 16 : 739-741, 2002

PubMed

10) Scherer SW, Gripp KW, Lucena J, et al : Observation of a parental inversion variant in a rare Williams-Beuren syndrome family with two affected children. Hum Genet 117 : 383-388, 2005

 

・ ウィリアムズノート 19第19.2版 http://www003.upp.so-net.ne.jp/Williams/index.html (2015年8月10日アクセス)

 

P.294 掲載の参考文献

1) Smith AC, McGavran L, Robinson J, et al : Interstitial deletion of (17) (p11.2p11.2) in nine patients. Am J Med Genet 24 : 393-414, 1986

PubMed

2) Shaw CJ, Bi W, Lupski JR : Genetic proof of unequal meiotic crossovers in reciprocal deletion and duplication of 17p11.2. Am J Hum Genet 71 : 1072-1081, 2002

PubMed

3) Slager RE, Newton TL, Vlangos CN, et al : Mutations in RAI 1 associated with Smith-Magenis syndrome. Nature Genet 33 : 466-468, 2003

 

4) Elsea SH, Girirajan S : Smith-Magenis syndrome. Eur J Hum Genet. 16 : 412-421, 2008

PubMed

5) Girirajan S, Vlangos CN, Szomju BB, et al : Genotype-phenotype correlation in Smith-Magenis syndrome : evidence that multiple genes in 17p11.2 contribute to the clinical spectrum. Genet Med 8 : 417-427, 2006

 

6) Williams SR, Zies D, Mullegama SV, et al : Smith-Magenis syndrome results in disruption of CLOCK gene transcription and reveals an integral role for RAI1 in the maintenance of circadian rhythmicity. Am J Hum Genet 90 : 941-949, 2012

PubMed

P.297 掲載の参考文献

1) Meadow SR : Anticonvulsant drugs and congenital abnormalities. Lancet 2 (7581) : 1296, 1968

PubMed

2) Speidel BD, Meadow SR : Maternal epilepsy and abnormalities of the fetus and newborn. Lancet 2 (7782) : 839-843, 1972

PubMed

3) Hill RM : Teratogenesis and antiepileptic drugs. N Engl J Med 289 : 1089-1090, 1973

PubMed

4) Dolens B, Raymond EJ, Gaulme J : Teratogenicity of valproic acid. J Pediatr 97 : 332-333, 1980

 

5) Robert E, Guibaud P : Maternal valproic acid and congenital neural tube defects. Lancet 2 (8304) : 937, 1982

PubMed

6) Kultima K, Nystr6m A-M, Stigson M : Valproic acid teratogenicity : Atoxicogenomics approach. Environ Health Perspect 112 : 1225-1235, 2004

 

7) Fathe K, Palacios A, Finnell RH : Brief report novel mechanism for valproate-induced teratogenicity. Birth Defects Res A Clin Mol Teratol 100 : 592-597, 2014

PubMed

8) Pack AM ; Therapy insight : clinical management of pregnant women with epilepsy. Nat Clin Pract Neurol 2 : 190-200, 2006

PubMed

9) Cohen MJ, Meador KJ, Browning N, et al : Fetal antiepileptic drug exposure : Adaptive and emotional/behavioral functioning at age 6 years. Epilepsy Behav 29 : 308-315, 2013

 

10) Holmes LB, Mittendorf R, Shen A, et al : Fetal effects of anticonvulsant polytherapies different risks from different drug combinations. Arch Neurol 68 : 1275-1281, 2011

PubMed

11) Holmes LB, Harvey EA, Coull BA : The teratogenicity of anticonvulsant drugs. N Engl J Med 344 : 1132-1138, 2001

PubMed

12) Arpino C, Brescianini S, Robert E : Teratogenic effects of antiepileptic drugs : use of an International Database on Malformations and Drug Exposure (MADRE). Epilepsia 41 : 1436-1443, 2000

PubMed

13) Pack AM : Therapy insight : clinical management of pregnant women with epilepsy. Nat Clin Pract Neurol 2 : 190-200, 2006

PubMed

P.300 掲載の参考文献

1) Hughes IA, Houk C, Ahmed SF, et al : Consensus statement on managemellt of intersex disorders. Arch Dis Child 91 : 554-563, 2006

PubMed

2) Verp MS, Simpson JL : Abnormal sexual differentiation and neoplasia. Cancer Genet Cytogenet 25 : 191-218, 1987

PubMed

3) Parker KL : Sexual differelltiation. In Griffin JE, Ojeda SR (eds) : Textbook of Endocrine Physiology, 4th ed, Oxford University Press, New York, pp183-201, 2000

 

4) Petit C, de la Chapelle A, Levilliers J, et al : An abnormal terminal X-y interchange accounts for most but not all cases of humaii XX maleness. Cell 49 : 595-602, 1987

 

5) Jakob S, Lovell-Badge R : Sex determination and the control of Soxg expression in mammals. FEBS J 278 : 1002-1009, 2011

 

P.302 掲載の参考文献

1) Correa-Cerro LS, Porter FD : 3β-hydroxysterol Δ7-reductase and the Smith-Lemli-Opitz syndrome. Mol Genet Metab 84 : 112-126, 2005

 

2) Koide T, Hayata T, Cho KWY : Negative regulation of Hedgehog signaling by the cholesterogenic enzyme 7-dehydrocholesterol reductase. Development 133 : 2395-2405, 2006

PubMed

3) Nowaczyk MJM : Smith-Lemli-Opitz Syndrome. GeneReview http://www.ncbi.nlm.nih.gov/books/NBK1143/ (2015年8月10日アクセス)

 

4) Tsukahara M, Hasui M, Saito C, et al : Smith-Lemli-Opitz syndrome in Japan. Am J Genet 75 ; 118-119, 1998

 

5) Nowaczyk MJM, Irons MB : Smith-Lemli-Opitz syndrome : Phenotype, natural history, and epidemiolory. Am J Med Genet Sem Med Genet 160C : 250-262, 2012

 

6) Goldenberg A, Wolf C, Chevy F, et al : Antenatal manifestations of Smith-Lemli-Opitz (RSH) syndrome : A retrospective survey of 30 cases. Am J Genet 124A : 423-426, 2004

 

7) Porter FD : RSH/Smith-Lemli-Opitz syndrome : A multiple congenital anomaly/mental retardation syndrome due to an inborn error of cholesterol biosynthesis. Mol Genet Metab 71 : 163-174, 2000

 

8) Svoboda MD, Christine JM, Eroglu Y, et al : Treatment of Smith-Lemli-Opitz syndrome and other sterol disorders. Am J Med Genet C Semin Med Genet 160C : 285-294, 2012

 

P.306 掲載の参考文献

1) Van Nostrand JL, Brady CA, Jung H, et al : Inappropriate p53 activation during development induces features of CHARGE syndrome. Nature 514 (7521) : 228-232, 2014

PubMed

2) Hartshome TS, Hefner MA, Davenport SLH, et al : CHARGE Syndrome (Genetics and Communication Disorders). Plural Publishing, 2010

 

3) Pagon RA, Graham JM, Zonana J, et al : Coloboma, congenital heart disease and choanal atresia with multiple anomalies : CHARGE association. J Pediatr 99 : 223-227, 1981

PubMed

4) Lalani SR, Hefner MA, Belmont JW, et al : CHARGE Syndrome. GeneReviews(R) http://www.ncbi.nlm.nih.gov/books/NBK1117/ (2015年8月10日アクセス)

 

5) Dammeyer J : Development and characteristics of children with Usher syndrome and CHARGE syndrome, Int J Pediatr Otorhinolaryngol 76 : 1292-1296, 2012

PubMed

・ (家族会) CHARGEの会 http://charge.2.pro.tok2.com/ (2015年8月10日アクセス)

 

・ (北米) CHARGE Syndrome Foundation http://www.chargesyndrome.org (2015年8月10日アクセス)

 

P.311 掲載の参考文献

1) Beighton P, De Paepe A, Steinmann B, et al : Ehlers-Danlos syndromes : revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK). Am J Med Genet 77 : 31-37, 1998

PubMed

2) Tinkle BT, Arzinger CL : Ehlers-Danlos syndrome. In Cassidy SB, AUanson JE (eds) : Management of Genetic Syndromes, 3rd ed, Wiley-Blackwell, New Jersey, pp337-358, 2010

 

3) Ong KT, Perdu J, De Backer J, et al : Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome : a prospective randomised, open, blinded-endpoints trial. Lancet 376 : 1476-1484, 2010

PubMed

4) Pepin M, Schwarze U, Superti-Furga A, et al : Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med 342 : 673-680, 2000

 

5) Dietz HC, Cutting GR, Pyeritz RE, et al : Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352 : 337-339, 1991

PubMed

6) Neptune ER, Frischmeyer PA, Arking DE, et al : Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 33 : 407-411, 2003

PubMed

7) Judge DP, Dietz HC : Marfan's syndrome. Lancet 366 : 1965-1976, 2005

PubMed

8) Loeys BL, Dietz HC, Braverman AC, et al : The revised Ghent nosology for the Marfan syndrome. J Med Genet 47 : 476-485, 2010

PubMed

・ The Ehlers-Danlos National Foundation http://www.ednf.org/ (2015年8月10日アクセス)

 

・ Malfait F, Wenstmp R, De Paepe A : Ehlers-Danlos Syndrome, Classic Type. GeneReviews http://www.ncbi.nlm.nih.gov/books/NBK1244/(2015年8月10日アクセス)

 

・ Levy HP : Ehlers-Danlos Syndrome, Hypermobility Type. GeneReviews http://www.ncbi.nlm.nih.gov/books/NBK1279/ (2015年8月10日アクセス)

 

・ Pepin MG, Byers PH : Ehlers-Danlos Syndrome Type IV. GeneReviews http://www.ncbi.nlm.nih.gov/books/NBK1494/ (2015年8月10日アクセス)

 

・ The Marfan Foundation : WHAT ARE THE SIGNS? http://www.marfan.org/about/signs (2015年8月10日アクセス)

 

・ Dietz HC : Marfan Syndrome. GeneReviews http://www.ncbi.nlm.nih.gov/books/NBK1335/ (2015年8月10日アクセス)

 

IV. 内分泌疾患

P.317 掲載の参考文献

1) Juul A, Skakkebeak NE : Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding Protein 3. J Pediatr 130 : 197-204, 1997

 

2) Hasegawa Y, Hasegawa T, Kotoh S, et al : Reproducibility of gowth hormone stimulation tests (arginine and insulin), insulin-like growth factor (IGF) -I and IGF-binding protein-3 measurements. Clin Pediatr Endocrinol 2 (Suppl 2) : 75-78, 1993

 

3) 田中敏章, 藤枝憲二, 清野佳紀, 他 : 成長ホルモン分泌不全性低身長症における遺伝子組換え成長ホルモンの短期的および長期的治療効果-KIGSデータベースの解析. 成長会誌 16 : 69-75, 2010

Medical*Online

4) Isojima T, Shimatsu A, Yokoya S, et al : Standardized centile curves and reference intervals of serum insulin-like growth factor-1 (IGF-1) levels in a normal Japanese population using the LMS method. Endocr J 59 : 771-780, 2012

 

5) Ergun-Longmire B, Mertens AC, Mitby P, et al : Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J Clin Endocrinol Metab 91 : 3494-3498, 2006

PubMed

6) Tauber M, Moulin P, Pienkowsli C, et al : Growth hommone (GH) retesting and auxological data in 131 GH-deficient patients after completion of treatment. J Clin Endocrinol Metab 82 : 352-356, 1997

 

P.321 掲載の参考文献

1) 日本小児科学会新生児委員会 : 新生児に関する用語についての勧告. 日小児会誌 98 : 1946-1950, 1994

 

2) Zabransky S : Caring for Children Born SGA, Springer, London, 2013

 

3) Tachibana M, et al : Pathological examination of the placenta in small for gestational age (SGA) children with or without postnatal catch-up growth. J Maternal-Fetal Neonatal Med, 2015 Apr 7 : 1-5 [Epub ahead of print]

PubMed

4) Karlberg J, Albertsson-Wikland K : Growth in fullterm small-for-gestational-age infants : from birth to final height. Pediatr Res 38 : 733-739, 1995

PubMed

5) Itabashi K, Mishina J, Tada H, et al : Longitudinal follow-up of heightup to five years of age in infants born preterm small for gestational age : comparison to full-term small for gestational age infants. Early Hum Dev 83 : 327-333, 2007

PubMed

6) Leger J, Noel M, et al ; Sudy group of IUGR : Growth factors and intrauterine growth retardation II. Serum growth hormone, insulin-like growth factor (IGF) I, and IGF binding protein 3 levels in children with intrauterine growth retardation compared with normal control subjects : prospective study from birth to two years of age. Pediatr Res 40 : 101-107, 1996

 

7) Boguszewski M, Rosberg S, et al : Spontaneous 24-hour growth horumone profiles in prepubertal small for gestatiollal age children. JCEM 80 : 2599-2606, 1995

PubMed

8) Van Pareren Y, Mulder P, Houdijk M, et al : Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age : results of a randomized, double-blind, dose-response GH trial. J Clin Endocrinol Metab 88 : 3584-3590, 2003

 

9) Gluckman PD, Hanson MA : Living with the past : evolution, development, and patterns of disease. Science 305 : 1733-1736, 2004

PubMed

10) 田中敏章, 他 : SGA性低身長症におけるGH治療ガイドライン. 日小児会誌 111 : 641-646, 2007

 

11) 長田久雄, 他 : SGA低身長児と健康児のQOL比較およびSGA低身長児の成長ホルモン治療によるQOLの変化. 小児保健研究 68 : 350-358, 2009

 

12) Hokken-Koelega A, et al : Effects of growth hormone treatment on cognitive function and head circumference in children born small for gestational age. Horm Res 64 : 95-99, 2005

PubMed

13) Wilton P : Pfizer International Growth database Annual report No23, 2006

 

P.325 掲載の参考文献

1) Cohen LE, Radovick S : Molecular basis of combined pituitary hormone deficiencies. Endocr Rev 23 : 431-442, 2002

PubMed

2) Pfaffle R, Klammt J : Pituitary transcription factors in the aetiology of combined pituitary hormone deficiency. Best Pract Res Clin Endocrinol Metab 25 : 43-60, 2011

PubMed

3) Alatzoglou KS, Dattani MT : Genetic forms of hypopituitarism and their manifestation in the neonatal period. Early Hum Dev 85 : 705-712, 2009

PubMed

4) Kelberman D, Rizzoti K, Lovell-Badge R, et al : Genetic regulation of pituitary gland development in human and mouse. Endocr Rev 30 : 790-829, 2009

PubMed

5) McCabe MJ, Alatzoglou KS, Dattani MT : Septooptic dysplasia and other midline defects : the role of transcription factors : HESX1 and beyond. Best Pract Res Clin Endocrinol Metab 25 : 115-124, 2011

PubMed

6) Colvin SC, Mullen RD, Pfaeffle RW, et al : LHX3 and LHX4 transcription factors in pituitary development and disease. Pediatr Endocrinol Rev 6 (Suppl 2) : 283-290, 2009

 

7) Dateki S, Fukami M, Uematsu A, et al : Mutation and gene copy number analyses of six pituitary transcription factor genes in 71 patients with combined pituitary hormone deficiency : identification of a single patient with LHX4 deletion. J Clin Endocrinol Metab 95 : 4043-4047, 2010

PubMed

8) Dateki S, Kosaka K, Hasegawa K, et al : Heterozygous OTX2 mutations are associated with variable pituitary phenotype. J Clin Endocrinol Metab 95 : 756-764, 2010

PubMed

9) Sun Y, Bak B, Schoenmakers N, et al : Loss-offunction mutations in IGSF1 cause an X-linked syndrome of central hypothyroidism and testicular emargement. Nat Genet 12 : 1375-1381, 2012

 

10) Asakura Y, Muroya K, Hanakawa J, et al : Combined pituitary hormone deficiency with unique pituitary dysplasia and morning glory syndrome related to a heterozygous PROKR2 mutation. Clin Pediatr Endocrinol 24 : 27-32, 2015

PubMed

P.330 掲載の参考文献

1) Eugster EA : Pituitary gigantism. UpToDate. http://www.uptodate.com/contents/pituitary-gigantism (2015年8月11日アクセス)

 

2) Williams F, Hunter S, Bradley L, et al. : Clinical experience in the screening and management of a large kindred with familial isolated pituitaly adenoma due to an aryl hydrocarbon receptor. J Clin Endocrinol Metab 99 : 1122-1131, 2014

 

3) Trivellin G, Daly AE Faucz FR, et al : Gigantism and Acromegaly due to Xq26 microduplications and GPR101 mutation. N Engl J Med 371 : 2363-2374, 2014

 

4) Backeljauw PF, Dattarti MT, Cohen P, et al : Excess growth and tall stature. In Sperling M (ed) : Pediatric Endocrinology, 4th ed, Elsevier, pp378-384, 2014

 

5) 厚生労働科学研究費補助金難治性疾患克服研究事業間脳下垂体機能障害に関する研究班 : 下垂体性巨人症の診断と治療の手引き (平成27年度改定) http://square.umin.ac.jp/endocrine/tebiki (2015年8月11日アクセス)

 

6) Katznelson L, Laws ER, Melmed S, et al : Acromegaly : An endocrine society clinical practice guideline. J Clin Endocrinol Metab 99 : 3933-3951, 2014

PubMed

7) Boyce A, Collins MT : Fibrous dysplasia/McCune-Albright syndrome. GeneReviews http://www.ncbi.nlm.nih.gov/books/NBK274564/ (2015年8月11日アクセス)

 

P.336 掲載の参考文献

1) Binder G : Short stature due to SHOX deficiency : genotype, phenotype, and therapy. Horm Res Paediatr 75 : 81-89, 2011

PubMed

2) Ogata T, Matsuo N, Nishimura G : SHOX haploinsufficiency and overdosage : impact of gonadal function status. J Med Genet 38 : 1-6, 2001

PubMed

3) Ogata T : SHOX haploinsufficiency : lessons from clinical studies. Current Opin Endocrinol Diabetes 9 : 13-20, 2002

 

4) Kosho T, Muroya K, Nagai T, et al : Skeletal features and growth patterns in 14 patients with haploinsufficiency of SHOX : implications for the development of Turner syndrome. J Clin Endocrinol Metab 84 : 4613-4621, 1999

PubMed

5) Fukami M, Matsuo N, Hasegawa T, et al : Longitudinal auxological study in a female with SHOX (short stature homeobox containing gene) haploinsufficiency and normal ovarian function. Eur J Endocrinol 149 : 337-341, 2003

 

6) Fukami M, Nishi Y, Hasegawa Y, et al : Statural growth in 31 Japanese patients with SHOX haploinsufficiency : support for a disadvantageous effect of gonadal estrogens. Endocr J 51 : 197-200, 2004

PubMed

7) Ogata T, Muroya K, Matsuo N, et al : Turner syndrome and Xp deletions : clinical and molecular studies in 47 patients. J Clin Endocrinol Metab 86 : 5498-5508, 2001

PubMed

8) Ogata T, Onigata K, Hotsubo T, et al : Growth hormone and gonadotropin-releasing hormoIle analog therapy in haploinsufficiency of SHOX. Endocr J 48 : 317-322, 2001

PubMed

9) Seki A, Jinno T, Suzuki E, et al : Skeletal deformity associated with SHOX deficiency. Clin Pediatr Endocrinol 23 : 65-72, 2014

PubMed

10) Massart E Bizzi M, Baggiani A, et al : Height out-come of the recombinant human growth hormone treatment in patients with SHOX gene haploinsufficiency : a meta-analysis. Pharmacogenomics 14 : 607-612, 2013

 

・ SHOX Database http://www.klinikum.uni-heidelberg.de/Shox-Datenbank-neu-test.1201.0.html (2015年8月11日アクセス)

 

P.342 掲載の参考文献

1) 厚生労働省科学研究費補助金 難治性疾患克服研究事業 間脳下垂体機能障害に関する調査研究班 : 自己免疫性視床下部下垂体炎の診断と治療の手引き (平成21年度改訂) http://rhhd.info/pdf/001016.pdf (2015年10月1日アクセス)

 

2) Imura H, Nakao K, Shimatsu A, et al : Lymphocytic infundibuloneurohypophysitis as a cause of central diabetes insipidus. N Engl J Med 329 : 683-689, 1993

PubMed

3) 片上秀喜 : リンパ球性下垂体炎. 成瀬光栄, 他 (編) : 内分泌代謝専門医ガイドブック, 診断と治療社, 東京, pp96-101, 2007

 

4) 厚生労働省科学研究費補助金 難治性疾患克服研究事業 間脳下垂体機能障害に関する調査班 : バゾプレシン分泌低下症 (中枢性尿崩症) の診断と治療の手引き (平成22年度改訂) http://rhhd.info/pdf/001015.pdf (2015年10月1日アクセス)

 

5) Fehn M, Bettendorf M, Ludecke DK, et al : Lymphocytic hypophysitis masking a suprasellar germinoma in a 12-year-old girl-a case report. Pituitary 1 (3-4) : 303-307, 1999

 

6) Mon SY, Mahmud H, Abbasi M, et al : A 23-Year-Old Female with a Mixed Germ Cell Tumor of the Pituitary Infundibulum : The Challenge of Differentiating Neoplasm from Lymphocytic Infundibuloneurohypophysitis-A Case Report and Literature Review. Case Rep Endocrinol, 2014 Article ID 129471

 

7) Watanabe S, Aihara Y, Kikuno A, et al : A highly sensitive and specific chemiluminescent enzyme immunoassay for placental alkaline phosphatase in the cerebrospinal fluid of patients with intracranial germinomas. Pediatr Neurosurg 48 : 141-145, 2012

PubMed

8) 椙村益久 : リンパ球性漏斗下垂体後葉炎の診断マーカー. 医学の歩み 247 : 533-536, 2013

 

9) Iwama S, Sugimura Y, Kiyota A, et al : Rabphilin-3A as a targeted autoantigen in lymphocytic infundibulo-neurohypophysitis. J Clin Endocrinol Metab 100 : 946-954, 2015

 

・ 厚生労働省科学研究費補助金 難治性疾患克服研究事業 : 診断と治療の手引き http://rhhd.info/sarch (2015年10月1日アクセス)

 

P.346 掲載の参考文献

1) Russell A : A diellcephalic syndrome of emaciation in infancy and childhood. Arch Dis Child 26 : 274, 1951

 

2) Burr IM, Slonim AE, Dallisll RK, et al : Diencephalic syndrome revisited. J Pediatr 88 : 439-444, 1976

 

3) Kilday, J P, Bartels U, Huang A, et al : Favorable survival and metabolic olltcome for children with diencephalic syndrome using a radiation-sparing approach. J Neurooncol 116 : 195-204, 2014

PubMed

4) 岡田雅彦 : 間脳症候群, 日本臨牀 (別冊新領域別症候群シリーズ, 神経症候群2版V), 日本臨牀社, 大阪. pp210-213. 2014

 

5) 宮田理英 : 間脳症候群. 小児科診療 72 (増刊) : 191, 2009

 

6) Allen JC : Initial management of children with hypothalamic and thalamic tumors and the modifying role of neurofibromatosis-1. Pediatr Neurosurg 32 : 154-162, 2000

PubMed

7) 百井亨 : 間脳症候群. 小児内科 34 (増刊) : 700-703, 2002

 

8) Gnekow AK, Falkenstein F, Hornstein S, et al : Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology. Neuro Oncol 14 : 1265-1284, 2012

 

9) Poussaint TY, Balnes PD, Nichols K, et al : Diencephalic syndrome : clinical features and imaging findings. Am J Neuroradiol 18 : 1499-1505, 1997

 

10) Sawamura Y, Kamoshima Y, Kato T, et al : Chemotherapy with cisplatin and vincristine for optic pathway/hypothalamic astrocytoma in young children. Jpn J Clin Oncol 39 : 277-283, 2009

PubMed

P.350 掲載の参考文献

1) 田島敏広 : 思春期遅発症. 有阪治 (編) : ビギナーのための小児内分泌診療ガイド, 1版, 中山書店, 東京, pp93-97, 2014

 

2) Dode C, Hardelin JP : Kallmann syndrome. Eur J Hum Genet 17 : 139-146, 2009

PubMed

3) Kallmann FJ, Schoenfeld WA, Barrera SE : The genetic aspects of primary eunuchoidism. Am J Mental Deficiency XLVIII : 203-236, 1944

 

4) Legouis R, Hardelin JP, Levilliers J, et al : The candidate gene for the X-linked Kallmann syndrome encodes a protein related to adhesion molecules. Cell 67 : 423-435, 1991

PubMed

5) Franco B, Guioli S, Pragliola A, et al : A gene deleted in Kallmann's syndrome shares homology with neural cell adhesion and axonal path-finding molecules. Nature 353 (6344) : 529-536, 1991

PubMed

6) Dode C, Levilliers J, Dupont JM, et al : Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 33 : 463-465, 2003

PubMed

7) Dode C, Teixeira L, Levilliers J, et al : Kallmann syndrome : mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet 2 : e175, 2006

PubMed

8) Falardeau J, Chung WC, Beenken A, et al : Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J Clin Invest 118 : 2822-2831, 2008

PubMed

9) Ogata T, Fujiwara I, Ogawa E, et al : Kallmann syndrome phenotype in a female patient with CHARGE syndrome and CHD7 mutation. Endocr J 53 : 741-743, 2006

 

10) 田中敏章 : 性腺機能低下症. 小児科診療 77 (増刊) : 599-601, 2014

 

P.357 掲載の参考文献

1) 望月弘 : SIADHとCSWS. 小児内科 40 (増刊) : 696-700, 2008

 

2) Hannon MJ, Thompson CJ : The syndrome of inappropriate antidiuretic hormone : prevalence, causes and consequences. Eur J Endocrinol 162 (Suppl 1) : S5-12, 2010

 

3) Gross P : Clinical management of SIADH. Ther Adv Endocrinol Metab 3 : 61-73, 2012

PubMed

4) Verbalis JG, Goldsmith SR, Greenberg A, et al : Diagnosis, evaluation, and treatment of hyponatremia : expert panel recommendations. Am J Med 126 (10 Suppl 1) : S1-42, 2013

 

5) Maesaka JK, Imbriano LJ, Ali NM, et at : Is it cerebral or renal salt wasting? Kidney Int 76 : 934-938, 2009

PubMed

6) 長谷幸治 : 中枢性塩類喪失症候群 . 小児内科 45 : 1570-1573, 2013

Medical*Online

7) Palmer BF : Hyponatraemia in a neurosurgical patient : syndrome of inappropriate antidiuretic hormone secretion versus cerebral salt wasting. Nephrol Dial Transplant 15 : 262-268, 2000

 

8) 日本小児内分泌学会 : 小児内分泌学, 診断と治療社. 東京, pp249-254, 2009

 

9) Spasovski G, Vanholder R, Allolio B : Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol 25 ; 170 : G1-47, 2014

 

・ 厚生労働科学研究費補助金 難治性疾患克服研究事業 間脳下垂体機能障害に関する調査研究班 平成22年度 総括・分担研究報告書バゾプレシン分泌過剰症 (SIADH) の診断と治療の手引き (平成22年度改訂), 2011年3月31日改訂 http://rhhd.info/pdf/001008.pdf (2015年8月12日アクセス)

 

・ 小児慢性特定疾病情報センター : 診断の手引き 中枢性塩喪失症候群 http://www.shouman.jp/instructions/5_9_14/ (2015年8月12日アクセス)

 

P.360 掲載の参考文献

1) Avioli LV, Earley LE, Kashima HK : Chronic and sustained hypernatremia, absence of thirst, diabetes insipidus, and adrenocorticotrophin insufficiency resulting from widespread destruction of the hypothalamus. Ann Intern Med 56 : 131-140, 1962

PubMed

2) Welt LG : Hypo-and hypernatremia. Ann Intern Med 56 : 161-164, 1962

PubMed

3) Mahoney JH, Goodman AD : Hypernatremia due to hypodipsia and elevated threshold for vasopressin release. Effects of treatment with hydrochlorothiazide, chlorpropamide and tolbutamide. N Engl J Med 279 : 1191-1196, 1968

PubMed

4) 横谷進 : 本態性高ナトリウム血症. 小児医学 21 : 531-547, 1988

 

5) Hiyama TY, Matsuda S, Fujikawa A, et al : Autoimmunity to the sodium-level sensor in the brain causes essential hypernatremia. Neuron 66 : 508-522, 2010

 

6) 宇都宮珠里, 檜山武史, 香川礼子. 他 : 脳弓下器官 (subfornical organ : SFO) に対する抗体反応を認めた本態性高Na血症の一例. ホルモンと臨床 60 : 1029-1034, 2012

 

7) 有阪治 : 中枢神経疾患におけるreset osmostat. 小児内科 45 : 1594-1597, 2013

Medical*Online

8) Robertson GL, Aycinera P : Neurogenic disorders of osmoregulation. Am J Med 72 : 339-353, 1982

 

9) 川口千晴, 高橋幸博 : 本態性高ナトリウム血症. 周産期医学 35 : 1610-1612, 2005

 

10) 横谷進 : 本態性高ナトリウム血症 (口渇中枢障害を伴う高ナトリウム血症). 田苗綾子. 他 (編) : 専門医による 新 小児内分泌疾患の治療. 診断と治療社, 東京, pp49-51, 2007

 

P.368 掲載の参考文献

1) 大山建司 : 第5章 思春期発来以上をきたす疾患. 日本小児内分泌学会 (編) : 小児内分泌学, 診断と治療社, 東京, pp268-275, 2009

 

2) Mahachoklertwattana P, Kaplan SL, Grumbach MM : The luteinizing hormone-releasing hormone-secreting hypothalamic hamartoma is a congenital malformation : natural history. J Clin Endocrinol Metab 77 : 118-124, 1993

PubMed

3) Styne DM, Grumbach MM : Puberty ontogeny, neuroendocrinology, physiology, and disorders. In Melmed S, Polonsky KS, Larsen PR, et al (eds) : Williams Textbook of Endocrinology, 12th ed, Elsevier Saunders, Philadelphia, pp1088-1105, 2011

 

4) De Roux N, Genin E, Carel JC, et al : Hypogonadotropic hypogonadism due to loss of function of the Kissl-derived peptide receptor GPR54. Proc Natl Acad Sci USA 100 : 10972-10976, 2003

 

5) Seminara SB, Messager S, Chatzidaki EE et al : The GPR54 as a regulator of puberty. N Engl J Med 349 : 1614-1627, 2003

PubMed

6) Dungan HM, Clifton DK, Steiner RA : Minireview : kisspeptin neurons as central processors in the regulation of gonadotropin-releasing hormone secretion. Endocrinology 147 : 1154-1158, 2006

PubMed

7) 小澤一史 : 新規生理活性神経ペプチド キスペプチンと性機能調節. 小児科 53 : 1329-1338, 2012

 

8) Pinilla L, Aguilar E, Dieguez C, et al : Kisspeptins and reproduction : physiological roles and regulatory mechanisms. Physiol Rev 92 : 1235-1316, 2012

PubMed

9) Rosenfield RL, Cooke DW, Radovick S : Puberty and its disorders in the female. In Sperling MA (ed) : Pediatric Endocrinology, 4th ed, Elsevier Saunders, Philadelphia, pp581-642, 2014

 

10) Ojeda SR, Lomniczi A, Mastronardi C, et al : Mini-review : the neuroendocrine regulation of the puberty : is the time ripe for a systems biology approach? Endocrinology 147 : 1166-1174, 2006

 

11) Ojeda SR, Dubay C, Lomniczi A, et al : Gene networks and endocrine regulation of puberty. Mol Cell Endocrinol 324 : 3-11, 2010

PubMed

12) Ojeda SR, Lomniczi A : Unraveling of the mystery of puberty. Nat Rev Endocrinol 10 : 67-69, 2014

PubMed

13) Teles MG, Bianco SDC, Brito VN, et al : A GPR54-activating mutation in a patient with central precocious puberty. N Engl J Med 358 : 709-715, 2008

 

14) Abreu AP, Dauber A, Macedo DB, et al : Central precocious puberty caused by mutations in the imprinted gene MKRN3. N Engl J Med 368 : 2467-2475, 2013

PubMed

15) Hagen CP, Sorensen K, Mieritz MG, et al : Circulating MNKR3 levels decline prior to pubertal onset and through puberty : a longitudinal study of healthy girls. J Clin Endocrinol Metab 100 : 1920-1926, 2015

PubMed

16) Jung H, Carmel P, Schwartz MS, et al : Some hypothalamic hamartomas contain transforming growth factorα, a puberty-inducing growth factor, but not luteinizing hormone-releasing hormone neurons. J Clin Endocrinol Metab 84 : 4695-4701, 1999

 

17) Matsuo N : Skeletal and sexual maturation in Japanese children. Clin Pediatr Endocrinol 2 (Suppl 1) : 1-4, 1993

 

18) Ashizawa K : Skeletal and sexual maturation and growth in Tokyo girls : longitudinal observations. Clin Pediatr Endocrinol 2 (Suppl 1) : 5-8, 1993

 

19) 田中敏章, 今井敏子 : 縦断的検討による女児の思春期の成熟と初経年齢の標準化. 日小児会誌 109 : 1232-1242, 2005

 

20) 厚生労働科学研究費費補助金難治性疾患克服研究事業 間脳下垂体機能障害に関する調査研究班 平成15年度総括・分担研究報告書. pp119-120, 2004

 

21) Carel JC, Eugster EA, Rogol A, et al : Consensus statement on the use of gonadotropin-releasing analogs in children. Pediatrics 123 : e752-762, 2009

PubMed

22) 安達昌功 : 思春期早発症の治療基準と予後との関係. 小児内科 44 : 612-616, 2012

Medical*Online

23) Ohyama K, Tanaka T, Tachibana K, et al : Timing for discontinuation of treatment with a long-acting gonadotropin-releasing hormone analog in girls with central precocious puberty. TAP-144SR CPP study group. Endocr J 45 : 351-356, 1998

 

24) Tanaka T, Niimi H, Matsuo N, et al : Results of long-terln follow-up after treatment of central precocious ouberty with leuprorelin acetate : evaluation ofeffectiveness of treatment and recovery of gonadal function. The TAP-144-SR Japanese study group on central precocious puberty. J Clin Endocrinol Metab 90 : 1371-1376, 2005

 

P.371 掲載の参考文献

1) McCune DJ : Osteita fibrosa cystica : the case of nine-year-old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Am J Dis Child 52 : 743-744, 1936

 

2) Albright E Butler AM, Smith P, et al : Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females. N Engl J Med 216 : 727-746, 1937

 

3) Vladimir V, Adrian FD, Albert B, et al : McCune-Albright syndrome : A detailed pathological and genetic analysis of disease effects in an adult patient. J Clin Endocrinol Metab 99 : E2029-2038, 2014

 

4) Dumitrescu CE, Collins MT : McCune-Albright syndrome. Orphartet J Rare Dis 3 : 12, 2008

PubMed

5) Narumi S, Matsuo K, Hasegawa T, et al : Quantitative and sensitive detection of GNAS mutations causing McCune-Albright syndrome with next generation sequences. PLos One 8 : e60525, 2013 doi : 10.1371/joumal. pone. 0060525

 

6) Mastorakos G, Mitsiades NS, Koutras DA, et al : Hyperthyroidism in McCune-Albright syndrome with a review of thyroid abnormalities sixty years after the first report. Thyroid 7 : 433-439, 1997

PubMed

7) Danon M, Crawford JD : The McCune-Albright syndrome. Ergeb Inn Med Kinderheilkd 55 : 81-115, 1987

PubMed

8) Collins MT, Chebli C, Robey PG, et al : Renal phosphate wasting in fibrous dysplasia of bone is part of a generalized renal tubular dysfunction similar to that seen in tumor-induced osteomalacia. J Bone Miner Res 16 : 806-813, 2001

PubMed

P.376 掲載の参考文献

1) Styne DM, Grumbach MM : Puberty : ontogeny, neuroendocrinology, physiology, and disorders. In Melmed S, Polonsky KS, Larsen PR, et al (eds) : Williams Textbook of Endocrinology, 12th ed, Saunders Elsevier, Philadelphia, pp1054-1233, 2011

 

2) Harrington J, Palmert MR : Distinguishing constitutional delay of growth and puberty from isolated hypogonadotropic hypogonadism : critical appraisal of available diagnostic tests. J Clin Endocrinol Metab 97 : 3056-3067, 2012

PubMed

3) Villanueva C, Argente J : Pathology or nomlal variant : what constitutes a delay in puberty? Horm Res Paediatr 82 : 213-221, 2014

PubMed

4) 佐々木悟郎, 長谷川奉延 : 性腺疾患. 小児科臨床 65 : 727-733, 2012

Medical*Online

5) Rosenfield RL : Diagnosis and management of delayed puberty. J Clin Endocrinol Metab 70 : 559-562, 1990

PubMed

6) LaFranchi S, Hanna CE, Mandel SH : Constitutional delay of growth : expected versus final adult height. Pediatrics 87 : 82-87, 1991

PubMed

7) Sedlmeyer IL, Palmert MR : Delayed puberty : analysis of a large case series from an academic center. J Clin Endocrinol Metab 87 : 1613-1620, 2002

 

8) Palmert MR, Dunkel L : Clinical practice. Delayed puberty. N Engl J Med 366 : 443-453, 2012

PubMed

9) Carel JC, Leger J : Clinical practice. Precocious puberty. N Engl J Med 358 : 2366-2377, 2008

PubMed

10) Odink RJ, Schoemaker J, Schoute E, et al : Predictive value of serum follicle-stimulating hormone levels in the differentiation between hypogonadotropic hypogonadism and constitutional delay of puberty. Horm Res 49 : 279-287, 1998

PubMed

11) Segal TY, Mehta A, Anazodo A, et al : Role of gonadotropin-releasing hormone and human chorionic gonadotropin stimulation tests in differentiating patients with hypogonadotropic hypogonadism from those with constitutional delay of growth and puberty. J Clin Endocrinol Metab 94 : 780-785, 2009

PubMed

12) Coutant R, Biette-Demeneix E, Bouvattier C, et al : Baseline inhibin B and anti-Mullerian hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty. J Clin Endocrinol Metab 95 : 5225-5232, 2010

PubMed

P.382 掲載の参考文献

1) Narumi S, Muroya K, Abe Y, et al : TSHR mutations as a cause ofcongenital hypothyroidisin in Japan : a population-based genetic epidemiology study. J Clin Endocrinol Metab 94 : 1317-1323, 2009

 

2) Narumi S, Muroya K, Asakura Y, et al : Transcription factor mutations and congenital hypothyroidism : systematic genetic screening of a population-based cohort of Japanese patients. J Clin Endocrinol Metab 95 : 1981-1985, 2010

PubMed

3) Narumi S, Muroya K, Asakura Y, et al : Molecular basis of thyroid dyshormonogenesis : genetic screening in population-based Japanese patients. JClin Endocrinol Metab 96 : E1838-1842, 2011

 

4) Tajima T, Nakamura A, Ishizu K : A novel mutation of IGSF1 in a Japanese patient of congenital central hypothyroidism without macroorchidism. Endocr J 60 : 245-249, 2013

 

5) Nakamura A, Bak B, Silander TL, et al : Three novel IGSF1 mutations in four Japanese patients with X-linked congenital central hypothyroidism. J Clin Endocrinol Metab 98 : E1682-1691, 2013

PubMed

6) Castanet M, Polak M, Bonaiti-Pellie C, et al : Nine-teen years of national screening for congenital hypothyroidism : familial cases with thyroid dysgenesis suggest the involvement of genetic factors. J Clin Endocrinol Metab 86 : 2009-2014, 2001

 

7) Ito M, Miyauchi A, Morita S, et al : TSH-suppressive doses oflevothyroxine are required to achieve preoperative native serum triiodothyronine levels in patients who have undergone total thyroidectomy. Eur J Endocrinol 167 : 373-378, 2012

PubMed

8) Devos H, Rodd C, Gagne N, et al : A search for the possible molecular mechanisms of thyroid dysgenesis : sex ratios and associated malformations. J Clin Endocrinol Metab 84 : 2502-2506, 1999

PubMed

9) Nishiyama S, Mikeda T, Okada T, et al : Transient hypothyroidism or persistent hyperthyrotropinemia in neonates bom to mothers with excessive iodine intake. Thyroid 14 : 1077-1083, 2004

PubMed

10) Hishinuma A, Fukata S, Kakudo K, et al : High incidence of thyroid cancer in long-standing goiters with thyroglobulin mutations. Thyroid 15 : 1079-1084, 2005

PubMed

・ 日本小児内分泌学会マス・スクーリング委員会, 日本マス・スクリーニング学会 : 先天性甲状腺機能低下症マス・スクリーニングガイドライン (2014年改訂版) http://jspe.umin.jp/medical/files/CH_gui.pdf (2015年8月12日アクセス)

 

P.389 掲載の参考文献

1) Brix TH, Kyvik KO, HegedUs L : A population-based study of chronic autoimmul) e hypothyroidism in Danish twins. J Clin Endocrinol Metab 85 : 536-539, 2000

 

2) Simmonds MJ, Kawoura FK, Brand OJ, et al : Skewed X chromosome inactivation and female preponderance in autoimmune thyroid disease : an association study and meta-analys is. J Clin Endocrinol Metab 99 : E127-131, 2014

 

3) Simmonds MJ : GWAS in autoimmune thyroid disease : redefining our understanding of pathogenesis. Nat Rev Endocrinol 9 : 277-287, 2013

PubMed

4) Farid NR, Sampson L, Moens H, et al : The association of goitrous autoimmune thyroiditis with HLA-DR5. Tissue Antigens 17 : 265-268, 1981

PubMed

5) Jacobson EM, Huber A, Tomer Y : The HLA gene coinplex in thyroid autoimmunity : from epidemiology to etiology. J Autoimmun 30 : 58-62, 2008

 

6) Menconi F, Monti MC, Greenberg DA, et al : Molecular amino acid signat, ures in the MHC class II peptide-binding pocket predispose to autoimmume thyroiditis in humans and in mice. Proc Natl Acad Sci USA 105 : 14034-14039, 2008

 

7) Ueda H, Howson JM, Esposito L, et al : Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423 : 506-511, 2003

 

8) Vang T, Liu WH, Delacroix L, et al : LYP inhibits T-cell activation when dissociated from CSK. Nat Chem Biol 8 : 437-446, 2012

PubMed

9) Shirasawa S, Harada H, Furugaki K, et al : SNPs in the promoter of a B cell-specific antisense transcript, SAS-ZFAT, determine susceptibility to autoimmune thyroid disease. Hum Mol Genet 13 : 2221-2231, 2004

 

10) Sakaguchi S, Miyara M, Costantino CM, et al : FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 10 : 490-500, 2010

PubMed

11) Stefan M, Jacobson EM, Huber AK, et al : Novel variant of thyroglobulin promoter triggers thyroid autoimmunity through an epigenetic interferon alpha-modulated mechanism. J Biol Chem 286 : 31168-31179, 2011

PubMed

12) Kawashima A, Tanigawa K, Akama T, et al : Innate immune activation and thyroid autoimmunity. J Clin Endocrinol Metab 96 : 3661-3671, 2011

PubMed

13) Nilsson M, Husmark J, Bjorkman U, et al : Cytokines and thyroid epithelial integrity : interleukin-1alpha induces dissociation of the junctional complex and paracellular leakage in filter-cultured human thyrocytes. J Clin Endocrinol Metab 83 : 945-952, 1998

PubMed

14) Ben-Skowronek I, Szewczyk L, Kulik-Rechberger B, et al : The differences in T and B cell subsets in thyroid of children with Graves' disease and Hashimoto's thyroiditis. World J Pediatr 9 : 245-250, 2013

 

15) Yamazaki K, Kanaji Y, Shizume K, et al : Reversible inhibition by interferons alpha and beta of 125I incorporation and thyroid hormone release by human thyroid follicles in vitro. J Clin Endocrinol Metab 77 : 1439-1441, 1993

PubMed

16) Caturegli P, Kimura H. A nonclassical model of autoimmune hypothyroidism. Thyroid 20 : 3-5, 2010

 

17) Inoue M, Taketani N, Sato T, et al : High incidence of chronic lymphocytic thyroiditis in apparently healthy school children : epidemiological and clinical study. Endocrinol Jpn 22 : 483-488, 1975

PubMed

18) Tomer Y, Davies TF : Infection, thyroid disease, and autoimmunity. Endocr Rev 14 : 107-120, 1993

PubMed

19) 新美仁男, 佐々木望. 松本生. 他 : 正常小児における抗甲状腺抗体の出現頻度. 日内分泌誌 52 : 626-629, 1976

 

20) Radetti G, Maselli M, Buzi F, et al : The natural history of the normal/mild elevated TSH serum levels in children and adolescents with Hashimoto's thyroiditis and isolated hyperthyrotropinaemia : a 3-year follow-up. Clin Endocrinol (Oxf) 76 : 394-398, 2012

PubMed

P.392 掲載の参考文献

1) Pearce EN, Farwell AP, Braverman LE : Thyroiditis. N Engl J Med 348 : 2646-2655, 2003

PubMed

2) Archana B, Glenn DB : Thyroiditis. Am Family Physician 73 : 1769-1776, 2006

 

3) Takai S, Miyauchi A, Matsuzaka F, et al. Internal fistula as a route of infection in acute suppurative thyroiditis. Lancet 313 : 751-752, 1979

 

4) Matsuoka H, Miyauchi A, Tomoda C, et al : Imaging studies in sixty patients with acute suppurative thyroiditis. Thyroid 21 : 1075-1080, 2011

 

5) Paes JE, Burman KD, Cohen J, et al : Acute bacterial suppurative thyroiditis : A clinical review and expert opinion. Thyroid 220 : 247-255, 2010

 

6) Miyauchi A, Matsuzaka E Kuma K, et al : Piriform sinus fistula : An underlying abnormality common in patients. Woeld J Surg 14 : 400-405, 1990

 

7) Dayan CM, Daniels GH : Chronic autoimmune thyroiditis. N Engl J Med 335 : 99-107, 1886

 

8) Ogawa E, Katsushima Y, Fujiwara I, et al : Subacute thyroiditis in children : Patient report and review of the literature. J Pediatr Endocrinol Metab 16 : 897-900, 2003

PubMed

9) Samuels MH : Subacute, silent, and postpartum thyroiditis. Med Clin North Am 96 : 223-233, 2012

PubMed

P.398 掲載の参考文献

1) 日本甲状腺学会 : バセドウ病治療ガイドライン 2011. 南江堂, 東京, 2011

 

2) Williamson S, Greene SA : Incidence of thyrotoxicosis in childhood : anational population based study in the UK and Ireland. Clin Endocrinol (Oxf) 72 : 358-363, 2010

 

3) Leger J, Kaguelidou F, Alberti C, et al : Graves' disease in children. Best Pract Res Clin Endocrinol Metab 28 : 233-243, 2014

PubMed

4) Gershengorn MC1, Neumann S : Update in TSH receptor agonists and antagonists. J Clin Endocrinol Metab 97 : 4287-4292, 2012

 

5) Nishihara E, Chen CR, Higashiyaina T, et al : Subclinical nonautoimmune hyperthyroidism in a family segregates with a thyrotropin receptor mutation with weakly increased constitutive activity. Thyroid 20 : 1307-1314, 2010

 

6) 佐藤浩一, 佐々木望, 原田正平, 他 : 小児期発症バセドウ病薬物治療のガイドライン 2008. 日小児会誌 112 : 946-952, 2008

 

7) Bahn RS, Burch HB, Cooper DS, et al : American Thyroid Association : American Association of Clinical Endocrinologists : Hyperthyroidism and other causes of thyrotoxicosis : management guidelines of the American Thyroid Association and Anierican Association of Clinical Endocrinologists. Endocr Pract 17 : 456-520, 2011

 

8) 福成信博 : 中毒性結節性甲状腺腫 (Plummer病). 甲状腺疾患診療マニュアル, 改訂2版, 診断と治療社, 東京, pp 129-131, 2014

 

9) Akamizu T1, Satoh T, Isozaki O, et al : Diagnostic criteria and clinico-epidemiological features of thyroid storm based on a nationwide survey. Thyroid 22 : 661-679, 2012

 

10) Leger J, Gelwane G, Kaguelidou E et al ; French Childhood Graves'Disease Study Group : Positive impact of long-term antithyroid drug treatment on the outcome of children with Graves' disease : national long-term cohort study. J Clin Endocrinol Metab 97 : 110-119, 2012

 

・ 難病情報センター : TSH受容体異常症 http://www.nanbyou.or.jp/entry/152 (2015年8月13日アクセス)

 

・ 日本甲状腺学会 : 甲状腺疾患診断ガイドライン 2013 http://www.japanthyroid.jp/doctor/guideline/japanese.html (2015年8月13日アクセス)

 

・日本核医学会分科会 腫瘍・免疫核医学研究会 甲状腺RI治療委員会 (編) : バセドウ病の放射性ヨウ素内用療法に関するガイドライン http://oncology.jsnm.org/files/pdf/pasedo-guideline_201309.pdf (2015年8月13日アクセス)

 

・ 日本甲状腺学会臨床重要課題 甲状腺クリーゼの診断基準作成と全国調査 診断基準 (第2版) http://wwwjapanthyroid.jp/doctor/img/crisis2.pdf (2015年8月13日アクセス)

 

・ 厚生労働省 : 重篤副作用疾患別対応マニュアル 甲状腺中毒症 http://www.mhlw.go.jp/topics/2006/11/dl/tp1122-1d05.pdf (2015年8月13日アクセス)

 

・ 妊娠初期のチアマゾール投与に関する注意喚起について (2011. 11. 30) http://wwwjapanthyroidjp/doctor/information/index.html (2015年8月13日アクセス)

 

P.404 掲載の参考文献

1) Rubin MR, Levine MA : Hypoparathyroidism and pseudohypoparathyroidism. In Rosen CJ (ed) : Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 8th ed, Jolm Wiley & Solls, Ames, pp579-589, 2013

 

2) Carpenter TO : Disorders of mineral metabolism in childhood. In Rosen CJ (ed) : Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 8th ed, John Wiley & Sons, Ames, pp651-658, 2013

 

3) 難波範行 : 副甲状腺機能低下症および偽性副甲状腺機能低下症. 内分泌・糖尿病・代謝内科 37 : 373-379, 2013

 

4) 難波範行, 大薗恵一 : カルシウム感知受容体における病態. 臨床検査 55 : 973-978, 2011

 

5) Endo Y, Noguchi S, Hara Y, et al : Dominant mutations in ORAI1 cause tubular aggregate myopathy with hypocalcemia via constitutive activation of store-operated Ca2+ channels. Hum Mol Genet 24 : 637-648, 2015

PubMed

6) Fukumoto S, Namba N, Ozono K, et al : Causes and differential diagnosis of hypocalcemia-recommendation proposed by expert panel supported by ministry of health, labour and welfare, Japan. Endocr J 55 : 787-794, 2008

 

7) Goswami R, Sharma R, Sreenivas V, et al : Prevalence and progression of basal ganglia calci fication and its pathogenic mechanism in patients with idiopathic hypoparathyroidism. Clin Endocrinol (Oxf) 77 : 200-206, 2012

 

8) Aggarwal S, Kailash S, Sagar R, et al : Neuropsychological dysfunction in idiopathic hypoparathyroidism and its relationship with intracranial calcification and serum total calcium. Eur J Endocrinol 168 : 895-903, 2013

PubMed

9) Sato K, Hasegawa Y, Nakae J, et al : Hydrochlorothiazide effectively reduces urinary calcium excretion in two Japanese patients with gain-of-function mutations of the calcium-sensing receptor gene. J Clin Endocrinol Metab 87 : 3068-3073, 2002

 

10) Winer KK Fulton KA, Albert PS et al : Effects of pump versus twice-daily injection delivery of synthetic parathyroid hormone 1-34 in children with severe congenital hypoparathyroidism. J Pediatr 165 : 556-663, 2014

PubMed

・ Calcium-Sensing Receptor Database http://www.casrdb.mcgill.ca (2015年8月13日アクセス)

 

P.410 掲載の参考文献

1) Bastepe M, Juppner H : Pseudohypoparathyroidism, Albright's hereditary osteodystrophy, and progressive osseous heteroplasia : Disorders caused by inactivating GNAS mutations. In Jameson JL, DeGroot LJ (eds) : Endocrinology, 6th ed, Elsevier Saunders, Philadelphia, pp1223-1235, 2010

 

2) 尾形悦郎, 山本通子, 松本俊夫, 他 : ヒトPTH- (1-34) によるEllsworth-Howard試験の実施法と判定基準 副甲状腺機能低下症患者における検討. 日内分泌会誌 60 : 971-984, 1984

Medical*Online

3) 安田敏行, 西岡正, 中島博徳, 他 : ヒトPTH- (1-34) を用いた小児におけるEllsworth-Howard試験の集計成績およびその診断基準. ホルモンと臨床 32 : 639-648. 1984

 

4) Nakamura Y, Matsumoto T, Tamakoshi A, et al : Prevalence of idiopathic hypoparathyroidism and pseudohypoparathyroidism in Japan. J Epidemiol 10 : 29-33, 2000

PubMed

5) Liu J, Litman D, Rosenberg MJ, et al : AGNAS1 imprinting defect in pseudohypoparathyroidism type IB. J Clin Invest 106 : 1167-1174, 2000

 

6) Bastepe M, Frohlich LE Hendy GN, et al : Autosomal donlinant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS. J Clin Invest 112 : 1255-1263, 2003

 

7) Bastepe M, Frohlich LF, Linglart A, et al : Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type Ib. Nat Genet 37 : 25-27, 2005

PubMed

8) Takatani R, Minagawa M, Molinaro A, et al : Similar frequency of paternal uniparental disomy involving chromosome 20q (patUPD20q) in Japanese and Caucasian patients affected by sporadic pseudohypoparathyroidism type Ib (sporPHP1B). Bone 79 : 15-20, 2015

PubMed

P.415 掲載の参考文献

1) Kollars J, Zarroug A, van Heerden J, et al : Primary hyperparathyroidism in pediatric patients. Pediatrics 115 : 974-980, 2005

PubMed

2) Roizen J, Levine MA : Primary hyperparathyroidism in children and adolescents. J Chinese Med Associat 75 : 425-434, 2012

 

3) Mallet E : Primary hyperparathyroidism in neonates and childhood. Homl Res 69 : 180-188, 2008

 

4) 今西康雄, 稲葉雅章 : 原発性副甲状腺機能亢進症の病態生理. 腎と骨代謝 26 : 263-271, 2013

 

5) 山口徹 : 副甲状腺腫瘍の病態生理と臨床像. 日本臨牀 69 (増 2) : 414-423, 2011

 

6) 山内美香, 杉本利嗣 : 副甲状腺腫瘍の検査・診断 ; 概論. 日本臨牀 69 (増 2) : 419-423, 2011

 

7) Durkin ET, Nichol PE Lund DP, et al : What is the optimal treatment for children with primary hyperparathyroidism?. J Pediatr Surg 45 : 1142-1146, 2010

 

8) 速藤逸朗, 松本俊夫 : 副甲状腺腫瘍の臨床研究現状と展望. 日本臨牀 69 (増 2) : 455-459, 2011

 

9) Reh CMS, Hendy GN, Cole DEC, et al : Neonatal hyperparathyroidism with a heterozygous calcium-sensing receptor (CASR) R185Q Mutation : Clinical benefit from cinacalcet. J Clin Endocrinol Metab 96 : E707-712, 2011

PubMed

10) Wilhelm-Bals A, Parvex P, Magdelaine C, et al : Successful use of bisphosphonate and calcimimetic in neonatal severe primary hyperparathyroidism. Pediatrics 129 : e812-816, 2012

PubMed

P.421 掲載の参考文献

1) 藤枝憲二 : 先天性副腎過形成症. 日本小児内分泌学会 (編) : 小児内分泌学. 診断と治療社, 東京, pp342-357, 2009

 

2) Tajima T, et al : Neonatal screening for congenital adrenal Ilyperplasia in Japan. Pediatr Endocrinol Rev 10 : 72-78, 2013

 

3) Morikawa S, Nakamura A, Fujikura K, et al : Results from 28 years of newborn creening for congenital adrenal hyperplasia in Sapporo. Clin Pediatr Endocrinol 23 : 35-43, 2014

 

4) Fukami M, Homma K, Hasegawa T, et al : Backdoor pathway for dihydrotestosterone biosynthesis : implications for normal and abnormal human sex development. Dev Dyn 42 : 320-329, 2013

 

5) 日本小児内分泌学会マス・スクリーニング委員会. 日本マス・スクリーニング学会 : 21-水酸化酵素欠損症の診断・治療のガイドライン (2014年改訂版) http://jspe.umin.jp/medical/gui.html (2015年8月13日アクセス)

 

6) Speiser PW, Azziz R, Baskin LS, et al : Endocrine Society : Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency : an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 95 : 4133-4160, 2010

PubMed

・ 日本小児内分泌学会マス・スクリーニング委員会, 日本マス・スクリーニング学会 : 21-水酸化酵素欠損症の診断・治療のガイドライン (2014年改訂版) http://jspe.umin,jp/medical/gui.html (2015年8月13日アクセス)

 

・ 副腎クリーゼを含む副腎皮質機能低下症の診断と治療に関する指針 http://square.umin.ac.jp/endocrine/rinshojuyo/pdf/zinhuzen.pdf (2015年8月13日アクセス)

 

P.426 掲載の参考文献

1) Clark AJL, Weber A : Adrenocorticotropin insensitivity syndromes. Endocrine Reviews 19 : 828-843, 1998

 

2) Chan LF, Clark AJL, Metherell LA : Familial glucocorticoid deficiency : Advances in the molecular understanding of ACTH action. Horm Res 69 : 75-82, 2008

PubMed

3) Chung Teng-Teng LL, Chan LE Metherell LA, et al : Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2. Clin Endocrinol 72 : 589-594, 2010

 

4) Handschug K, Sperling S, Yoon SJ, et al : Triple A syndrome is caused by mutations in AAAS, a new WD-repeat protein gene. Hum Molecul Genet 10 : 283-290, 2001

 

5) Fujieda K, Tajima T : Molecular basis of adrenal insufficiency Pediatr Res 57 : 62R-69R, 2005

PubMed

6) Lin L, Achermann JC : Inherited adrenal hypoplasia : not just for kids! Clin Endocrinol 60 : 529-537, 2004

 

7) Ferraz-de-Souza B, Lin L, Achermann JC : Steroidogenic factor-1 (SF-1, NR5A1) and human disease. Mol Cell Endocrinol 336 : 198-205, 2011

PubMed

8) Lin L, Achermann JC : Steroidogenic factor-1 (SF-1, Ad4BP, NR5A1) and disorders of testis development. Sex Dev 2 : 200-209, 2008

PubMed

9) Hasegawa T, Fukami M, Sato N, et al : Testicular dysgenesis without adrenal insufficiency in a 46, XY patient with a heterozygous inactive mutation of steroidogenic factor-1. J Clin Endocrinol Metab 89 : 5930-5935, 2004

 

10) Charmandari E, Nicolaides NC, Chrousos GP : Adrenal insufficiency. Lancet 383 : 2152-2167, 2014

PubMed

・ 厚生労働省科学研究費補助金難治性疾患克服に関する調査研究「副腎ホルモン産生異常に関する調査研究」http://www.pediatric-world.com/fuku.jin/index.html (2015年8月13日アクセス)

 

P.429 掲載の参考文献

1) Young WF Jr : Endocrine hypertension. In Melmed S, Polonsky KS, Larsen PR, et al (eds) : Williams Textbook of Endocrinology, 12th ed, WB Saunders, Philadelphia, pp564-571, 2011

 

2) Taguchi R, Yamada M, Nakajima Y, et al : Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas. J Clin Endocrinol Metab 97 : 1311-1319, 2012

PubMed

3) Zennaro M-C, Boulkroun S, Fernandes-Rosa F : An update on novel mechanisms of primary aldosteronism. J Endocrinol 224 : R63-77, 2015

PubMed

4) Weiner D : Endocrine and hypertensive disorders of potassium regulation : primary aldosteronism. Semin Nephrol 33 : 265-276, 2013

 

5) Founder JW, Carey RM, Fardella C, et al : Case detection, diagnosis, and treatment of patients with primary aldosteronism : An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 93 : 3266-3281, 2008

 

6) Nishikawa T, Omura M, Satoh E et al : Guideline for the diagnosis and treatment of primary aldosteronism-The Japan Endocrine Society 2009. Endocrine J 58 : 711-721, 2011

 

・ 難病情報センター : 診断・治療指針 (医療従事者向け). 原発性アルドステロン症 http://www.nanbyou.orjp/entry/248 (2015年8月13日アクセス)

 

P.434 掲載の参考文献

1) Riepe FG : Clinical and molecular features of type 1 pseudohypoaldosteronism. Horm Res 72 : 1-9, 2009

PubMed

2) Hudson WH, Youn C, Ortlund EA : Crystal structure of the mineralocorticoid receptor DNA binding domain in complex with DNA. PLoS One 9 (9) : e107000, 2014

PubMed

3) Uchida S, Sohara E, Rai T, et al : Regulation of with-no-lysine kinase signaling by Kelch-like proteins. Biol Cell 106 : 45-56, 2014

PubMed

4) Pathare G, Hoenderop JGJ, Bindels RJM, et al : A molecular update on pseudohypoaldosteronism type II. Am J Physiol Renal Physiol 305 : F1513-1520, 2013

PubMed

5) Boyden LM, Choi M, Choate KA, et al : Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalities. Nature 482 : 98-102, 2012

PubMed

6) Mayan H, Vered I, Mouallem M, et al : Pseudohypoaldosteronism type H : marked sensitivity to thiazides, hypercalciuria, normomagnesemia, and low bone mineral density. J Clin Endocririol Metab 87 : 3248-3254, 2002

 

7) Diaz-Thomas A, Pascual-Y-Baralt JF : Pseudohypoaldosteronism Medication. Medscape http://emedicine.medscape.com/article/924100-medication#6 (2015年8月13日アクセス)

 

P.438 掲載の参考文献

1) Ten S1, New M, Maclaren N : Clinical review 130 : Addison's disease 2001. J Clin Endocrinol Metab 86 : 2909-2922, 2001

 

2) 日本内分泌学会. 厚生労働科学研究費補助金政策研究事業「副腎ホルモン産生異常に関する調査研究」班合同作成 : 副腎クリーゼを含む副腎皮質機能低下症の診断と治療に関する指針 (最終版) http://square.umin.acjp/endocrine/rinsho_juyo/pdf/zinhuzen.pdf (2015年8月13日アクセス)

 

3) Husebye ES1, Allolio B, Arlt W, et al : Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency. J Intern Med 275 : 104-115, 2014

 

4) Miller WL, Fluck CE : Adrenal cortex and its disorder. In Sperling MA (eds) : Pediatric Endocrinology, 4th ed, Saunders, Philadelphia, pp473-526, 2014

 

5) Hsieh S, White PC : Presentation of primalry adrenal insufficiency in childhood. J Clin Endocrinol Metab 96 : E925-928, 2011

PubMed

6) Brandao Neto RA, de Carvalho JF : Diagnosis and classification of Addison's disease (autoimmune adrenalitis). Autoimmun Rev 13 : 408-411, 2014

PubMed

7) Bethin KL, Muglia LJ : Adrenal insufficiency. In Radovick S, MacGillivray MH (eds) : Pediatric Endocrinology : A Practical Clinical Guide, 2nd ed, Springer, New York, pp 199-258, 2013

 

P.442 掲載の参考文献

1) 石井智弘 : Cushing症候群. 小児内科 44 (増刊) : 214-217, 2012

 

2) Keil MF : Quality of life and other outcomes in children treated for Cushing syndrome. J Clin Endocrinol Metab 98 : 2667-2678, 2013

PubMed

3) More J, et al : Ectopic ACTH syndrome in children and adolescents. J Clin Endocrinol Metab 96 : 1213-1222, 2011

PubMed

4) Magiakou MA, et al. : Cushing's syndrome in children and adolescents presentation, diagnosis and therapy. N Engl J Med 331 : 629-636, 1994

PubMed

5) Stwart PM, Krone NP : Glucocorticoid exess. In Melmed S, et al (eds) : Williams Textbook of Endocrinology, 12ed ed, Saunders, Philadelphia, pp497-515, 2011

 

6) Nieman LK, et al : The diagnosis of Cushing's syndrome : An Endocrin Society clinical practice guideline. J Clin Endocrinol Metab 93 : 1526-1540, 2008

 

7) Arnaldi G, et al : Diagnosis and complications of Cushing's syndrome : Aconsensus statement. J Clin Endclinol Metab 88 : 5593-5602, 2003

 

P.445 掲載の参考文献

1) Bausch B, Wellner U, Bausch D, et al : Long-term prognosis of patients with pediatric pheochromocytoma. Endocr Relat Cancer 21 : 17-25, 2014

PubMed

2) Waguespack SG, Rich T, Grubbs E, et al : A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 95 : 2023-2037, 2010

 

3) Armstrong R, Sridhar M, Greenhalgh KL, et al : Phaeochromocytoma in children. Arch Dis Child 93 : 899-904, 2008

PubMed

4) Dahia PLM : Pheochromocytoma and paraganglioma pathogenesis : leaming from genetic heterogeneity. Nat Rev Cancer 14 : 108-119, 2014

 

5) 大関武彦 : II 各論 G. 褐色細胞腫. 日本小児内分泌学会 (編) : 小児内分泌学. 診断と治療社. 東京, pp382-385, 2009

 

6) Eisenhofer G, Goldstein DS, Walther MM, et al : Biochemical diagnosis of pheochromocytoma : how to distinguish true-from false-positive test results. J Clin Endocrinol Metab 88 : 2656-2666, 2003

PubMed

7) Ludwig AD, Feig DI, Brandt ML, et al : Recent advances in the diagnosis and treatment of pheochromocytoma in children. Am J Surg 194 : 792-796, 2007

PubMed

8) Kravarusic D, Pinto-Rojas A, Al-Assiri A, et al : Laparoscopic resection of extraadrenal pheochromocytoma : case report and review of the literature in pediatric patients. J Pediatr Surg 42 : 1780-1784, 2007

PubMed

9) Scholz T, Eisenhofer G, Pacak K, et al : Current treatment of malignant pheochromocytoma. J Clin Endocrinol Metab 92 : 1217-1225, 2007

PubMed

P.455 掲載の参考文献

1) 大山建司 : 性分化疾患の実態調査結果. 日小児会誌 115 : 1-4, 2011

 

2) Ahmed SF, Khwaja O, Hughes IA : The role of a clinical score in the assessment of ambiguous genitalia. BJU Int 85 : 120-124, 2008

 

3) Ishii T, Matsuo N, Inokuchi M, et al : A cross-sectional growth reference and chart of stretched penile length for Japanese boys aged 0-7 years. Horm Res Paediatr 82 : 388-393, 2014

 

4) 横谷進, 加藤和夫, 諏訪城三 : 未熟児・新生児・乳児における陰茎及び陰核の大きさの計測. ホルモンと臨床 31 : 1215-1220, 1983

 

5) Callegari C, Everett S, Ross M, et al : Anogenital ratio : measure of fetal virilization in premature and full-term newborn infants. J Pediatr 111 : 240-243, 1987

PubMed

6) Rey RA, Belville C, Nihoul-Fekete C, et al : Evaluation of gonadal function in 107 intersex patients by means of serum antimUllerian hormone measurement. J Clin Endocrinol Metab 84 : 627-631, 1999

PubMed

7) Mendez JP, Schiavon R, Diaz-Cueto L, et al : A reliable endocrine test with human menopausal gonadotropins for diagnosis of true hermaphroditism in early infancy. J Clin Endocrinol Metab 83 : 3523-3526, 1998

PubMed

8) Cox K, Bryce J, Jiang J, et al : Novel associations in disorders of sex development : findings from the I-DSD registry. J Clin Endocrinol Metab 99 : E348-355, 2014

PubMed

9) Cools M, Looijenga LH, Wolffenbuttel KP, et al : Managing the risk of gerni cell tumourigenesis in disorders of sex development patients. Endocr Dev 27 : 185-196, 2014

 

10) Furtado PS1, Moraes F, Lago R, et al : Gender dysphoria associated with disorders of sex development. Nat Rev Urol 9 : 620-627, 2012

 

・ 日本小児内分泌学会性分化委員会 : 性分化疾患初期対応の手引き http://jspe.umin.jp/medical/files/seibunkamanual_2011.1.pdf (2015年8月13日アクセス)

 

・ 日本小児内分泌学会性分化・委員会 : 性分化疾患対応の手引き (小児期) http://jspe.umin.jp/files/dsd_ver7.pdf (2015年8月13日アクセス)

 

P.460 掲載の参考文献

1) 田中敏章, 横谷進, 長谷川奉延, 他 : ターナー症候群におけるエストロゲン補充療法ガイドライン. 日小児会誌 112 : 1048-1050, 2008

 

2) Ishii T, Matsuo N, Inokuchi M, et al : A cross-sectional growth reference and chart of stretched penile length for Japanese boys aged 0-7 years. Horm Res Paediatr 82 : 388-393, 2014

 

3) Matsuo N, Ishii T, Takayama JI, et al : Reference standard of penile size and prevalence of buried penis in Japanese newborn male infartts. Endocr J 61 : 849-853, 2014

PubMed

P.464 掲載の参考文献

1) Shenker A, Laue L, Kosugi S, et al : A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty. Nature 365 : 652-654, 1993

PubMed

2) Yano K, Hidaka A, Saji M, et al : A sporadic case of male-limited precocious puberty has the same constitutively activating point mutation in luteinizing hormone/choriogonadotropin receptor gene as familial cases. J Clin Endocr Metab 79 : 1818-1823, 1994

 

3) Yano K, Saji M, Hidaka A, et al : A new constitutively activating Point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty. J Clin Endocr Metab 80 : 1162-1168, 1995

PubMed

4) Yano K, Kohn LD, Saji M, et al : A case of male-limited precocious puberty caused by a point mutation in the second transmembrane domain of the luteinizing hormone choriogonadotropin receptor gene. Biochem Biophys Res Commun 220 : 1036-1042, 1996

 

5) Shinagawa T, Katsumata N, Sato N, et al : Japanese familial patients with male-limited precocious puberty. Endocrine J 47 : 777-782, 2000

 

6) Nagasaki K, Katsumata N, Ogawa Y, et al : Novel C617Y mutation in the 7th transmembrane segment of luteinizing hormone/choriogonadotropin receptor in a Japanese boy with peripheral precocious puberty. Endocrine J 57 : 1055-1060, 2010

 

7) Yoshizawa-Ogasawara A, Katsumata N, Horikawa R, et al : Third-generation aromatase inhibitor improved adult height in a Japanese boy with testotoxicosis. Clin Pediatr Endocrinol 23 : 53-58, 2014

 

8) Kosugi S, Van Dop C, Geffner ME, et al : Characterization of heterogeneous mutations causing constitutive activation of the luteinizing hormone receptor in familial male precocious puberty. Hum Molec Genet 4 : 183-188, 1995

PubMed

9) Rosenthal IM, Refetoff S, Rich B, et al : Response to challenge with gonadotropin-releasing hormone agonist in a mother and her two sons with a constitutively activating mutation of the luteinizing hormone receptor--a clinical research center study. J Clin Endocr Metab 81 : 3802-3806, 1996

 

10) Schedewie HK, Reiter EO, Beitins IZ, et al : Testicular Leydig cell hyperplasia as a cause of familial sexual precocity. J Clin Endocr Metab 52 : 271-278, 1981

PubMed

11) Reiter EO, Brown RS, Longcope C, et al : Male-limited familial precocious puberty in three generations-apparent Leydig-cell autonomy and elevated glycoprotein hormone alpha subunit. N Engl J Med 311 : 515-519, 1984

PubMed

12) Egli CA, Rosenthal SM, Grumbach MM, et al : Pituitary gonadotropin-independent male-limited autosomal dominant sexual precocity in nine generations : familial testotoxicosis. J Pediatr 106 : 33-40, 1985

PubMed

13) Kreher NC, Pescovitz OH, Delameter P, et al : Treatment of familial male-limited precocious puberty with bicalutamide and anastrozole. J Pediatr 149 : 416-420, 2006

PubMed

14) Lenz AM, Shulman D, Eugster EA, et al : Bicalutamide and third-generation aromatase inhibitors in testotoxicosis. Pediatrics 126 : e728-733, 2010

PubMed

15) Reiter EO, Mauras N, McCormick K, et al : Bicalutamide plus anastrozole for the treatment of gonadotropin-independent precocious puberty in boys with testotoxicosis : a phase II, open-label pilot study (BATT). J Pediatr Endocrinol Metab 23 : 999-1009, 2010

 

16) Martin MM, Wu SM, Martin ALA, et al : Testicular seminoma in a patient with a constitutively activating mutation of the luteinizing hormone/chorionic gonadotropin receptor. Eur J Endocr 139 : 101-106, 1998

 

17) Liu G, Duranteau L, Carel JC, et al : Leydig-cell tumors caused by an activating mutation of the gene encoding the luteinizing hormone receptor. N Engl J Med 341 : 1731-1736, 1999

PubMed

18) Canto P, Soderlund D, Ramon G, et al : Mutational analysis of the luteinizing hormone receptor gene in two individuals with Leydig cell tumors. Am J Med Genet 108 : 148-152, 2002

PubMed

・ Bicalutamide Anastrozole Treatment for Testotoxicosis, Astrazeneca (米国, 臨床試験第II相 [BATT] study) https://clinicaltrials.gov/ct/show/NCT00094328 (2015年8月13日アクセス)

 

P.471 掲載の参考文献

1) Oeffinger KC, et al ; Childhood Cancer Survivor Study. : Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355 : 1572-1582, 2006

PubMed

2) de Fine Licht S, et al : ALiCCS study group : Hospital contacts for endocrine disorders in Adult Life after Childhood Cancerin Scandinavia (ALiCCS) : apopulation-based cohort study. Lancet 383 : 1981-1989, 2014

 

3) Shalet SM, et al : Growth and pituitary function in children treated for brain tumours or acute lymphoblastic leukaemia. Horm Res 30 : 53-61, 1988

 

4) 日本小児内分泌学会CCS委員会 : 小児がん経験者 (CCS) のための医師向けフォローアップガイド ver 1.1 http://jplsg.jp/menu11_contents/CCS%20follow-up%20guide%20ver1.1.pdf (2015年8月13日アクセス)

 

5) Sigurdson AJ, et al : Primary thyroid cancer after afirst tumour in childhood (the Childhood Cancer Survivor Study) : a nested case-control study. Lancet 365 : 2014-2023, 2005

 

V. 腎・泌尿器疾患

P.477 掲載の参考文献

1) Iseki K, Iseki C, Ikemiya Y, et al : Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 49 : 800-805, 1996

 

2) Pollak MR, Quaggin SE, Hoenig MP, et al : The glomerulus : the sphere of influence. Clin J Am Soc Nephrol 9 : 1461-1469, 2014

PubMed

3) Tryggvason K, Patrakka J, Wartiovaara J : Hereditary proteinuria syndromes and mechanisms of proteinuria. N Engl J Med 354 : 1387-1401, 2006

PubMed

4) Sadowski CE, Lovric S, Ashraf S, et al : A Single-gene cause in 29. 5%of cases of steroid-resistant nephrotic syndrome. J Am Soc Nephrol 26 : 1279-1289, 2015

 

5) D'Agati VD, Kaskel FJ, Falk RJ : Focal segmental glomerulosclerosis. N Engl J Med 365 : 2398-2411, 2011

PubMed

6) Wei C, El Hindi S, Li J, et al : Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17 : 952-960, 2011

PubMed

7) Harita Y, Ishizuka K, Tanego A, et al : Decreased glomerular filtration as the primary factor of elevated circulating suPAR levels in focal segmental glomerulosclerosis. Pediatr Nephrol 29 : 1553-1560, 2014

PubMed

8) D'Amico G, Bazzi C : Pathophysiology of proteinuria. Kidney Int 63 : 809-825, 2003

PubMed

9) Bazzi C, Petrini C, Rizza V, et al : A modern approach to selectivity of proteinuria and tubulointerstitial damage in nephrotic syndrome. Kidney Int 58 : 1732-1741, 2000

PubMed

10) Christensen EI, Birn H : Megalin and cubilin : multifunctional endocytic receptors. Nat Rev Mol Cell Biol 3 : 256-266, 2002

PubMed

11) Dickson LE, Wagner MC, Sandoval RM, et al : The proximal tubule and albuminuria : really! J Am Soc Nephrol 25 : 443-453, 2014

PubMed

12) Cravedi P, Remuzzi G : Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney disease. Br J Clin Pharmacol 76 : 516-523, 2013

PubMed

13) Methven S, MacGregor MS, Traynor JP, et al : Comparison of urinary albumin and urinary total protein as predictors of patient outcomes in CKD. Am J Kidney Dis 57 : 21-28, 2011

PubMed

P.485 掲載の参考文献

1) Quiman RJ, Tobin JL, Beales PL : Modeling ciliopathies : Primary cilia in development and disease. Curr Top Dev Biol 84 : 249-310, 2008

 

2) Torres VE, Harris PC : Mechanisms of disease : autosomal dominant and recessive polycystic kidney diseases. Nat Clin Pract Nephrol 2 : 40-55, 2006

PubMed

3) Dell KM, Sweeney WE Jr, Avner ED : Polycystic kidney disease. In Avner ED, Harmon WE, Niaudet P, (eds) : Pediatric Nephrology, 6th ed, Springer, Berlin Heidelberg, pp849-887, 2009

 

4) Wolf MT, Hildebrandt F : Nephronophthisis. Pediatr Nephrol 26 : 181-194, 2011

PubMed

5) Sweeney WE Jr, Avner ED : Diagnosis and management of childhood polycystic kidney disease. Pediatr Nephrol 26 : 675-692, 2011

PubMed

6) Sweeney WE Jr, Avner ED : Pathophysiology of childhood polycystic kidney diseases : new insights into disease-specific therapy. Pediatr Res 75 : 148-157, 2014

PubMed

7) Tbrres VE, Harris PC, Pirson Y : Autosomal dominant polycystic kidney disease. Lancet 369 : 1287-1301, 2007

 

8) TorresVE, Chapman AB, Devuyst O, et al : TEMPO 3 : 4Trial investigators : Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med 367 : 2407-2418, 2012

 

9) Guay-Woodford LM, Desmond RA : Autosomal recessive polycystic kidney disease : the clinical experience in North America. Pediatrics 111 : 1072-1080, 2003

PubMed

・エビデンスに基づく多発性嚢胞腎 (PKD) 診療ガイドライン 2014 http://www.jsn.or.jp/guideline/pdf/PKD_141023.pdf (2015年8月14日アクセス)

 

P.490 掲載の参考文献

1) 武田修明 : 忌性糸球体腎炎. 川戸英彦, 五十嵐隆 (編) : 血尿と蛋白尿全原出版, 東京, pp89-98, 1992

 

2) 池住洋平 : 急性糸球体腎炎. 小児内科 40 (増刊) : 806-810, 2008

 

3) Tasic V : Postinfectious glomerulonephritis. In Geary DE Schaefer F (eds) : Comprehensive Pediatric Nephrology, Mosby, Philadelphia, pp309-317, 2008

 

4) Endo A, Fuchigami T, Hasegawa M, et al : Posterior reversible encephalopathy syndrome in childhood : report of four cases and review of the literature. Pediatr Emerg Care 28 : 153-157, 2012

PubMed

5) 塚原宏一, 桑門克治, 武田修明 : 間質性腎炎 (TINUを除く). 金子一成 (編) : 50の典型例で学ぶ小児の腎泌尿器疾患, 診断と治療社, 東京, pp160-163, 2011

 

P.494 掲載の参考文献

1) Ozen S, Bilginer Y : Henoch-Schomein purpura/immunoglobulin-A vasculitis. In Hochberg MC, Silman N, Smolen JS, et al (eds) : Rheumatology, 6th ed, Elsevier Mosby, Philadelphia, pp1338-1343, 2015

 

2) Jennette JC, Falk RJ, Bacon PA, et al : 2012 revised International Chapel Hill Consensus Conference Nomenclature of vasculitides. Arthritis Rheum 65 : 1-11, 2013

 

3) Pohl M : Henoch-Schonlein purpura nephritis. Pediatr Nephrol 30 : 245-252, 2015

PubMed

4) Davin JC, Coppo R : Henoch-Schonlein purpura nephritis in children. Nat Rev Nephrol 10 : 563-573, 2014

PubMed

5) Haas M : lgA nephropathy and IgA vasculitis (Henoch-Schonlein purpura) nephritis. In Jennette JC, Olson JL, Silva FG, et al (eds) : Heptinstams Pathology of the Kidney, 7th ed, Wolters Kluwer, Philadelphia, pp463-523, 2014

 

6) Lau KK, Suzuki H, Novak J, et, al : Pathogenesis of Henoch-Schonlein purpura nephritis. Pediatr Nephrol 25 : 19-26, 2010

 

7) Coppo R, Aniore A : Henoch-Schoenlein purpura. In Avner ED, Harmon WE, Niaudet P, et al (eds) : Pediatric Nephrology, 6th ed, Springer-Verlag, Berlin, Heidelberg, pp1111-1126, 2009

 

8) 中西浩一, 吉川徳茂 : IgA腎症・紫斑病性腎炎. 小児科臨床 63 : 707-713. 2010

Medical*Online

9) KDIGO guidelines on glomerulonephritis : Henoch-Schonlein purpura nephritis. Kidney Int Suppl 2 : 218-220, 2012

 

10) 五十嵐隆 : Henoch-Schonlein紫斑病性腎炎 : 小児腎疾患の臨床, 5版, 診断と治療社, 東京, pp 186-188, 2012

 

P.500 掲載の参考文献

1) Rosove MH : Thrombotic microangiopathy. Semin Arthritis Rheum 43 : 797-805, 2014

PubMed

2) Verhave JC, Wetzels JFM, van de Kar NCAJ : Novel aspects of atypical haemolytic uraemic syndrome and the role of eculizumab. Nephrol Dial Transplant 29 : iv 131-141, 2014

 

3) Loirat C, Fremeaux-bacci V : Atypical hemolytic uremic syndrome. Orphanet J Rare Dis 6 : 60, 2011

 

4) 溶血性尿毒症症候群の診断・治療ガイドライン作成班 : 五十嵐隆 (総括責任者) : 溶血性尿毒症症候群の診断・治療ガイドライン, 東京医学社. 東京. 2013

 

5) Warwicker P, Goodship THJ, Donne RL, et al : Genetic studies into inherited and sporadic hemolytic uremic syndrome. Kidney Int 53 : 836-844, 1998

 

6) 日本腎臓学会・日本小児科学会合同「非典型溶血性尿毒症症候群診断基準作成委員会 : 非典型溶血性尿毒症症候群診断基準. 日腎会誌 55 : 91-93, 2013

 

7) Zuber J, Fakhouri F, Roumenina LT, et al : Use of eculizmab for haemolytic uraemic syndrome and C3 glomerulopathies. Nat Rev Nephrol 8 : 643-657, 2012

 

8) Hofer J, Rosales A, Fischer C, et al : Extre-renal manifestations of complelnent-mediated thrombotic microangiopathies. Frontier Pediatr 2 : Article 97, 1-16, 2014

 

9) Kawamura N, Yamazaki T, Tamai H : Risk factors for the development of Escherichia coli O157 : H7 associated with hemolytic uremic syndrome. Pediatr Int 41 : 218-222, 1999

PubMed

10) Garg AX, Suri RS, Barrowman N, et al : Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome : A systematic review, meta-analysis, and meta-regression. JAMA 290 : 1360-1370, 2003

PubMed

・ 非典型溶血性尿毒症症候群診断基準 http://www.jsn.or.jp/guideline/pdf/ahus2013.pdf (2015年8月14日アクセス)

 

・ 溶血性尿毒症症候群の診断・治療ガイドライン http://www.jspn.jp/file/pdf/20140618_guideline. pdf (2015年8月14日アクセス)

 

P.505 掲載の参考文献

1) 松尾清一, 山縣邦弘, 槇野博史, 他 : 急速進行性腎炎症候群の診療指針第2版. 日腎会誌 53 : 509-555, 2011

 

2) 松尾清一, 木村健二郎, 有村義宏, 他 : エビデンスに基づく急速進行性腎炎症候群 (RPGN) 診療ガイドライン2014. 日腎会誌 57 : 139-232, 2015

 

3) Shinha A, Puri K, Hari P, et al : Etiology and outcome of crescentic glomerulonephritis. Indian Pediatr 50 : 283-288, 2013

 

4) Jannette JC, Falk RJ, Bacon PA, et al : 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65 : 1-11, 2013

 

5) Bagga A : Crescentic glomerulonephritis. In Avner ED, Harmon WE, Niaudet P, et al (eds) : Pediatric Nephrology, 6th ed, Springer-Verlag, Berlin, Heidelberg, pp815-828, 2009

 

6) Hattori M, Kurayama H, Koitabashi Y, et al : Antineutrophil cytoplasmic autoantibody-associated glomerulonephritis in children. J Am Soc Nephrol 12 : 1493-1500, 2001

 

7) 伊藤秀一 : 急速進行性糸球体腎炎. 小児内科 44 (増刊) : 612-614, 2012

 

8) Stone JH, Merkel PA, Spiera R, et al : Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363 : 221-232, 2010

PubMed

9) Jones RB, Tervaert JW Hauser T, et al : Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med 363 : 211-220, 2010

PubMed

10) Guillevin L, Pagnoux C, Karras A, et al : Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med 371 : 1771-1780, 2014

PubMed

11) Berden AE, Ferrario F, Hagen EC, et al : Histologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 21 : 1628-1636, 2010

PubMed

12) Noone DG, Twilt M, Hayes WN, et al : The new histopathologic classification of ANCA-associated GN and its assocition with renal outcomes in childhood. Clin J Am Soc Nephrol 9 : 1684-1691, 2014

 

13) Li X, Liagn S, Zheng C, et al : Clinicopathological characteristics and outcollle of pediatric patients with systemic small blood vessel vasculitis. Pediatr Nephrol 29 : 2365-2371, 2014

 

・ 日本小児腎臓病学会 http://www.jspn.jp (2015年8月14日アクセス)

 

P.509 掲載の参考文献

1) Alchi B, Jayne D : Membranoproliferative glomerulonephritis. Pediatr Nephrol 25 : 1409-1418, 2010

PubMed

2) Sethi S, Nester CM, Smith RJ : Membranoproliferative glomerulonephritis and C3 glomerulopathy : resolving the confusion. Kidney Int 81 : 434-441, 2012

PubMed

3) Masani N, Jhaveri KD, Fishbane S : Update on membranoproliferative GN. CJASN 9 : 600-608, 2014

PubMed

4) Fakhouri F, Fremeaux-Bacchi V, Noel LH, et al : C3 glomerulopathy : a new classification. Nat Rev Nephrol 6 : 494-499, 2010

PubMed

5) Kawamura T, Usui J, Kaseda K, et al : Primary membranoproliferative glomerulonephritis on the decline : decreased rate from the 1970s to the 2000s in Japan. Clin Exp Nephrol 17 : 248-254, 2013

 

6) Habbig S, Mihatsch MJ, Heinen S, et al : C3 deposition glomerulopathy due to a functional factor H defect. Kidney Int 75 : 1230-1234, 2009

PubMed

7) Tarshish P, Bemstein J, Tobin JN, et al : Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone-a report of the International Study of Kidney Disease in Children. Pediatr Nephrol 6 : 123-130, 1992

 

8) Bomback AS, Smith RJ, Barile GR, et al : Eculizumab for dense deposit disease and C3 glomerulonephritis. CJASN 7 : 748-756, 2012

PubMed

9) Medjeral-Thomas NR, O'Shaughnessy MM, O'Regan JA, et al : C3 glolnerulopathy : clinicopathologic features and predictors of outcome. CJASN 9 : 46-53, 2014

PubMed

P.514 掲載の参考文献

1) Markowitz GS, D'Agati VD : Membranous glomerulonephritis. In Jennette JC, Olso JL, Silva FG, et al (eds) : Heptinstall's Pathology of the Kidney, 7th ed, Wolters Kluwer, Philadelphia, pp255-300, 2015

 

2) Debiec H, Guigonis～V, Mougenot B, et al : Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 346 : 2053-2060, 2002

 

3) Beck LH Jr, Bonegio RG, Lambeau G, et al : M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361 : 11-21, 2009

PubMed

4) Cossey LN, Walker PD, Larsen CP : Phospholipase A2 receptor staining in pediatric idiopathic membranous glomerulopathy. Pediatr Nephrol 28 : 2307-2311, 2013

PubMed

5) Jefferson JA, Couser WG : Membranous nephropathy in the pediatric population. In Avner ED, Harmon WE, Niaudet P, et al (eds) : Pediatric Nephrology, 6th ed, Springer, Philadelphia, pp799-814, 2009

 

6) Nangaku M, Couser WG : Mechanisms of immunedeposit formation and the mediation of immune renal injury. Clin Exp Nephrol 9 : 183-191, 2005

PubMed

7) Makker SP : Membranous glomerulonephritis. In Avner ED, Hamlon WE, Niaudet P (eds) : Pediatric Nephrology, 5th ed, Lippincott Williams & Wilkins, Philadelphia, pp641-654, 2004

 

8) Kanigicherla D, Gummadova J, McKenzie EA, et al : Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kidney Int 83 : 940-948, 2013

 

9) IgG4関連腎臓病ワーキンググループ報告 : IgG4関連腎臓病診療指針. 日腎会誌 53 : 1062-1073, 2011

 

10) 三上直朗. 濱崎祐子, 池宮城雅子, 他 : 乳児期に発症し尿細管基底膜にも沈着を示した膜性腎症の1例. 日小児腎臓病会誌 25 (Supple) : 173, 2012

 

11) Markowitz GS, Seigle RL, D'Agati VD : Three-year-old boy with partial Fanconi syndrome. Am J Kidney Dis 34 : 184-188, 1999

PubMed

12) 本田一穂 : 膜性腎症. 日本腎臓学会・腎病理診断標準化委員会/日本腎病理協会 (編) : 腎生検病理アトラス (「腎生検病理診断標準化への指針」病理改訂版), 東京医学社, 東京, pp98-104, 2010

 

13) The KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2 : 139-274, 2012

 

14) Lee BH, Cho HY, Kang HG, et al : Idiopathic membranous nephropathy in children. Pediatr Nephrol 21 : 1707-1715, 2006

PubMed

15) Zhu B, Huang J : Successful treatment and clearing of circulating CD19-positive cells by rituximab in a child with idiopathic membranous nephropathy. Pediatr Nephrol 26 : 637-638, 2011

 

P.519 掲載の参考文献

1) D'Agati VD, Kaskel FJ, Falk RJ : Focal segmental glomerulosclerosis, N Engl J Med 365 : 2398-2411, 2011

 

2) Sethi S, Glassock RJ, Fervenza FC : Focal segmental glomerulosclerosis : towards a better understanding for the practicing nephrologist. Nephrol Dial Transplant 30 : 375-384, 2015

PubMed

3) Wei C, El Hindi S, Li J, et al : Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med 17 : 952-960, 2011

PubMed

4) Harita Y, Ishizuka K, Tanego A, et al : Decreased glomenular filtration as the primary factor of elevated circulating suPAR levels in focal segmental glomerulosclerosis. Pediatr Nephrol 29 : 1553-1560, 2014

 

5) Sadowski CE, Lovric S, Ashraf S, et al : A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J Am Soc Nephrol [Epub ahead of print], 2014

 

6) D'Agati VD, Fogo AB, Bruijn JA, et al : Pathologic classification of focal segmental glomerulosclerosis : a working proposal. Am J Kidney Dis 43 : 368-382, 2004

PubMed

7) 服部元史 : 小児巣状糸球体硬化症. 腎と透析 76 : 897-900, 2014

 

8) Kidney Disease : Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group : KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2 : 139-274, 2012

 

9) 日本腎臓学会 (編) : エビデンスに基づくCKD診療ガイドライン 2013. 東京医学社, 東京, 2013

 

10) 日本小児腎臓病学会 (編) : 小児特発性ネフローゼ症候群診療ガイドライン 2013, 診断と治療社, 東京, 2013

 

P.525 掲載の参考文献

1) Kawasaki Y : Mechanism of onset and exacerbation of chronic glomerulonephritis and its treatment. Pediatr Int 53 : 795-806, 2011

PubMed

2) Nozawa R, kawasaki Y, Suzuki H, et al : Clinicopathological features and the prognosis of IgA nephropathy in Japanese children on long-term observation. Clin Nephrol 64 : 171-179, 2005

PubMed

3) Gharavi AG, Kiryluk K, Choi, et al : Genome-wide association study identifies susceptibility loci for IfA nephropathy. Nat Genet 43 : 321-327, 2011

 

4) Kunisawa J, Nochi T, Kiyono H : Immunological commonalities and distinctions between airway and digestive immunity. Trend Immunol 29 : 505-513, 2008

PubMed

5) 日本小児腎臓病学会小児IgA腎症治療ガイドライン作成委員会 : 小児IgA腎症治療ガイドライン1.0, pp 1-16, 2007. 7. 14 http://www.jspn.jp/file/pdf/Iga.pdf

 

6) Yoshikawa N, et al : A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. J Am Soc Nephrol 10 : 101-109, 1999

PubMed

7) Kawasaki Y, Suzuki J, Suzuki H, et al : Efficacy of prednisolone and mizoribine therapy for diffuse IgA nephropathy. Am J Nephrol 24 : 147-153, 2004

PubMed

8) Kawasaki Y, Hosoya M, Suzuki H, et al : Efficacy of multidrug therapy combined with mizoribine in children with diffuse IgA nephropathy in comparison with multidrug therapy without mizoribine and with methylprednisolone pulse therapy. Am J Nephrol 24 : 576-581, 2004

PubMed

9) Wung Y, Chen J, Wang Y, et al : A meta-analysis of the clinical remission rate and long-term efficacy of tonsillectomy in patients with IgA nephropathy. Nephrol Dial Transplant 26 : 1923-1931, 2011

 

10) Kawasaki Y, Hosoya M, Suzuki H, et al : Efficacy of tonsillectomy pulse therapy versus multiple-drug therapy for IgA nephropathy. Pediatr Nephrol 21 : 1701-1706, 2006

PubMed

11) Kawasaki Y, Suyama K, Hosoya M, et al : Tonsillectomy with methylprednisolone pulse therapy as rescue treatment for steroid-resistant IgA nephropathy in children. Tohoku J Exp Med 218 : 11-16, 2009

PubMed

12) Kawasaki Y, Suyama K, Hosoya M, et al : Resistance factors for the treatment of immunoglobulin A nephropathy with diffuse mesangial proliferation. Nephrology 19 : 384-391, 2014

 

13) Yata N, Nakanishi K, Shima Y, et al : Improved renal survival in Japanese children with IgA nephropathy. Pediatr Nephrol 23 : 905-912, 2008

PubMed

P.530 掲載の参考文献

1) Hinkes BG, Mucha B, Vlangos CN, et al : Nephrotic syndrome in the first year of life : two thirds of cases are caused by mutations in 4 genes (NPHS1, NPHS2, WT1, and LAMB2). Pediatrics 119 : e907-919, 2007

PubMed

2) Jalanko H, Holmberg C : Congenital nephrotic syndrome. In Avner ED (eds) : Pediatric Nephrology, 6th ed, Lippincott Williams & Wilkins, Philadelphia, pp601-619, 2009

 

3) Holmberg C, Laine J, R6nnholm K, et al : Congenital nephrotic syndrome. Kidney Int 53 (Suppl) : S51-56, 1996

 

4) Kestila M, Lenkkeri U, Manikko M, et al : Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome. Mol Cell 1 : 575-582, 1998

 

5) Sako M, Nakanishi K, Obana M, et al : Analysis of NPHS1, NPHS2, ACTN4, and WT1 in Japanese patients with congenital nephrotic syndrome. Kidney Int 67 : 1248-1255, 2005

PubMed

6) Machuca E, Benoit G, Nevo F, et al : Genotype-phenotype correlations in non-Finnish congenital nephrotic syndrome. J Am Soc Nephrol 21 : 1209-1217, 2010

PubMed

7) Mattoo TK, al-Sowailem AM, al-Harbi MS, et al : Nephrotic syndrome in 1st year of life and the role of unilateral nephrectomy. Pediatr Nephrol 6 : 16-18, 1992

PubMed

8) Kovacevic L, Reid CJ, Rigden SP : Management of congenital nephrotic syndrome. Pediatr Nephrol 18 : 426-430, 2003

PubMed

9) Wasilewska AM, Kuroczycka-Saniutycz E, Zoch-Zwierz W : Effect of cyclosporine A on proteinuria in the course of glomerulopathy associated with WT1 mutations. Eur J Pediatr 170 : 389-391, 2011

PubMed

10) Kuusniemi AM, Qvist E, Sun Y, et al : Plasma change and retransplantation in recurrent nephrosis of patients with congenital nephrotic syndrome of the Finnish type (NPHS1). Transplantation 83 : 1316-1323, 2007

 

P.535 掲載の参考文献

1) 日本小児腎臓病学会 (編) : 小児特発性ネフローゼ症候群診療ガイドライン 2013. 診断と治療社, 東京, pp1-77, 2013

 

2) Garin EH, Diaz LN, Mu W, et al : Urinary CD 80 excretion increases in idiopathic minimal-change disease. J Am Soc Nephrol 20 : 260-266, 2009

 

3) Shimada M, Ishimoto T, Pui Y, et al : Toll-like 3 ligands induce CD80 expression in human podocytes via an NF-κB-dependent pathway. Nephrol Dial Transpl 27 : 81-89, 2012

 

4) Fomoni A, Sageshima J, Wei C, et al : Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med 3 : 85ra46, 2011

PubMed

5) Kidney Disease : Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group : KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2 : 139-274, 2012

 

6) Gipson DS, Massengill SE Yao L, et al : Management of childhood onset nephrotic syndrome. Pediatrics 124 : 747-757, 2009

 

7) Bagga A, Ali U, Banerjee S, et al : Management of steroid-sensitive nephrotic syndrome : revised guidelines. Indian Pediatr 45 : 203-214, 2008

PubMed

8) Iijima K, Sako M, Nozu K, et al : Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome : amulticentre, double-blind, randomized, placebo-controlled trial. Lancet 384 : 1273-1281, 2014

 

9) 飯島一誠 : 特発性ネフローゼ症候群. 日本小児腎臓病学会 (編) 小児腎臓病学, 診断と治療社, 東京, p218, 2012

 

P.541 掲載の参考文献

1) 日本小児腎臓病学会 (編) : 小児特発性ネフローゼ症候群診療ガイドライン 2013, 診断と治療社, 東京, 2013

 

2) Sharma M, Shrma R, Reddy SR, et al : Proteinuria after injection of human focal segmental glomerulosclerosis factor. Transplantation 73 : 366-372, 2002

 

3) Avila-Casado Mdel C, Perez-Tbrres I, Auron A, et al : Proteinuria in rats induced by serum from patients with collapsing glomerulopathy. Kidney Int 66 : 133-143, 2004

 

4) Gallon L, Leventhal J, Skaro A, et al : Resolution of recurrent focal segmental glomerulosclerosis after retransplantation. N Engl J Med 366 : 1648-1649, 2012

PubMed

5) Wei C, Moller CC, Altintas MM, et al : Modification of kidney barrier function by the urokinase receptor. Nat Med 14 : 55-63, 2008

PubMed

6) Shimada M, Araya C, Rivard C, et al : Minimal change disease : a "two-hit" podocyte immune disorder? Pediatr Nephrol 26 : 645-649, 2011

PubMed

7) Hashimura Y, Nozu K, Kanegane H, et al : Minimal change nephrotic syndrome associated with imnune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome. Pediatr Nephrol 24 : 1181-1186, 2009

 

8) Hamasaki Y, Yoshikawa N, Hattori S, et al : Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome. Pediatr Nephrol 24 : 2177-2185, 2009

PubMed

9) Ishikura K, Hamasaki Y, Sakai T, et al : Posterior reversible encephalopathy syndrome in children with kidney diseases. Pediatr Nephrol 27 : 375-384, 2012

PubMed

10) Kamei K, Okada M, Sato M, et al : Rituximab treatment combined with methylprednisolone pulse therapy and immunosuppressants for childhood steroid-resistant nephrotic syndrome. Pediatr Nephrol 29 : 1181-1187, 2014

PubMed

11) Cattran DC, Rao P : Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis 32 : 72-79, 1998

PubMed

・ KIDNEY DISEASE・IMPROVING GLOBAL OUTCOMES : GLOMERULONEPHRITIS (GN) http://kdigo.org/home/glomerulonephritis-gn/ (2015年8月16日アクセス)

 

P.547 掲載の参考文献

1) Hudson BG, Tryggvason K : Alport syndrome, Goodpasture's syndrome, and Type IV collagen. N Engl J Med 348 : 2543-2556, 2003

PubMed

2) Kruegel J, Rubel D, Gross O : Alport syndrome-insights from basic and clinical research. Nat Rev Nephrol 9 : 170-178, 2013

PubMed

3) Yoshikawa N, Caneron AH, White RH : The glomerular basal lamina in hereditary nephritis. J Pathol 135 : 199-209, 1981

 

4) Hashimura Y, Nozu K, Kaito H, et al : Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV α5 chain. Kidney Int 85 : 1208-1213, 2014

 

5) Moriniere V, Dahan K, Hilbert P, et al : Improving mutation screening infamilial hematuric nephropathies through next generation sequencing. J Am Soc Nephrol 25 : 2740-2751, 2014

 

6) The international Alport mutation consortium : DNA variant databases improve test accuracy and phenotype prediction in Alport syndrome. Pediatr Nephrol 29 : 971-977, 2014

PubMed

7) Malone AE phelan PJ, HaU G, et al : Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis. Kidney Int 86 : 1253-1259, 2014

 

8) Savige J, Gregory M, Gross O, et al : Expert guidelines for the management of Nport syndrome and thin basement membrane nephropathy. J Am Soc Nephrol 24 : 364-375, 2013

 

9) Webb NJA, Lam C, Shahinfar S, et al : Efficacy and safety of losartan in children with Alport syndrome-results from a subgroup analysis of a prospective, randomized, placebo-or amlodipine-controlled trial. Nephrol Dial Transplant 26 : 2521-2526, 2011

PubMed

10) Gross O, Licht C, Anders HJ, et al : Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int 81 : 494-501, 2012

PubMed

11) Gross O, Friede T, Hilgers R, et al : Safety and efficacy of the ACE-inhibitor Ramipril in Alport syndrome : The double-blind, randomized, placebo-controlled, multicenter phasem early pro-tect Alport trial in pediatric patients. ISRN Pediatrics 2012 ; 2012 : 436046 doi : 10.5402/2012/436046 [Epub 2012 Jul 1]

 

12) Gomez IG, MacKenna DA, Johnson BG, et al : Anti-microRNA-21 oligonucleotides prevent Alport nephropathy progression by stimulating metabolic pathways. JCI 125 : 141-156, 2015

PubMed

P.552 掲載の参考文献

1) Bensman A, Dunand O, Ulinski T : Urinary tract infections. In Avner ED, Harmon VE, Niaudet P, et al (eds) : Pediatric Nephrology, 6th ed, Springer-Verlag, Berlin, Heidelberg, pp1299-1310, 2009

 

2) Mathews R, Mattoo TK : Primary vesicoureteral reflux and reflux nephropathy. In Johnson RJ, Feehally J, Floege J (eds) : Comprehensive Clinical Nephrology, 5th ed, Saunders Elsevier, Philadelphia, pp737-745, 2015

 

2) 豊村麻記子, 吉村博. 安次嶺馨, 他 : 沖縄県立中部病院における上部尿路感染症-1施設における統一された診断からフォローアップまでの臨床的検討. 日児腎誌 14 : 121-128, 2001

 

3) Committee on Quality lmprovement, Subcommittee on Urinary Tract Infection : Practice parameter : the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. Pediatrics 103 : 843-852, 1999

 

3) Silva JM, Santos Diniz JS, Marino VS, et al : Clinical course of 735 children and adolescents with primary vesicoureteral reflux. Pediatr Nephrol 21 : 981-988, 2006

PubMed

4) Subcommittee On Urinary Tract Infection, Steering Committee On Quality Improvement And Management : Urinary tract infection : clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months. Pediatrics 128 : 595-610, 2011

 

4) Nakai H, Kakizaki H, Konda R, et al : Clinical characteristics of primary vesicoureteral reflux in infants : Multicenter retrospective study in Japan. J Urol 169 : 309-312, 2003

PubMed

5) Peters CA, Skoog SJ, Arant BS Jr, et al : Summary of the AUA guideline on management of primary vesicoureteral reflux in children. J Urol 184 : 1134-1144, 2010

 

5) Williams G, Craig JC : Diagnosis and management of urinary tract infections. In Geary DE Schaefer F (eds) : Comprehensive Pediatric Nephrology, Mosby, Philadelphia, pp539-548, 2008

 

6) Subcommittee on urinary tract infection, steering committee on quality improvement and management : Urinary tract infection : Clinical practice guideline for the diagnosis and management of the initial UT1 in febrile infants and children 2 to 24 months. Pediatrics 128 : 595-610, 2011

 

6) 塚原宏一 : 尿路感染症. 小児内科 40 (増刊) : 867-873, 2008

 

7) Hoberman A, Charron M, Hickey RW : Imaging studies after a first febrile urinary tract infection in young children. N Engl J Med 348 : 195-202, 2003

PubMed

7) 浅沼宏, 中井秀郎, 宍戸清一郎, 他 : 乳児期Refluxing megauretep-High grade VURとの鑑別診断の重要性. 日泌尿器会誌 90 : 818-825, 1999

 

8) 坂井清英, 竹本淳, 近田龍一郎 : DMSA腎シンチグラムによるVURの腎障害の評価と落とし穴. 日小児泌尿器会誌 18 : 16-22, 2009

 

8) Mori R, Lakhanpaul M, Verrier-Jones K : Diagnosis and management of urinary tract infection in children : summary of NICE guidance. BMJ 335 : 395-397, 2007

PubMed

9) Hansson S, Dhamey M, Sigstro O, et al : Dimercapto-succinic acid scintigraphy instead of voiding cystourethrography for infants with urinary tract infection. J Urol 172 : 1071-1074, 2004

 

9) 今村正明, 碓井智子, 上仁数義, 他 :日本語版DVSS (Dysfunctional Voiding Symptom Score) の公式認証-小児質問票における言語学的問題を中心に. 日泌尿器会誌 105 : 112-121, 2014

 

10) Preda I, Jodal U, Sixt R, et al : Normal dimercaptosuccinic acid scintigraphy makes voiding cystourethrography unnecessary after urinary tract infection. J Pediatr 151 : 581-584, 2007

PubMed

10) Craig JC, Simpson JM, Williams GJ, et al : Antibiotic prophylaxis and recurrent urinary tract infection in children. N Engl J Med 361 : 1748-1759, 2009

PubMed

11) The RIVUR Trial investigators : Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med 370 : 2367-2376, 2014

PubMed

11) Asanuma H, Satoh H, Matsui Z, et al : 609 Color Doppler sonographic evaluation of ureteric jet angle in detecting high grade vesicoureteral reflux in children (AUA annual meeting, 2012). J Urol 187 (Suppl) : e248, 2012 doi : http://dx. doi. org/10.1016/j. juro. 2012. 02. 687

 

12) The RIVUR Trial investigators ; Hoberman A, Greenfield SP, Mattoo TK, et al : Antimicrobial prophylaxis for children with vesicoureteral reflux. N Engl J Med 370 : 2367-2376, 2014

PubMed

P.558 掲載の参考文献

1) Khoury AE, Bagli DJ : Vesicoureteral reflux. In Wein AJ, Kavoussi LR, Novick AC, et al (eds) : Campbell-Walsh Urology, 10th ed, Saunders Elsevier, Philadelphia, pp3267-3309, 2011

 

P.563 掲載の参考文献

1) Taguchi A, Nishinakamura R : Nephron reconstitution from pluripotent stem cells. Kidney Int 87 : 894-900, 2015

PubMed

2) Renkema KY, Winyard PJ, Skovorodkin IN, et al : Novel perspectives for investigating congenital anomalies of the kidneyand urinarytract (CAKUT). Nephrol Dial Transplant 26 : 3843-3851, 2011

 

3) Hwang DY, Dworschak GC, Kohl S, et al : Mutations in 12 known dominant disease-causing genes clarify many congenital anomalies of the kidney and urinary tract. Kidney Int 85 : 1429-1433, 2014

PubMed

4) 三村維真理 : 腎臓領域におけるエピジェネティクスの進展. 日腎会誌 57 : 241-247, 2015

 

5) Marrone AK, Ho J : MicroRNAs : potential regulators of renal development genes that contribute to CAKUT Pediatr Nephrol 29 : 565-574, 2014

PubMed

6) 粟津緑 : 腎発生から見たbranching morphogenesis. 日小児腎臓病会誌 27 : 19-22, 2014

 

7) Schreuder MF Safety in glomerular number. Pediatr Nephrol 27 : 1881-1887, 2012

PubMed

8) Westland R, Kurvers RAJ, van Wijk JAE, et al : Risk factors for renal injury in children with solitary functioning kidney. Pediatrics 131 : e478-485, 2013

PubMed

9) 厚生労働科学研究費補助金難治性疾患等克服研究事業 先天性腎尿路異常を中心とした小児慢性腎臓病の自然史の解明と早期診断・腎不全進行抑制の治療法の確立班 : 小児慢性腎臓病 (小児CKD) 診断時の腎機能評価の手引き, 2014年2月28日発行

 

10) 島川憲次 : 多嚢胞性異形成腎 (MCDK). 島田憲次 (編) : 小児泌尿器疾患ガイドブック, 診断と治療社, 東京, pp74-76, 2015

 

P.567 掲載の参考文献

1) Reddy PP, Mandell J : Prenatal diagnosis : Therapeutic implications. Urol Clin North Am 25 : 171-180, 1998

PubMed

2) Johnston JH, Evans JP, Glassberg KL, et al : Pelvic hydronephrosis in children : areview of 219 personal cases. J Urol 117 : 97-101, 1977

 

3) Carr MC, El-Ghoneimei A : Anomalies and surgery of the ureteropelvic junction in children. In Wein JW, Kavoussi LR, Novick AC, et al (eds) : Campbell's Urology, 9th ed, Saunders, Philadelphia, pp3359, 2007

 

4) 島田憲次 (編) : 先天性水腎症〔腎盂尿管移行部狭窄 (PUJO)〕. 小児泌尿器疾患診療ガイドブック, 診断と治療社 : . 東京, pp65-70, 2014

 

5) 小児泌尿器科学会学術委員会 : 周産期. 乳児期に発見される腎盂. 腎盂尿管拡張の診断基準 : 1. 超音波診断法を用いた腎盂, 腎盂尿管拡張の記載方法. 2. 利尿レノグラフィー実施のための標準プロトコール, 日小児泌会誌 8 : 96-99. 1999

 

6) Whitaker RH : Methods of assessing obstruction in dilated ureters. Br J Urol 45 : 15-21, 1973

PubMed

7) Rohrschneider WK, Haufe S, Wiesel M, et al : Functional and morphologic evaluation of congenital urinary tract dilatation by using combined static-dynamic MR urography : findings in kidneys with a single collecting system. Radiology 224 : 683-694, 2002

PubMed

8) Matsumoto F, Shimada K, Kawagoe M, et al : Delayed decrease in differential renal function after successful pyeloplasty in children with unilateral antenatally detected hydronephrosis. Int J Urol 14 : 488-490, 2007

PubMed

9) 松本富美, 島田憲次 : 腎盂形成術 (解放手術). 柿崎秀宏, 他 (編) : 小児泌尿器科手術 (新Urologic Surgeryシリーズ 7), メジカルビュー社, . 東京, pp10-17, 2010

 

10) Matsui F, Shimada K, Matsumoto F, et al : Late recurrence of symptomatic hydronephrosis in patients with prenatally detected hydronephrosis and spontaneous improvement. J Urol 180 : 322-325, 2008

PubMed

P.571 掲載の参考文献

1) Tojo A, Endou H : Intrarenal handling of proteins in rats using fractional micropuncture technique. Am J Physiol 263 : F601-606, 1992

PubMed

2) Scheel O, Zdebik AA, Lourdel S, et al : Voltage-dependentelectrogenic chloride/proton exchange by endosomal CLC proteins. Nature 436 : 424-427, 2005

PubMed

3) Gekle M : Renal tubule albumin transport. Annu Rev Physiol 67 : 573-594, 2005

PubMed

4) Novarino G, Weinert S, Rickheit G, et al : Endosomal chloride-proton exchange rather than chloride conductance is crucial for renal endocytosis. Science 328 : 1398-1401, 2010

PubMed

5) Okamoto T, Tajima T, Hirayama T, et al : Apatient with Dent disease and features of Bartter syndrome caused by a novel mutation of CLCN5. Eur J Pediatr 171 : 401-404, 2012

 

6) Hichri H, Rendu J, Monnier N, et al : From Lowe syndrome to Dent disease : correlations between mutations of the OCRL1 gene and clinical and biochemical phenotypes. Hum Mutat 32 : 379-388, 2011

PubMed

7) Sekine T, Komoda E Miura K, et al : Japanese Dent disease has a wider clinical spectrum than Dent disease in Europe/USA : genetic and clinical studies of 86 unrelated patients with low molecular weight proteinuria. Nephrol Dial Transplant 29 : 376-384, 2014

 

8) B6kenkamp A, B6ckenhauer D, Cheong HI, et al : Dent-2 disease : amild variant of Lowe syndrome. J Pediatr 155 : 94-99, 2009

 

9) Hoopes RR, Raja KM, Koich A, et al : Evidence for genetic heterogeneity in Dent's disease. Kidney Int 65 : 1615-1620, 2004

PubMed

10) 関根孝司 : Dent病. 日本腎臓病学会 (編) : 小児腎臓病学, 診断と治療社. 東京, pp254-257, 2011

 

11) Cebotaru V, Kaul S, Devtlyst O, et al : High citrate diet delays progression of renal insufficiency in the CIC-5 knockout mouse model of Dent's disease. Kidney Int 68 : 642-652, 2005

 

P.574 掲載の参考文献

1) Enomoto A, Kimura H, Chairoungdua A, et al : Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 417 : 447-452, 2002

PubMed

2) Anzai N, Ichida K, Jutabha P, et al : Plasma urate level is directly regulated by a voltage-driven urate effiux transporter URATv1 (SLC2A9) in humans. J Biol Chem 283 : 26834-26838, 2008

 

3) Matsuo H, Chiba T, Nagamori S, et al : Mutations in glucose transporter 9 gene SLC2Ag cause renal hypouricemia. Am J Hum Genet 83 : 744-751, 2008

PubMed

4) Shima Y, Nozu K, Nozu Y, et al : Recurrent EIARF and PRES with severe renal hypouricemia by compound heterozygous SLC2Ag mutation. Pediatrics 127 : e1621-1625, 2011

PubMed

5) Ichida K, Hosoyamada M, Hisatome I, et al : Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion. J Am Soc Nephrol 15 : 164-173, 2004

PubMed

6) Fujinaga S, Ito A, Nakagawa M, et al : Posterior reversible encephalopathy syndrome with exercise-induced acute kidney injury in renal hypouricemia type 1. Eur J Pediatrics 172 : 1557-1560, 2013

 

7) Mou LJ, Jiang LP, Hu Y : A novel homozygous GLUT9 mutation cause recurrent exercise-induced acute renal failure and posterior reversible encephalopathy syndrome. J Nephrol 28 : 387-392, 2015

 

8) Ohta T, Sakano T, Igarashi T, et al : Exercise-induced acute renal failure associated with renal hypouricaemia : results of a questionnaire-based survey in Japan. Nephrol Dial Transplant 19 : 1447-1453, 2004

 

P.579 掲載の参考文献

1) Knoers N, Levtchenko EN : Nephritogenic diabetes insipidus. In Avner ED, Harmon WE, Niaudet P, et al (eds) : Pediatric Nephrology, 6th ed, Springer-Verlag, Berlin, Heidelberg, pp 1005-1018, 2009

 

2) Bichet DG : Lithium, Cyclic AMP signaling, A-kinase anchoring Proteins, and aquaporin-2. J Am Soc Nephrol 17 : 920-922, 2006

PubMed

3) Schrier RW : Body water homeostasis : Clinical disorders of urinary dilution and concentration. J Am Soc Nephrol 17 : 1820-1832, 2006

PubMed

4) Sands JM, Bichet DG : Nephrogenic diabetes insipidus. Ann Intem Med 144 : 186-194, 2006

 

5) Bockenhauser D, Bichet DG : Inherited nephrongenic diabetes insipidus : concentrating on humans. Am J Physiol Renal Physiol 304 : F1037-1042, 2013

 

6) 里村憲一 : 腎性尿崩症, 日本小児腎臓病学会 (編) : 小児腎臓病学, 1版, 診断と治療社, 東京, pp277-280, 2012

 

7) 佐々木聡 : 腎性尿崩症. 小児内科 44 (増刊) : 656-657, 2012

 

P.584 掲載の参考文献

1) 日本泌尿器学会, 日本泌尿器内視鏡学会, 日本尿路結石症学会 (編) : 尿路結石症診療ガイドライン, 2版, 金原出版, 東京, 2013

 

2) Habbig S, Beck BB, Hoppe B : Nephrocalcinosis and urolithiasis in children. Kidney Int 80 : 1278-1291, 2011

PubMed

3) 太田和秀 : 尿路結石. 日本小児腎臓病学会 (編) : 小児腎臓病学, 診断と治療社, 東京, pp361-365, 2012

 

4) Smith J, Stapleton FB : Epidemiology of and risk factors for nephrolithiasis in children, UpToDate http://www.uptodate.com/contents/epidemiology-of-and-risk-factors-for-nephrolithiasis-in-children (2015年8月18日アクセス)

 

5) Fujita T, Shimooka T, Sugita Y, et al : Acute renal failure due to obstructive uric acid stones associated with acute gastroenteritis. Pediatr Nephrol 24 : 2467-2469, 2009

PubMed

6) Hoppe B, Leumann E, Milliner DS : Urolithiasis and nephrocalcinosis in childhood. In Geary DE Schaefer F (eds) : Comprehensive Pediatric Nephrology, 1st ed, Mosby, Philadelphia, pp499-525, 2008

 

7) Alon US : Medical treatment of pediatric urolithiasis. Pediatr Nephrol 24 : 2129-2135, 2009

PubMed

8) Jones C, Mugbal Z. : Disorders of mineral metabolism and nephrolithiasis. In Webb N, Postlethwaite R (eds) : Clinical Paediatric Nephrology, 3rd ed, Oxford University Press, Oxford, New York, pp73-101, 2003

 

9) Straub M, Gschwend J, Zorn C : Pediatric urolithiasis : the current surgical managelnent. Pediatr Nephrol 25 : 1239-1244, 2010

PubMed

・ 日本尿路結石症学会ウェブサイト http://jsur.umin.jp/ (2015年8月18日アクセス)

 

P.588 掲載の参考文献

1) Akaukra K, Egoshi K, Ueda T, et al : The longterm outcomeof cystinuriain Japan. Urol Int 61 : 86-89, 1998

 

2) Rosenberg LE, Downing S, Durant JL, et al : Cystinuria : biochemical evidence for three genetically distinct diseases. J Clin Invest 45 : 365-371, 1966

PubMed

3) Chairoungdua A, Segawa H, Kim JY, et al : Identification of an amino acid transporter associated with the cystinuria-related type II membrane glycoprotein. J Biol Chem 274 : 28845-28848, 1999

PubMed

4) Dello Strologo L, Pras E, Pontesilli C, et al : Comparison between SLC3A1 and SLC7A9 cystinuria patients and carriers : a need for a new classification. J Am Soc Nephrol 13 : 2547-2553, 2002

PubMed

5) Shigeta Y, Kanai Y, Chairoungdua A, et al : A novel missense mutation of SLC7Ag frequent in Japanese cystinuria cases affecting the C-terminus of the transporter. Kidney Int 69 : 1198-1206, 2006

 

6) Sakamoto S, Chairoungdua A, Nagamori S, et al : A novel role of the C-terminus of b 0, +AT in the ER-Golgi trafficking of the rBAT-b 0, +AT heterodinieric amino acid trallsporter. Biochem J 417 : 441-448, 2009

 

7) Ito H, Murakami M, Miyauchi T, et al : The incidence of cystinuria in Japan. J Urol 129 : 1012-1014, 1983

PubMed

8) 日本泌尿器科学会, 日本Endourology・ESWL学会. 日本尿路結石症学会 (編) : 尿路結石症診療ガイドライン. 金原出版, 東京, 2002

 

・ 日本尿路結石症学会 http://jsur.uminjp/ (2015年8月18日アクセス)

 

P.593 掲載の参考文献

1) Kaneko K, Tuchiya K, Kawamura R, et al. : Low prevalence of hypercalciuria in Japanese children. Nephron 91 : 439-443, 2001

 

2) Monico CG, Milliner DS : Genetic determinants of urolithiasis. Nat Rev Nephrol 8 : 151-162, 2012

 

3) Frick KK, Bushinsky DA : Molecular mechanisms of hypercalciuria. J Am Soc Nephrol 14 : 1082-1095, 2003

PubMed

4) RyaIl LE, Ing SW : Idiopathic hypercalciuria and bone health. Curr Osteoporos Rep 10 : 286-295, 2012

 

5) Srivastava T, Schwaderer A : Diagnosis and management of hypercalciuria in children. Curr Opin Pediatr 21 : 214-219, 2009

PubMed

6) Fallahzadeh MK, Fallahzadeh MH, Mowla A, et al : Hypercalciuria in children with urinary tract symptoms. Saudi J Kidney Dis Transpl 21 : 673-677, 2010

PubMed

7) Smith J, Stapleton FB : Epidemiology of and risk factors for nephrolithiasis in children. http://www.uptodate.com/contents/epidemiology-of-and-risk-factors-for-nephrolithiasis-in-children (2015年8月18日アクセス)

 

8) 岡田満, 吉岡加寿夫, 坂野一美, 他 : 小児の特発性高Ca尿症 スクリーニングする際の基準値について. 日小児会誌 90 : 2701-2706, 1986

 

9) Reilly RF, Huaung CL : The mechanism of hypercalciuria with NaCl cotransporter inhibition. Nat Rev Nephrol 7 : 669-674, 2011

 

10) Balestracci A, Battaglia LM, Toledo I, et al : Idiopathic hypercalciuria in children with urinary tarct infection. Arch Argent Pediatr 112 : 428-433, 2014

 

・ Leslie SW. Batuman V, et al : Hypercalciuria (Updated : Aug 26, 2013). Medscape http://emedicine.medscape.com/article/2182757-overview (2015年8月18日アクセス)

 

P.598 掲載の参考文献

1) Simon DB, Karet FE, Hamdan JM, et al : Bartter's syndrome, hypokalaemic alkalosis with hypercalciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 13 : 183-188, 1996

 

2) Simon DB, Karet FE, Rodriguez-Soriano J, et al : Genetic heterogeneity of Bartter's syndrome revealed by mutations in the K'channel, ROMK. Nat Genet 14 : 152-156, 1996

 

3) Simon DB, Bindra RS, Mansfield TA, et al : Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet 17 : 171-178, 1997

PubMed

4) Birkenhager R, Otto E, Schurmann MJ, et al : Mutation of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nat Genet 29 : 310-314, 2001

PubMed

5) Nijenhuis T, Vallon V, van der Kemp AW, et al : Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest 115 : 1651-1658, 2005

PubMed

6) Reilly RE Huang CL : The mechanism of hypocalciuria with NaCl cotransporter inhibition. Nat Rev Nephrol 7 : 669-674, 2011

 

7) Nozu K, Iijima K, Kanda K, et al : The pharmacological characteristics of molecular-based inherited salt-losing tubulopathies. J Clin Endocrinol Metab 95 : E511-518, 2010

PubMed

8) Huang CL, Kuo E : Mechanism of hypokalemia in magnesium deficiency. J Am Soc Nephrol 18 : 2649-2652, 2007

PubMed

9) Nozu K, Fu XJ, Kaito H, et al : A novel mutation in KCNJ1 in a Bartter syndrome case diagnosed as pseudohypoaldosteronism. Pediatr Nephrol 22 : 1219-1223, 2007

 

10) Woda CB, Miyawaki N, Ramalakshmi S, et al : Ontogeny of now-stimulated potassium secretion in rabbit cortical collecting duct : functional and molecular aspects. Am J Physiol Renal Physiol 285 : F629-639, 2003

 

・ 難治性疾患克服事業 腎・泌尿器系の希少難治性疾患群に関する調査研究班 (Bartter症候群・Gitelman症候群) http://www.med.kobe-u.ac.jp/sgridk/research_bartter_gitelman.html (2015年8月19日アクセス)

 

P.603 掲載の参考文献

1) Klootwijk ED, Reichold M, Unwin RJ, et al : Renal Fanconi syndrome : taking a proximal look at the nephron. Nephrol Dial Transplant, 2014 doi : 10.1093/ndt/gfu377

 

2) Hall AM, Bass P, Unwin RJ : Drug-induced renal Fanconi syndrome. QJM 107 : 261-269, 2014

PubMed

3) Klootwljk ED, Reichold M, Helip-Wooley A, et al : Mistargeting of peroxisomal EHHADH and inherited renal Fanconi's syndrome. N Engl J Med 370 : 129-138, 2014

PubMed

4) Chen YT : Type I glycogen storage disease : kidney involvement, pathogenesis and its treatment. Pediatr Nephrol 5 : 71-76, 1991

PubMed

5) Matsusaka T, Niimura E Shimizu A, et al : Liver angiotensinogen is the primary source of renal angiotensin II. J Am Soc Nephrol 23 : 1181-1189, 2012

 

6) 大和田操, 鈴木健 : 先天性代謝異常と尿. 小児内科 19 : 1005-1012, 1987

 

・ OMIM : Online Mendelian Inheritance in Man http://www.omim.org (2015年8月19日アクセス)

 

P.610 掲載の参考文献

1) Kiran BV, Barman H, Iyengar A : Clinical profile and outcome of renal tubular disorders in children. Indian J Nephrol 24 : 362-366, 2014

PubMed

2) Gil-Pefia H, Mejia N, Santos F : Renal tubular acidosis. J Pediatr 164 : 691-698, 2014

 

3) Miura K, Sekine T, Takahashi K, et al : Mutational analyses of the ATP6VlBl and ATP6VOA4 genes in patients with primary distal renal tubular acidosis. Nephrol Dial Transplant 28 : 2123-2130, 2013

 

4) Karet E Finberg K, Nelson R, et al : Mutations in the gene encoding Blsubunit of H+ -ATPase cause renal tubular acidosis with sensorineural deafness. Nat Genet 21 : 84-90, 1999

 

5) Both T, Zietse R, van Daele P : Everything you need to know about distal renal tubular acidosis in autoimmune disease. Rheumatol Int 34 : 1037-1045, 2014

PubMed

6) 河原克雅 : 腎近位尿細管性アシドーシスの新しい機序. 医学のあゆみ 249 : 263-265, 2014

Medical*Online

7) Igarashi T, Inatomi J, Sekine T, et al : Mutations in SLC4A4 cause permanent isolated proximal renal tubular acidosis with ocular abnormalities. Nat Genet 23 : 264-266, 1999

PubMed

P.615 掲載の参考文献

1) Jaipaul N : Genitourinary Disorders : Tubointerstitial Nephritis. The Merck Manual Professional Version http://www.merckmanuals.com/professional/genitourinary_disorders/tubulointerstitial_diseases/tubulointerstitial_nephritis.html (2015年8月19日アクセス)

 

2) Schwarz A, Krause PH, Kunzendorf U, et al : The outcome of acute interstitial nephritis : risk factors for the transition from acute to chronic interstitial nephritis. Clin Nephrol 54 : 179-190, 2000

PubMed

3) Baker RJ, Pusey CD : The changing profile of acute tubulointerstitial nephritis. Nephrol Dial Transplant 19 : 8-11, 2004

 

4) 川野充弘, 佐伯敬子, 中島衡, 他 : IgG4関連腎臓病ワーキンググループ報告 IgG4関連腎臓病診療指針. 日腎会誌 53 : 1062-1073, 2011

 

5) Zeisberg M, Neilson EG : Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 21 : 1819-1834, 2010

PubMed

6) Praga M, Gonzalez E : Acute interstitial nephritis. Kidney Int 77 : 956-961, 2010

PubMed

7) 伊藤秀一 : 免疫抑制薬の臨床応用実践論 (第34回) 間質性腎炎ぶどう膜炎症候群 (TINU症候群). 炎症と免疫 19 : 522-528, 2011

 

8) Kodner CM, Kudrimoti A : Diagnosis and management of acute interstitial nephritis. Am Fam Physician 67 : 2527-2534, 2003

PubMed

9) 金子一成 : 各種病態にみられる腎障害 感染症 エルシニア感染症による急性腎不全. 別冊日本臨牀 腎臓症候群 (第2版) 下-その他の腎臓疾患を含めて. 日本臨牀社, 大阪, pp625-628, 2012

 

10) Abed L, Merouani A, Haddad E, et al : Presence of autoantibodies against tubular and uveal cells in a patient with tubulointerstitial nephritis and uveitis (TINU) syndrome. Nephrol Dial Transplant 23 : 1452-1455, 2008

 

11) 竹村司 : 間質性腎炎. 小児科診療 66 : 679-684, 2003

Medical*Online

12) Muriithi AK, Nasr SH, Leung N : Utility of urine eosinophils in the diagnosis of acute interstitial nephritis. Clin J Am Soc Nephrol 8 : 1857-1862, 2013

PubMed

13) 細島康宏, 桑原頌治, 斎藤亮彦 : Clinical nephrology尿細管・間質障害 : メガリンとその関連分子をめぐる最近の話題. Annual Review腎臓 2014, 中外医学社, 東京, pp 175-181. 2014

 

14) Rossert J : Drug-induced acute interstitial nephritis. Kidney Int 60 : 804-817, 2001

PubMed

15) Gonzalez E, Gutierrez E, Galeano C, et al : Early steroid treatment improves the recovery of renal function in patients with drug-induced acute interstitial nephritis. Kidney Int 73 : 940-946, 2008

PubMed

16) TakedarY, Nishikimi T, Akimoto K, et al : Beneficial effects of a combination of Rho-kinase inhibitor and ACE inhibitor on tubulointerstitial fibrosis induced by unilateral ureteral obstruction. Hypertens Res 33 : 965-973, 2010

PubMed

P.623 掲載の参考文献

1) Murray PT, Devarajan P, Levey AS, et al : A framework and key research questions in AKI diagnosis and staging in different environments. Clin J Am Soc Nephrol 3 : 864-868, 2008

PubMed

2) Kidney Disease : Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group : KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2 : 1-138, 2012

 

3) Susantitaphong P, Cruz DN, Cerda J, et al : World incidence of AKI : Ameta-analysis. Clin J Am Soc Nephrol 8 : 1482-1493, 2013

 

4) Bailey D, Phan V, Litalien C, et al : Risk factors of acute renal failure in critically ill children : a prospective descriptive epidemiological study. Pediatr Crit Care Med 8 : 29-35, 2007

PubMed

5) Medina Villanueva A, Lopez-Herce Cid J, Lopez Fernandez Y, et al : Acute renal failure in critically-ill children. A preliminary study. An Pediatr (Barc) 61 : 509-514, 2004

PubMed

6) Chang JW, Jeng MJ, Yang LY, et al : The epidemiology and prognostic factors of Inortality in critically in children with acute kidney injury in Taiwan. Kidney Int 87 : 632-639, 2015

PubMed

7) Momtaz HE, Sabzehei MK, Rasuli B, et al : The main etiologies of acute kidney injury in the newborns hospitalized in the neonatal intensive care unit. J Clin Neonatol 3 : 99-102, 2014

PubMed

8) Hui-Stickle S, Brewer ED, Goldstein SL : Pediatric ARF epidemiology at a tertiary care center from 1999 to 2001. Am J Kidney Dis 45 : 96-101, 2005

 

9) Duzova A, Bakkaloglu A, Kalyoncu M, et al : Etiology and outcome of acute kidney injury in children. Pediatr Nephrol 25 : 1453-1461, 2010

PubMed

10) Liafio F, Pascual J : Epidemiology of acute renal failure : aprospective, multicenter, communitybased study. Madrid Acute Renal Failure Study Group. Kidney Int 50 : 811-818, 1996

 

11) Mishra J, Dent C, Tarabishi R, et al : Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365 : 1231-1238, 2005

PubMed

12) Negishi K, Noiri E, Doi K, et al : Monitoring of urinary L-type fatty acid-binding Protein predicts histological severity of acute kidney inj ury. Am J Pathol 174 : 1154-1159, 2009

 

13) Andreoli SP : Acute kidney injury in children. Pediatr Nephrol 24 : 253-263, 2009

PubMed

14) Askenazi DJ, Feig DI, Graham NM, et al : 3-5 year longitudinal follow-up of pediatric patients after acute renal failure. Kidney Int 69 : 184-189, 2006

PubMed

P.632 掲載の参考文献

1) Ishikura K, Uemura O, Ito S, et al : Pre-dialysis chronic kidney disease in children : results of a nationwide survey in Japan. Nephrol Dial Transplant 28 : 2345-2355, 2013

PubMed

2) Remuzzi G, Bertani T : Is glomerulosclerosis a consequence of altered glomerular perineability to macromolecules? Kidney Int 38 : : 384-394, 1990

PubMed

3) 五十嵐隆 : 画像検査. 小児腎疾患の臨床. 改訂4版, 診断と治療社, 東京, p91, 2010

 

4) 日本腎臓学会 : CQ1小児CKDの診断基準とステージ分類は成人と異なるか? エビデンスに基づくCKD診療ガイドライン 2013, 東京医学社, 東京. pp166-167, 2013

 

5) 日本小児CKD研究グループ : 小児の腎機能障害の診断と小児CKDステージ判定のアルゴリズム. 小児慢性腎臓病 (小児CKD) 診断時の腎機能評価の手引き, 診断と治療社 : 東京, pp8-9, 2014

 

6) Uemura O, Honda M, Matsuyama T, et al : Age, gender, and body length effects on reference serum creatinine levels determined by an enzymatic method in Japanese children. Clin Exp Nephrol 15 : 894-699, 2011

 

7) Uemura O, Nagai T, Ishikura K, et al : Creatinine-based equations to estimate glomerular filtration rate in Japanese children and adolescents with chronic kidney disease. Clin Exp Nephrol 18 : 626-633, 2014

PubMed

8) Nagai T, Uemura O, Ishikura K, et al : Creatinine-based equations to estimate glomerular filtration rate in Japanese children aged between 2 and 11 years old with chronic kidney disease. Clin Exp Nephrol 17 : 877-881, 2013

PubMed

9) 日本腎臓学会 : 6-2 腎機能の評価法 : 小児CKD診療ガイド 2012. 日腎会誌 54 : 1066-1068, 2012

 

10) Uemura O, Nagai T, Ishikura K, et al : Cystatin C-based equation to estimate glomerular filtration rate in Japanese children and adolescents. Clin Exp Nephrol 18 : 718-725, 2014

PubMed

11) Adrissino G, Vigano S, Testa S, et al : No clear evidence of ACEi efficacy on the progression of chronic kidney disease in children with hypodysplastic nephropathy--report from the ItalKid Project database. Nephrol Dial Transplant 22 : 2525-2530, 2007

 

12) Ishikura K, Uemura O, Hamasaki Y, et al : Progression to end-stage kidney disease in Japanese children with chronic kidney disease : Results of a nationwide prospective cohort study. Nephrol Dial Transplant 29 : 878-884, 2014

PubMed

13) Wong H, Mylrea K, Feber J, et al : Prevalence of complications in children with chronic kidney disease according to KDOQI. Kidney Int 70 : 585-590, 2006

PubMed

14) National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescellts : The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114 : 555-576, 2004

 

15) ESCAPE Trial Group : Strict blood-pressure control and progression of renal failure in children. N Engl J Med 361 : 1639-1650, 2009

PubMed

16) Akbari A, Clase CM, Acott P, et al : Canadian Society of Nephrology Commentary on the KDIGO Clinical Practice Guideline for CKD Evaluation and Management. Am J Kidney Dis 65 : 177-205, 2015

PubMed

17) Fathallah-Shaykh SA, Flynn JT, Pierce CB, et al : Progression of Pediatric CKD of Nonglomerular Origin in the CKiD Cohort. Clin J Am Soc Nephrol 29 : [Epub ahead of print], 2015

 

18) Parekh RS, Carroll CE, Wolfe RA, et al : Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr 141 : 191-197, 2002

 

・ P-CKDのホームページ http://www.pckd.jpn.org/ (2015年8月19日アクセス)

 

P.639 掲載の参考文献

1) Luma GB, Spiotta RT : Hypertension in children and adolescents. Am Fam Physician 73 : 1558-1568, 2006

PubMed

2) Viera AJ, Neutze DM : Diagnosis of secondary hypertension : an age-based approach, Am Fam Physician 82 : 1471-1478, 2010

PubMed

3) Kapur G, Baracco R : Evaluation of hypertension in children. Curr Hypertens Rep 15 : 433-443, 2013

PubMed

4) Tullus K, Brennan E, Hamilton G, et al : Renovascular hypertension in children. Lancet 371 (9622) : 1453-1463, 2008

PubMed

5) Flynn JT, Tullus K : Severe hypertension in children and adolescents : pathophysiology and treatment. Pediatr Nephrol 24 : 1101-1112, 2009

PubMed

6) 第11章 小児の高血圧. 日本高血圧学会高血圧治療ガイドライン作成委員会 (編) : 高血圧治療ガイドライン 2014, 日本高血圧学会, 東京, pp104-107, 2014

 

7) 小児期心疾患における薬物療法ガイドライン, 循環器病の診断と治療に関するガイドライン (2010-2011年度合同研究班報告), pp89-301, 2012 http://www.j-circ.or.jp/guideline/pdf/JCS2012_sachi_h.pdf (2015年8月19日アクセス)

 

8) National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents : The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114 (2 Suppl 4th Report) : 555-576, 2004

 

9) Hirsch AT, Haskal ZJ, Hertzer NR, et al : ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease. Circulation 113 : e463-654, 2006

PubMed

10) Lurbe E, Cifkova R, Cruickshank JK, et al : Management of high blood pressure in children and adolescents : recommendations of the European Society of Hypertension. J Hypertens 27 : 1719-1742, 2009

PubMed

P.645 掲載の参考文献

1) Neveus T, von Gontard A, Hoebeke P, et al : The standardization of tern」inology of lower urinary tract function in children and adolescents : report from the Standardisation Committee of the International Children's Continence Society. J Urol 176 : 314-324, 2006

 

2) von Gontard A, Mauer-Mucke K, Pluck J, et al : Clinical behavioral problems in day-and night-wetting children. Pediatr Nephrol 13 : 662-667, 1999

PubMed

3) Neveus T, Eggert P, Evens J, et al : Evaluation of and treatment for monosymptomatic enuresis : a standardization document from the International Children's Continence Society. J Urol 183 : 441-447, 2010

 

4) 金子一成 : 夜尿症. 小児内科 40 (増刊) : 964-968, 2008

 

5) 金子一成 : 夜尿症. 小児内科 44 (増刊) : 670-671, 2012

 

6) 赤司俊二 : 夜尿症. 小児科診療 66 : 2067-2072, 2003

Medical*Online

7) 河内明宏, 上仁数義, 小林憲市 : 夜尿症の病態・病因. 外来小児科 16 : 327-331. 2013

Medical*Online

8) Jarvelin MR, Huttunen NP, Seppanen J, et al : Screening of urinary tract abnormalities among day and nightwetting children. Scand J Urol Nephrol 24 : 181-189, 1990

PubMed

9) Hjalmas K, Arnold T, Bower W, et al : Nocturnal enuresis : an international evidence based management strategy. J Urol 171 : 2545-2561, 2004

PubMed

10) Bates DG : The bladder and urethra. In Slovis TL (ed) : Caffey's Pediatric Diagnostic Imaging, 11th ed, Mosby Elsevier, Philadelphia, pp2356-2393, 2008

 

11) Simoneaux SF, Greenbaum LA : Diagnostic imaging. In Avner ED, et al (eds) : Pediatric Nephrology, 6th ed, Springer-Verlag, Berlin, Heidelberg, pp 535-564, 2009

 

12) Neveus T : Nocturnal enuresis-theoretic back-ground and practical guidelines. Pediatr Nephrol 26 : 1207-1214, 2011

 

13) Cohen-Zrubavel V, et al : Sleep and sleepiness in children with nocturnal enuresis. Sleep 34 : 191-194, 2011

PubMed

14) Yeung CK, et al : Cortical arousal in children with severe enuresis. N Engl J Med 358 : 2414-2415, 2008

PubMed

15) Ohtomo Y, et al : Traditional Japanese medicine, Yokukansan, for the treatment of nocturnal enuresis in children. Pediatr Int 55 : 737-740, 2013

PubMed

16) Schwab M, Wenzel D, Ruder H : Hyponatremia and cerebral convulsion due to short term DDAVP therapy for control of enuresis nocturna. Eur J Pediatr 155 : 46-48, 1996

PubMed

17) Glazener CM, Evans JH : Desmopressin for nocturnal enuresis in children. Cochrane Database Syst Rev 2002, CD002112

PubMed

18) U. S. Food and Drug Administration, 2007 Safety Alerts for Human Medical Products : Desmopressin Acetate (marketed as DDAVP Nasal Spray, DDAVP Rhinal Tube, DDAVP, DDVP, Minirin, and Stimate Nasal Spray). http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm152113.htm (2015年8月20日アクセス)

 

19) Kaneko K : Treatment for nocturnal enuresis : the current. state in Japan. Pediatr Int 54 : 8-13, 2012

 

20) 大友義之 : 夜尿症の生活指導・治療-薬物治療を中心に. 外来小児科 16 : 346-349, 2013

 

・ 日本夜尿症学会 http://www.jsen.jp (2015年8月20日アクセス)

 

・ おねしょ卒業! プロジェクト http://onesho.com (2015年8月20日アクセス)

 

・ International Children's Continence Society http://www.i-c-c-s.org (2015年8月20日アクセス)

 

P.651 掲載の参考文献

1) 多田実 : 神経因性膀胱. 小児内科 44 (増刊) : 668-669, 2012

 

2) 多田実 : 排尿機能とその発達. 小児外科 39 : 871-875, 2007-2008

 

3) 柿崎秀宏, 小柳知彦 : 神経因性膀胱の診断と治療. 日泌尿会誌 86 : 833-852, 1995

 

4) 多田実, 滝本至得, 吉田利夫, 他 : 泌尿器科領域-神経因性膀胱における管理と手術. 小児外科 37 : 1469-1473, 2005-2012

 

5) Kakizaki H, Moriyama K, Ameda K, et al : Diamater of the extemal urethral sphincter as a predictor of detrusor-sphincter incoordination in children : comparative study of voiding cystourethrograpy. J Urol 169 : 655-658, 2003

 

6) 多田実. 滝本至得 : 小児における排尿異常と対処-UDSはどこまで必要か-遺尿における非侵襲的検査と対処. 泌尿器外科 17 : 203-208, 2004

 

7) Cain MP, Wu SD, Austin PF, et al : Alpha blocker therapy for children with dysfunctional voiding and urinary retention. J Urol 170 : 1514-1517, 2003

PubMed

8) Woodhouse CRJ : Myelomeningocele in young adults. BJU 95 : 223-230, 2005

PubMed

9) Palmer JS, Kaplan WE, Firlit CF : Erectile dysfunction in patients with spina bifida is a treatable condition J Urol 164 : 958-961, 2000

PubMed

10) 小林堅一郎, 多田実, 益子貴行, 他 : 経尿道的逆流防止術を施行した続発性膀胱尿管逆流症の検討. 日小児泌尿会誌 23 : 96, 2003

 

・ 日本小児泌尿器科学会 http://jspu.jp (2015年8月20日アクセス)

 

・ 日本二分脊椎症協会 http://sbajpn.com (2015年8月20日アクセス)

 

・ 日本排尿機能学会 http://www.luts.gr.jp (2015年8月20日アクセス)

 

VI. 免疫不全

P.658 掲載の参考文献

1) Stiehm ER Approach to the child with recurrent infections. UpTbDate, 2015 http://www.uptodate.com/contents/approach-to-the-child-with-recurrent-infections (2015年8月20日アクセス)

 

2) Al-Herz W, Bousfiha A, Casanova JL, et al : Primary immunodeficiency diseases : an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 5 : 162, 2014 doi : 10.3389/fimmu. 2014. 00162

 

3) Gray PE, Namasivayam M, Ziegler JB : Recurrent infection in children : when and how to investigate for primary immunodeficiency? J Paediatr Child Health 48 : 202-209, 2012

PubMed

4) Casanova JL, Fieschi C, Zhang Sy, et al : Revisiting human primary immunodeficiencies. J Intern Med 264 : 115-127, 2008

PubMed

5) 原寿郎 : 発熱の原因と診断. 原寿郎 (編著) : 小児の発熱 A to Z, 診断と治療社, 東京, pp 1-12, 2012

 

P.663 掲載の参考文献

1) Chinen J, Shearer WT Secondary immunodeficiencies, including HIV infection. J Allergy Clin Immunol 125 : S195-203, 2010

PubMed

2) Bonilla FA : Secondary immunodeficiency due to underlying disease states, environmental exposures, and miscellaneous causes. UpToDate Topic 3946 Version 10.0. http://www.uptodate.com/contents/secondary-immunodeficiency-due-to-underlying-disease-states-environmental-exposures-and-miscellaneous-causes (2015年8月20日アクセス)

 

3) Barrow M, Fleisher TA : Secondary immunodificiency induced by drugs and biologic therapies. UpToDate Topic 3939 Version 13.0. http://www.uptodate.com/contents/secondary-immunodeficiency-induced-by-drugs-and-biologic-therapies (2015年8月20日アクセス)

 

4) Marrack P, Kappler J : Subversion of the immune system by pathogens. Cell 76 : 323-332, 1994

PubMed

5) Gnffin DE : Measles virus-induced suppression of immune responses. Immunol Rev 236 : 176-189, 2010

 

6) Sakuma Y, Katoh T, Owada K, et al : Initial functional status predicts infections during steroid therapy for renal diseases. Clin Nephrol 63 : 68-73, 2005

PubMed

7) de Mattos AM, Olyaei AJ, Bennett WM : Pharmacology of immunosuppressive medications used in renal diseases and transplantation. Am J Kidney Dis 28 : 631-667, 1996

PubMed

8) Powell JD, Pollizzi KN, Heikamp EB, et al : Regulation of immune responses by mTOR. Annu Rev Immunol 30 : 39-68, 2012

PubMed

9) Kamel OW, van de Rijn M, Weiss LM, et al : Brief report : reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis. N Engl J Med 328 : 1317-1321, 1993

PubMed

10) Breda L, Del Torto M, De Sanctis S, et al : Biologics in children's autoimmune disorders : efficacy and safety. Eur J Pediatr 170 : 157-167, 2011

 

P.677 掲載の参考文献

1) Al-Herz W, Bousfiha A, Casanova JL, et al : Primary immunodeficiency diseases : an update on the classification froln the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 22 : 162, 2014

 

2) Kwan A, Abraham RS, Currier R, et al : Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA 312 : 729-738, 2014

PubMed

3) Kung C1, Pingel JT, Heikinheimo M, et al : Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease. Nat Med 6 : 343-345, 2000

 

4) Roberts JL, Buckley RH, Luo B, et al : CD45-deficient severe combined immunodeficiency caused by uniparental disomy. Proc Natl Acad Sci USA 109 (26) : 10456-10461, 2012

PubMed

5) Friedrich W, Hoenig M, Pannicke U, et al : Reticular dysgenesis. In Hans D. Ochs, C. I. Smith E, Puck JM (eds) : Primary Immunodeficiency Diseases : A Molecular and Genetic Approach, 3rd ed, Oxford University Press, Oxford, pp269-273, 2013

 

6) Punwani D1, Pelz B, Yu J, et al : Coronin-1A : immune deficiency in humans and mice. J Clin Immunol 35 : 100-107, 2015

 

7) Shearer WT, Dunn E, Notarangelo LD, et al : Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome : the Primary Immune Deficiency Treatment Consortium experience. J Allergy Clin Immunol 133 : 1092-1098, 2014

PubMed

8) Otsu M, Yamada M, Nakajima S, et al : Outcomes in two Japanese adenosine deaminase-deficiency patients treated by stem cell gene therapy with no cytoreductive conditioning. J Clin Immunol 35 : 384-398, 2015

PubMed

9) Hacein-Bey-Abina Sl, Pai SY, Gaspar HB, et al : A modified γ-retrovirus vector for X-linked severe combined immunodeficiency. N Engl J Med 371 : 1407-1417, 2014

 

10) 小野寺雅史 : 遺伝子治療の展望とその課題. 小児内科 40 : 1553-1558, 2014

 

・ Primary Immunodeficiency database in Japan (PIDJ) http://pidj.rcai.riken.jp (2015年8月20日アクセス)

 

P.684 掲載の参考文献

1) Al-Herz W, Bousfiha A, Casanova JL, et al : Primary immunodeficiency diseases : an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 5 : 162, 2014

PubMed

2) van der Burg M, Gennery AR : Educational paper. The expanding clinical and immunological spectrum of severe combined immunodeficiency. Eur J Pediatr 170 : 561-571, 2011

PubMed

3) Shearer WT, Dunn E, Notarangelo LD, et al : Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omennsyndrome : the Primary Immune Deficiency Treatment Consortium experience. J Allergy Clin Immunol 133 : 1092-1098, 2014

 

4) Villa A, Notarangelo LD, Roifman CM : Omenn syndrome : inflammation in leaky severe combined immunodeficiency. J Allergy Clin Immunol 122 : 1082-1086, 2008

PubMed

5) Todoric K, Koontz JB, Mattox D, et al : Autoimmunity in immunodeficiency. Curr Allergy Asthma Rep 13 : 361-370, 2013

PubMed

6) Kwan A, Abraham RS, Currier R, et al : Newborn screnig for severe combined immunodeficiency in 11 screening programs in the United States. JAMA 312 : 729-738, 2014

PubMed

7) Bousfiha AA, Jeddane L, Ailal F, et al. A phenotypic approach for IUIS PID classification and diagnosis : guidelines for clinicians at the bedside. J Clin Immunol 33 : 1078-1087, 2013

PubMed

8) de la Morena MT, Nelson RP Jr : Recent advances in transplantation for prinlary immune deficiency diseases : a comprehensive review. Clin Rev Allergy Immunol 46 : 131-144, 2014

 

9) Buckley RH, Fischer A : Bone marrow transplantation for primary immunodeficiency diseases. In Ochs DH, Smith CIE, Puck JM (eds) : Primary Immunodeficiency Diseases, 3rd ed, Oxford Universtiy Press, New York, pp854-875, 2014

 

10) Shapiro RS : Malignancies in the setting of primary immunodeficiency : Implications for hematologists/oncologists. Am J Hematol 86 : 48-55, 2011

PubMed

・ PIDJ (Primary Immunodeficiency Database in Japan) http://pidj.rcai.riken.jp (2015年8月20日アクセス)

 

・ RAPID (Resource of Asian Primary Immunodeficiency Diseases) http://web16.kazusa.or.jp/rapid/ (2015年8月20日アクセス)

 

P.690 掲載の参考文献

1) Derry JMJ, Ochs HD, Francke U : Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell 78 : 635-644, 1994

PubMed

2) Thrasher AD : WASP in immune-system organization and function. Nature Rev 2 : 635-646, 2002

 

3) Imai K, Morio T, Nonoyama S, et al : Clinical course of patients with WASP gene mutations. Blood 103 : 456-464, 2004

PubMed

4) Shcherbina A, Rosen FS, Remold-O'Donnell E : WASP levels in platelets and lymphocytes of Wiskott-Aldrich syndrome protein correlate with cell dysfunction. J Immunol 163 : 6314-6320, 1999

PubMed

5) Kawai S, Sasahara Y, Tsuchiya S, et al : Flow cytometric demonstration of intracytoplasmic Wiskott-Aldrich syndrome protein in peripheral lymphocyte subpopulations. J Immunol Methods 260 : 195-205, 2002

 

6) Kobayashi R, Ariga T, Nonoyama S, et al : Out-come in patients with Wiskott-Aldrich syndrome following stem cell transplantation : an analysis of 57 patients in Japan. Br J Haematol 135 : 362-366, 2006

 

7) Klein C, Nguyen D, Snapper SB, et al : Gene therapy for Wiskott-Aldrich syndrome : rescue of T-cell signaling and amelioration of colitis upon transplantation of retrovirally transduced hematopoietic stem cells in mice. Blood 101 : 2159-2166, 2003

PubMed

8) Boztug K, Schmidt M, Schwarzer A, et al : Stemcell gene therapy for the Wiskott-Aldrich syndrome. New Engl J Med 363 : 1918-1927, 2010

PubMed

9) de la Fuente MA, Sasahara Y, Ramesh N, et al : WIP is a chaperone for Wiskott-Aldrich syndrome protein (WASP). Proc Natl Acad Sci USA 104 : 926-931, 2007

PubMed

10) Lanzi G, Moratto D, Vairo D, et al : A novel primary immunodeficiency due to deficiellcy in the WASP-interacting protein. WIP J Exp Med 209 : 29-34, 2012

PubMed

・ PIDJ (Primary Immunodeficierlcy Database in Japan) http://pidj.rcai.riken.jp (2015年8月21日アクセス)

 

・ WASPbase http://pidj.rcai.riken.jp/waspbase/ (2015年8月21日アクセス)

 

P.695 掲載の参考文献

1) Savitsky K, et al : A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268 : 1749-1753, 1995

PubMed

2) O'Driscoll M, et al : DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell 8 : 1175-1185, 2001

PubMed

3) Buck D, et al : Cemunnos, a novel nonhomologous end-joining factor, is mutated in human immunodeficiency with microcephaly. Cell 124 : 287-299, 2006

PubMed

4) van der Burg M, et al : ADNA-PKcs mutation in a radiosensitive T-B-SCID patient inhibits Artemis activation and nonhomologous end-joining. J Clin Invest 119 : 91-98, 2009

 

5) Moshous D, et al : Artemis, a novel DNA double-strand break repair/V (D) Jrecombination protein, is mutated in human severe combined immune deficiency. Cell 105 : 177-186, 2001

 

6) Stewart GS, et al : The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling cascade at sites of DNA damage. Cell 136 : 420-434, 2009

PubMed

7) Baple EL, et al : Hypomorphic PCNA mutation underlies a human DNA repair disorder. J Clin Invest 124 : 3137-3146, 2014

PubMed

8) Stewart GS, et al : The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell 99 : 577-587, 1999

PubMed

9) Waltes R, et al : Human RAD50 deficiency in a Nijmegen breakage syndrome-like disorder. Am J Hum Genet 84 : 605-616, 2009

 

10) Varon R, et al : Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 93 : 467-476, 1998

PubMed

・ A-T children's project http://www.tmd.ac.jp/med/ped/atcp/index.html (2015年8月21日アクセス)

 

・e-免疫.com http://www.emeneki.com/ (2015年8月21日アクセス)

 

P.701 掲載の参考文献

1) Minegishi Y : Hyper-IgE syndrome. Curr Opin Immunol 21 : 487-492, 2009

PubMed

2) Grimbacher B, Holland SM, Puck JM : Hyper-IgE syndromes. Immunol Rev 203 : 244-250, 2005

PubMed

3) Minegishi Y, Saito M, Tsuchiya S, et al : Dominantnegative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 448 : 1058-1062, 2007

PubMed

4) Winkelstein JA, Marino MC, Johnston RB Jr, et al : Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79 : 155-169, 2000

 

5) Minegishi Y, Saito M, Nagasawa M, et al : Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome. J Exp Med 206 : 1291-1301, 2009

PubMed

6) Puel A, Cypowyj S, Bustamante J, et al : Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332 : 65-68, 2011

PubMed

7) Siegel AM, Heimall J, Freeman AE et al : A critical role for STAT3 transcription factor signaling in the development and maintenance of human T cell memory. Immunity 35 : 806-818, 2011

 

P.704 掲載の参考文献

1) Merscher S, Funke B, Epstein JA, et al : TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome. Cell 104 : 619-629, 2001

PubMed

2) Jerome LA, Papaioannou VE : DiGeorge syndrome phenotype in mice mutallt for the T-box gene, Tbx1. Nat Genet 27 : 286-291, 2001

 

3) Yagi H, Furutani Y, Hamada H, et al : Role of TBX1 in htnman del22q11.2 syndrome. Lancet 362 (9393) : 1366-1373, 2003

PubMed

4) Bittel DC, Yu S, Newkirk H, et al : Refining the 22q11.2 deletion breakpoints in DiGeorge syndrome by aCGH. Cytogeliet Genome Res 124 : 113-120, 2009

PubMed

5) Hwang VJ, Maar D, Regan J, et al : Mapping the deletion endpoints in individuals with 22q11.2 deletion syndrome by droplet digital PCR. BMC Med Genet 15 : 106, 2014

PubMed

6) Markert ML, Devlin BH, A-lexieff MJ, et al : Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation : outcome of 44 consecutive transplants. Blood 109 : 4539-4547, 2007

 

・ 原発性免疫不全症候群情報サイト「e-免疫.com」http://www.emeneki.com/ (2015年8月21日アクセス)

 

P.707 掲載の参考文献

1) Durandy A, Kracker S, Fischer A : Primary antibody deficiency. Nat Rev Immunol 13 : 519-533, 012

 

2) Conley ME, Broides A, Hernadez-Trujillo V, et al : Genetic analysis of patients with defects in early B-cell development. Immunol Rev 203 : 216-234, 2005

 

3) van der Burg M, van Zelm MC, Driessen GJA, et al : New frontiers of primary antibody deficiencies. Cell Mol Life Sci 69 : 59-73, 2012

PubMed

4) 矢田純一 : 免疫不全. 矢田純一 (編) : 医系免疫学, 改訂12版中外医学社, 東京, pp490-539, 2011

 

5) 種市尋宙, 金兼弘和, 二谷武. 他 : わが国におけるX連鎖無γグロブリン血症の臨床診断に関する検討. 日小児会誌 108 : 1118-1122, 2004

 

6) Futatani T, Miyawaki T, Tsukada S, et al : Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow ctyometric analysis and its clinical application to carrier detection. Blood 91 : 595-602, 1998

PubMed

7) Bonagura VR, Marchlewski R, Cox A, et al : Biologic IgG level in primary immunodeficiency disease : the IgG level that protects against recurrent infection. J Allergy Clin Immunol 122 : 210-212, 2008

PubMed

8) Turvey SE, Leo SH, Boos A, et al : Successful approach to treatment of Helicobacter bilis infection in X-linked agammaglobulinemia. J Clin Immunol 32 : 1404-1408, 2012

 

9) Staines Boone AT, Torres Martinez MG, Lopez Herrera G, et al : Gastric adenocarcinoma in the cntext of X-linked agammaglobulinemia : case report and review of the literature. J Clin Immunol 34 : 134-137, 2014

PubMed

10) Honda E Kano H, Kanegane H, et al : The kinase Btk negatively regulates the production of reactive oxygen species and stimulation-induced apoptosis in human neutrophils. Nat Immunol 13 : 369-378, 2012

 

・ e-免疫.com http://www.emeneki.com/ (2015年8月21日アクセス)

 

P.712 掲載の参考文献

1) Morio T : 分類不能型免疫不全症 (CVID) の多彩な病像と分子基盤. Rinsho Ketsueki 54 : 1983-1991, 2013

 

2) Yong PF, Thaventhiran JE, Grimbacher B : "A rose is a rose is a rose," but CVID is not CVID common variable immune deficiency (CVID), what do we know in 2011? Adv Immunol 111 : 47-107, 2011

 

3) Salzer U, Warnatz K, Peter HH : Common variable immunodeficiency-an update. Arthritis Res Ther 14 : 223-234, 2012

PubMed

4) Wehr C, Kivioja T, Schmitt C, et al : The EUROclass trial : defining subgroups in common variable immunodeficieny. Blood 111 : 77-85, 2008

 

5) Durandy A, Kracker S, Fischer A : Primary antibody deficiencies. Nat Rev Immunol 13 : 519-533, 2013

PubMed

6) Kamae C, Nakagawa N, Sato H, et al : Common variable immunodeficiency classification by quantifying T-cell receptor and immunoglobulin kappa-deleting recombination excision circles. J Allergy Clin Immunol 131 : 1437-1440, e1435, 2013

 

7) Morio T : Common variable immunodeciency : an update on etiology, pathophysiology, and classification. Jpn J Clin Immunol 35 : 14-22, 2012

 

8) Abolhassan H, Sagvand BT, Shokuhfar T, et al : A review on guidelines for management and treatment of common variable immunodeficiency. Expert Rev Clin Immunol 9 : 561-575, 2013

 

9) Cunningham-Rundles C : The many faces of common variable immunodeficiency. Hematology Am Soc Hematol Educ Program, 2012 (310-305) doi : 10.1182/asheducation-2012. 1. 301

 

10) Cunningham-Rundles C : How I treat common variable imnlune deficiency. Blood 116 : 7-15, 2010

 

・ PIDJ (Primary lmmunodeficiency Database in Japan) http://pidj.rcai.riken.jp/ (2015年8月21日アクセス)

 

P.717 掲載の参考文献

1) Durandy A, Kracker S, Fischer A : Primary antibody deficiencies. Nat Rev Immunol 13 : 519-533, 2013

PubMed

2) Aruffo A, Farrington M, Hollenbaugh D, et al : The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72 : 291-300, 1993

PubMed

3) Ferrari S, Giliani S, Insalaco A, et al : Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci USA 98 : 12614-12619, 2001

PubMed

4) ReVy P, Muto T, LeVy Y, et al : Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (HIGM2). Cell 102 : 565-575, 2000

PubMed

5) Imai K, Slupphaug G, Lee W-I, et al : Human uracil-DNA glycosylase deficiency associated with profoundly impaired imniunoglobulin class-switch recombination. Nat Immunol 4 : 1023-1028, 2003

PubMed

6) Peron S, Metin A, Gardes P, et al : Human PMS2 deficiency is associated with impaired immunoglobulin class switch recombination. J Exp Med 205 : 2465-2472, 2008

PubMed

7) Gardes P, Forveille M, Alyanakian M-A, et al : Human MSH6 deficiency is associated with impaired antibody maturation. The J Immunol 188 : 2023-2029, 2012

 

8) Imai K, Catalan N, Plebani A, et al : Hyper-IgM syndrome type 4 with a B lymphocyte-intrinsic selective deficiency in Ig class-switch recombination. J Clin Invest 112 : 136-142, 2003

 

9) Mitsui-Sekinaka K, Imai K, Sato H, et al : Clinical features and hematopoietic stem cell transplantations for CD40 ligand deficiency in Japan. J Allergy Clin Immunol, 2015 doi : 10.1016/j. jaci. 2015. 02. 020 [Epub ahead of print]

 

10) Quartier P, Bustamante J, Sanal O, et al : Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to activation-induced cytidine deaminase deficiency. Clin Immunol 110 : 22-29, 2004

PubMed

・ PIDJ http://pidj.rcai.riken.jp (2015年8月21日アクセス)

 

・ RAPID http://web16.kazusa.or.jp/rapid/ (2015年8月21日アクセス)

 

P.721 掲載の参考文献

1) Al-Herz W, Bousfiha A, Casanova JL, et al : Primary immunodeficiency diseases : an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Frontiers in immunology 5 : 162, 2014

PubMed

2) Durandy A, Kracker S, Fischer A : Primary anti-body deficiencies. Nature reviews. Immunology 13 : 519-533, 2013

 

3) Terada T, Kaneko H, Li AL, et al : Analysis of Ig subclass deficiency : First reported case of IgG2, IgG4, and IgA deficiency caused by deletion of C alpha 1, psi C gamma, C gamma 2, C gamma 4, and C epsilon in a Mongoloid patient. J Allergy Clin Immunol 108 : 602-606, 2001

 

4) Tashita H, Fukao T, Kaneko H, et al : Molecular basis of selective IgG2 deficiency. The mutated membrane-bound form of gamma2 heavy chain caused complete IGG2 deficiency in two Japanese siblings. J Clin Invest 101 : 677-681, 1998

PubMed

5) Peron S, Metin A, Gardes P, et al : Human PMS2 deficiency is associated with impaired immunoglobulin class switch recombination. J Exp Med 205 : 2465-2472, 2008

PubMed

6) Gardes P, Forveille M, Alyanakian MA, et al : Human MSH6 deficiency is associated with impaired antibody maturation. J Immunol 188 : 2023-2029, 2012

PubMed

7) 金子英雄, 鈴木啓子, 近藤直実 : IgA・IgAサブクラスとIgA欠損症の病態. 日臨免疫会誌 32 : 142-148, 2009

 

8) Castigli E, Wilson SA, Garibyan L, et al : TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 37 : 829-834, 2005

PubMed

9) Angulo I, Vadas O, Garcon F, et al : Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage. Science 342 : 866-871, 2013

PubMed

10) Lucas CL, Kuehn HS, Zhao F, et al : Dominant-activating germline mutations in the gene encoding the PI (3) Kcatalytic subunit p110delta result in T cell senescence and human immunodeficiency. Nat Immunol 15 : 88-97, 2014

 

・ Primary Immunodeficiency Database in Japan (PIDJ) http://pidj.rcai.rikenjp (2015年8月21日アクセス)

 

P.726 掲載の参考文献

1) Janka GE, Lehmberg K : Hemophagocytic syndromes-An update. Blood Rev 28 : 135-142, 2014

PubMed

2) Chandrakasan S, Filipovich AH : Hemophagocytic lymphohistiocytosis : Advances in pathophysiology, diagnosis, and treatment. J Pediatr 163 : 1253-1259, 2013

PubMed

3) Nagai K, Yamamoto K, Fujiwara H, et al : Subtypes of familial hemophagocytic lymphohistiocytosis in Japan based on genetic and functional analyses of cytotoxic T lymphocytes. PLoS One 5 : e14173, 2010

PubMed

4) Nagai K, Ochi F, Terui K, et al : Clinical characteristics and outcomes of Chediak-Higashi syndrome : A nationwide survey of Japan. Pediatr Blood Cancer 60 : 1582-1586, 2013

PubMed

5) Pagel J, Beutel K, Lehmberg K, et al : Distinct mutations in STXBP2 are associated with variable clinical presentations in patients with familial hemophagocytic lymphohistiocytosis type 5 (FHL5). Blood 119 : 6016-6024, 2012

PubMed

6) Yasumi T, Hori M, Hiejima E, et al : Laboratory parameters identify familial hemophagocytic lymphohistiocytosis from other forms of paediatric haemophagocytosis. Br J Haematol 170 : 532-538, 2015

PubMed

7) Creput C, Galicier L, Buyse S, et al : Understanding organ dysfunction in hemophagocytic lymphohistiocytosis. Intensive Care Med 24 : 1177-1187, 2008

 

8) Bode SF, Lehmberg K, Maul-Pavicic A, et al : Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis. Arthritis Res Ther 14 : 213, 2012

 

9) Murata Y, Yasumi T, Shirakawa R, et al : Rapid diagnosis of FHL3 by flow cytometric detection of intraplatelet Munc 13-4 protein. Blood 118 : 1225-1230, 2011

 

10) Marsh RA, Vaughn G, Kim MO, et al : Reducedintensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation. Blood 116 : 5824-5831, 2010

PubMed

P.731 掲載の参考文献

1) Cannons JL, Tangye SG, Schwartzberg PL. : SLAM family receptors and SAP adaptors in immunity. Annu Rev Immunol 29 : 665-705, 2011

PubMed

2) Claus M, Meinke S, Bhat R, et al : Regulation of NK cell activity by 2B4, NTB-A and CRACC. Front Biosci 1 : 956-965, 2008

PubMed

3) Vaux DL, Silke J : IAPs, RINGs and ubiquitylation. Nat Rev Mol Cell Biol 6 : 287-297, 2005

PubMed

4) Damgaard RB, Fiil BK, Speckmann C, et al : Disease-causing mutations in the XIAP BIR2 domain impair NOD2-dependent immune signaling. EMBO Mol Med 5 : 1278-1295, 2013

PubMed

5) Latour S, Aguilar C. : XIAP deficiency syndrome in humans. Semin Cell Dev Biol 39 : 115-123, 2015

PubMed

6) Aguilar C, Lenoir C, Lambert N, et al : Characterization of Crohn disease in X-linked inhibitor of apoptosis-deficient male patients and female symptomatic carriers. J Allergy Clin Immunol 134 : 1131-1141, 2014

 

7) Padhlopnik Schniid J, Canioni D, Moshous D, et al : Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency). Blood 117 : 1522-1529, 2011

 

8) Kanegane H, Yang X, Zhao M, et al : Clinical features and outcome of X-linked lymphoproliferative syndrome type 1 (SAP deficiency) in Japan identified by the combination of flow cytometric assay and genetic analysis. Pediatr Allergy Immu-nol 23 : 488-493, 2012

 

9) Yang X, Kanegane H, Nishida N, et al : Clinical and genetic characteristics of XIAP deficiency in Japan. J Clin Immunol 32. 411-420, 2012

PubMed

10) Milone MC, Tsai DE, Hodinka RL, et al : Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapy. Blood 105 : 994-996, 2005

PubMed

11) Booth C, Gilmour KC, Veys P, et al : X-linked lyinphoproliferative disease due to SAP/SH2D1A deficiency : a multicenter study on the manifestations, management and outcome of the disease. Blood 117 : 53-62, 2011

PubMed

12) Marsh RA, Rao K, Satwani P, et al : Allogeneic hematopoietic cell transplantation for XIAP deficiency : an international survey reveals poor outcomes. Blood 121 : 877-883, 2013

PubMed

13) Tsuma Y, Imamura T, Ichise E, et al : Successful treatment of idiopathic colitis related to XIAP deficiency with allo-HSCT using reduced-intensity conditioning. Pediatr Transplant 19 : E25-28, 2015

 

P.735 掲載の参考文献

1) Rieux-Laucat F, Le Deist F, Hivroz C, et al : Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268 : 1347-1349, 1995

PubMed

2) Fisher GH, Rosenberg FJ, Straus SE, et al : Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81 : 935-946, 1995

 

3) Rao VK, Oliveira JB : How I treat autoimmune lymphoproliferative syndrome. Blood 118 : 5741-5751, 2011

 

4) Li P, Huang P, Yang Y, et al : Updated understanding of autoimmune lymphoproliferative syndrome (ALPS). Clin Rev Allerg Immunol, 2015 doi : 10.1007/s12016-015-8466-y

 

5) Takagi M, Shinoda K, Piao J, et al : Autoimmune lymphoproliferative syndrome-like disease with somatic KRAS mutation. Blood 117 : 2887-2890, 2011

PubMed

・ NIH : National Institute of Allergy and Infectious Diseases, Health & Research Topics, Autoimmune Lymphproliferative Syndrome (ALPS) http://www3.niaid.nih.gov/topics/ALPS/ (2015年8月24日アクセス)

 

P.743 掲載の参考文献

1) Newburger PE, Boxer LA : Leukopenia. In Kliegman RM, Stanton BF, Schor NE et al (eds) : Nelson Textbook of Pediatrics, 19th ed, Elsevier Saunders, pp746-752, 2011

 

2) Al-Herz W, et al : Primary immunodeficiency diseases : an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Frontier immunol 162 : 1-33, 2014

 

3) Horwitz MS, Duan Z, Korkmaz B, et al : Neutrophil elastase in cyclic and severe congenital neutropenia. Blood 109 : 1817-1824, 2007

PubMed

4) Horwitz MS, Corey SJ, Grimes HL, et al : ELANE mutations in cyclic and severe congenital neutropenia : genetics and paphophysiology. Hematol Oncol Clin North Am 27 : 19-41, 2013

 

5) Klein C : Genetic defects in severe congenital neutropenia : emerging insights into life and death of human neutrophil granulocytes. Annu Rev Immunol 29 : 399-413, 2011

PubMed

6) Kawaguchi H, Kobayashi M, Nakamura K, et al : Dysregulation of trartscriptions in primary granule constituents during myeloid proliferation and differentiation in pateints with severe congenital neutropenia. J Leukoc Biol 73 : 225-234, 2003

 

7) Benson KF, Li FQ, Person RE, et al : Mutations associated with neutropenia in dogs and humans disrupt intraacellular transport of neutrophil elastase. Nat Genet 35 : 90-96, 2003

PubMed

8) Kollner I, Sodeik B, Schreek S, et al : Mutations in neutrophil elastase causing congenital neutroepnia lead to cytoplasmic protein accumulation and induction of the unfolded protein response. Blood 108 : 493, 500, 2006

 

9) Grenda DS, Murakami M, Ghatak J, et al : Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis. Blood 110 : 4179-87, 2007

PubMed

10) Kawaguchi H, Kobayashi M, Nakamura K, et al : Dysregulation of transcription in primary granule constituents during myeloivproliferation and differentiation in patients with severe congenital neutropenia. J Leukoc Biol 73 : 225-234, 2003

PubMed

11) Skokowa J, Fobiwe JP, Dan L, et al : Neutrophil elastase is severely downregulated in severe congenital neutropenia independent of ELA2 or HAX1 mutations but dependent on LEF1. Blood 114 : 3044-3051, 2010

PubMed

12) Klein C, Grudzien M, Appaswamy G, et al : HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet 39 : 86-92, 2007

PubMed

13) Ishikawa N, Okada S, Miki M, et al : Neurodevelopmental abnormalities associated with severe congenital neutropenia due to the R86X mutation in the HAX1 gene. J Med Genet 45 : 802-807, 2008

 

14) Horwitz MS, Benson KE Person RE, et al : ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat Genet 23 : 433-436, 1999

 

15) Sera Y, Kawaguchi H, Nakamura K, et al : A comparison of the defective granulopoiesis in childhood cyclic neurtropenia and in severe congenital neutropenia. Haematologica 90 : 1032-1041, 2005

 

16) Rosenberg PS, Zeidler C, Bolyard AA : Stable long-term risk of leukemia in patients with severe congenital neutropenia maintained on G-CSF therapy. Br J Haematol 150 : 196-199, 2010

 

17) Rosenberg PS, Alter BP, Bolyard AA, et al : The incidence of leukemia and mortality from sepsis in pateints with severe congenital neutropenia receiving long-term G-CSF therapy. Blood 107 : 4628-4635, 2006

 

18) 岡田賢, 中村和洋, 小林正夫 : 先天性好中球減少症と血液腫瘍. 臨床血液 51 : 553-558. 2010

 

19) Zeidler C : Stem cell transplantation I patients with severe congenital neutropenia without evidence of leukemic transformation. Blood 95 : 1195-1198, 2000

PubMed

20) Oshirna K, Hanada R, Kobayashi R, et al : Hematopoietic stem cell transplantation in pateints with severe congenital neutropenia : analysis of 18 Japanese cases. Pediatr Transplant 14 : 657-663, 2010

 

21) Carlsson G, Winiarski J, Ljungman P, et al : Hematopoietic stem cell transplantaion in pateints with severe congenital neutropenia. Pediatr Blood Cancer 56 : 444-451, 2011

 

22) Connelly J, Choi SW, Levine JE : Hematopoieticstem cell transplantation for severe congenital neutropenia. Curr Opin Hematol 19 : 44-51, 2012

 

23) Bux J, Behrens G, Jaeger G, et al : Diagnosis and clinical course of aut, oinnnune neutroepenia in infancy. Analysis of 240 cases. Blood 91 : 181-186, 1998

 

24) Bruin MCA, Von dem Borne AEGKr, Tamminga RYJ, et al : Neutrophil antibody specificity in different types of childhood autoimmune neutropenia. Blood 94 : 1797-1802, 1999

 

25) 中村和洋, 佐藤貴, 小林正夫 : 抗好中球抗体と乳幼児自己免疫性好中球減少症. 日小児血液会誌 18 : 17-22, 2004

 

26) Nakamura K, Miki M, Karakawa S, et al : Deficiency of regulatory T cells in children with autoimmune neutropenia. Br J Haematol 145 : 642-647, 2009

PubMed

27) 小林正夫 : 小児好中球減少症. 日小児会誌 100 : 614-622, 2005

 

28) Bux J : Human neutrophil alloantigens. Vox Sang 94 : 277-285, 2008

PubMed

29) 中村和洋, 小林正夫 : 新生児の好中球減少症. 日産婦新生児血会誌 18 : 149-153, 2009

Medical*Online

30) Kobayashi M, Nakamura K, Kawaguchi H, et al : Significance of the detection of antineutrophil antibodies in children with chronic neutron. Blood 99 : 3468-3471, 2002

 

31) Kobayashi M, Sato T, Kawaguchi H, et al : Efficacy of prophylactic use of trimethoprini-sulfamethoxazole in autoimmune neutropenia in infancy. J Pediatr Hematol Oncol 25 : 553-557, 2003

PubMed

32) Etzitoni A : Leukocyte adhesion deficiencyes : moleculer basis, clinical findings, and therapeutic options. Adv Exp Med Biol 601 : 51-60, 2007

 

33) Hanna S, Etzioni A : Leukocyte adhesion deficiencyes. Ann NY Acad Sci 1250 : 50-55, 2012

PubMed

34) Luhn K, Wild MK, Eckhardt M, et al : The gene defective in leukocyte adhesion deficiency II encoded a putative GDP-fucose transporter. Nat Genet 28 : 69-72, 2001

PubMed

35) Yakubenia S, Wild MK : Leukocyte adhesion deficiency II. FEBS J 273 : 4390-4398, 2006

PubMed

36) Kuijpers TW, Van Bruggen R, Kamerleek N, et al : Natural history and early diagnosis of LADI/variant syndrome. Blood 109 : 3529-3537, 2007

 

37) Moser M, Nieswandt B, Ussar S, et al : Kidllin 3 is essentiall for integrin activation and platelet aggregateon. Nat Med 14 : 325-330, 2008

 

38) Svensson L, Howarth K, McDowall A, et al : Leukocyte adhesion deficiency III is caused by mutations in Kindlin3 affedts integrin activation. Nat Med 15 : 306-312, 2009

PubMed

P.749 掲載の参考文献

1) Nunoi H : Two breakthroughs in CGD studies. Jpn J Clin Immunol 30 : 1-10, 2007

 

2) Kawai T : A therapeutic approach towards chronic granulomatous disease. Jpn J Clin Immunol 37 : 437-446, 2014

 

3) Marciano BE, Spalding C, Fitzgerald A, et al : Common severe infections in chronic granulomatous disease. Clin Infect Dis Dec 60 : 1176-1183, 2015

PubMed

4) Winkelstein JA, Marino MC, Johnston RB Jr, et al : Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79 : 155-69, 2000

 

5) Magnani A, Brosselin P, Beaute J, et al : Inflammatory manifestations in a single-center cohort of patients with chronic granulomatous disease. J Allergy Clin Immunol 134 : 655-662, 2014

 

6) Uzel G, Orange JS, Poliak N, et al : Complications of tumor necrosis factor-α blockade in chronic granulolnatous disease-related colitis. Clin Infect Dis 51 : 1429-1434, 2010

 

7) Kawai T, Watanabe N, Yokoyama M, et al : Thalidomide attenuates excessive inflamlnation without interrupting lipopolysaccharide-driven infiammatory cytokine production in chronic granulomatous disease. Clin Immunol 147 : 122-128, 2013

 

8) Kawai T, Watanabe N, Yokoyama M, et al : Interstitial lung disease with multiple microgranulomas in chronic granulomatous disease. J Clin Immunol 34 : 933-940, 2014

PubMed

9) Kuhns DB, Alvord WG, Heller T, et al : Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med 363 : 2600-2610, 2010

PubMed

P.754 掲載の参考文献

1) Bustamante J, Boisson-Dupuis S, Abel L, et al : Mendelian susceptibility to mycobacterial disease : Genetic, immunological, and clinical features of inborn errors of IFN-gamma immunity. Semin Immunol 26 : 454-470, 2014

PubMed

2) de Beaucoudrey L, Samarina A, Bustamante J, et al : Revisiting human IL-12Rbetal deficiency : a survey of 141 patients from 30 countries. Medicine (Baltimore) 89 : 381-402, 2010

PubMed

3) Hirata O, Okada S, Tsumura M, et al : Heterozygosity for the Y701C STAT1 mutation in a multiplex kindred with multifocal osteomyelitis. Haematologica 98 : 1641-1649, 2013

 

4) Prando C, Samarina A, Bustanlante J, et al : Inherited IL-12p40 deficiency : genetic, immunologic, and clinical features of 49 patients from 30 kindreds. Medicine (Baltimore) 92 : 109-122, 2013

PubMed

5) Hoshina T, Takada H, Sasaki-Mihara Y, et al : Clinical and host genetic characteristics of Mendelian susceptibility to mycobacterial diseases in Japan. J Clin Immunol 31 : 309-314, 2011

PubMed

6) Bax HI, Freeman AF, Ding L, et al : Interferon alpha treatment of patients with impaired interferon gamma signaling. J Clin Immunol 33 : 991-1001, 2013

PubMed

7) Ward CM, Jyonouchi H, Kotenko SV, et al : Adjunctive treatment of disseminated Mycobacterium avium complex infection with interferon alpha-2b in a patient with complete interferon-gamma receptor R1 deficiency. Eur J Pediatr 166 : 981-985, 2007

 

8) Kong XF, Vogt G, Itan Y, et al : Haploillsufficiency at the human IFNGR2 locus contributes to mycobacterial disease. Hum Mol Genet 22 : 769-781, 2013

PubMed

9) Zhang X, Bogunovic D, Payelle-Brogard B, et al : Human intracellular ISG15 prevents interferon-alpha/beta over-amplification and auto-inflammation. Nature 517 : 89-93, 2015

PubMed

10) Filipe-Santos O, Bustamante J, Haverkalnp MH, et al : X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J Exp Med 203 : 1745-1759, 2006

 

P.760 掲載の参考文献

1) Hanson EP, Monaco-Shawver L, Solt LA, et al : Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity. J Allergy Clin Immunol 122 : 1169-1177, e1116, 2008

 

2) Picard C, von Bernuth H, Ghandil P, et al : Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency. Medicine 89 : 403-425, 2010

PubMed

3) Lafaille FG, Pessach IM, Zhang SY, et al : Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature 491 (7426) : 769-773, 2012

PubMed

4) Picard C, Casanova JL, Puel A : Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IkappaBalpha deficiency. Clin Microbiol Rev 24 : 490-497, 2011

PubMed

5) Zhang SY, Herman M, Ciancanelli MJ, et al : TLR3 immunity to infection in mice and humans. Curr Opin Immunol 25 : 19-33, 2013

 

6) Takada H, Yoshikawa H, Imaizumi M, et al : Delayed separation of the unlbilical cord in two siblings with interleukin-1 receptor-associated kinase 4 deficiency : rapid screening by flow cytometer J Pediatrics 148 : 546-548, 2006

PubMed

P.765 掲載の参考文献

1) Cypowyj S, Picard C, Marodi L, et al : Immunity to infection in IL-17-deficient mice and humans. Eur J Immunol 42 : 2246-2254, 2012

PubMed

2) Puel A, Cypowyj S, Marodi L, et al : Inbom errors of human IL-17 immunity underlie chronic mucocutaneous candidiasis. Curr Opin Allergy Clin Immunol 12 : 616-622, 2012

PubMed

3) Puel A, Cypowyj S, Bustamante J, et al : Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 332 : 65-68, 2011

PubMed

4) Liu L, Okada S, Kong XE et al : Gain-of-function human STATI mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med 208 : 1635-1648, 2011

 

5) van de Veerdonk FL, Plantinga TS, Hoischen A, et al : STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med 365 : 54-61, 2011

PubMed

6) Boisson B, Wang C, Pedergnana V, et al : An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis. Immunity 39 : 676-686, 2013

PubMed

7) Mizoguchi Y, Tsumura M, Okada S, et al : Simple diagnosis of STAT1 gain-of-function alleles in patients with chronic mucocutaneous candidiasis. J Leukoc Biol 95 : 667-676, 2014

PubMed

8) Lanternier F, Cypowyj S, Picard C., et al : Primary immunodeficiencies underlying fungal infections. Curr Opin Pediatr 25 : 736-747, 2013

PubMed

9) Marazzi MG, Bondi E, Giannattasio A, et al : Intracranial aneurysm associated with chronic mucocutaneous candidiasis. Eur J Pediatr 167 : 461-463, 2008

PubMed

10) Sharfe N, Nahum A, Newell A, et al : Fatal combined immunodeficiency associated with heterozygous mutation in STAT1. J Allergy Clin Immunol 133 : 807-817, 2014

PubMed

P.769 掲載の参考文献

1) Almeida de Jesus A, Goldbach-Mansky R : Monogenic autoinflammatory diseases : concept and clinical manifestations. Clinical immunology 147 : 155-174, 2013

PubMed

2) Masters SL, Simon A, Aksentijevich I, et al : Horror autoinflammaticus : the molecular pathophysiology of autoinflammatory disease (*). Ann Rev Immunol 27 : 621-668, 2009

 

3) 特集 : 自己炎症性疾患の新しい知見. 日臨免疫会誌 34 : 327-419, 2011

 

4) Ozen S, Bilginer Y : A clinical guide to autoinflammatory diseases : familial Mediterranean fever and next-of-kin. Nature reviews. Rheumatology 10 : 135-147, 2014

PubMed

5) Migita K, Uehara R, Nakamura Y, et al : Familial Mediterranean fever in Japan. Medicine 91 : 337-343, 2012

PubMed

6) Lachmann HJ, Papa R, Gerhold K, et al : The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation : a series of l58 cases from the Eurofever/EUROTRAPS international registry. Ann Rheum Dis 73 : 2160-2167, 2014

 

7) Levy R, Gerard L, Kuemmerle-Deschner J, et al : Phenotypic and genotypic characteristics of cryopyrin-associated periodic syndrome : aseries of 136 patients from the Eurofever Registry. Ann Rheum Dis 2014 doi : 10.1136/annrheumdis-2013-204991 [Epub ahead of print]

 

8) Rose CD, Pans S, Casteels I, et al : Blau syndrome : cross-sectional data from a multicentre study of clinical, radiological and functional out-comes. Rheumatology (Oxford) 54 : 1008-1016, 2015

 

9) van der Burgh R, Ter Haar NM, Boes ML, et al : Mevalonate kinase deficiency, a metabolic autoinflammatory disease. Clin Immunol 147 : 197-206, 2013

PubMed

10) Kanazawa N : Rare hereditary autoinflammatory disorders : towards an understanding of critical in vivo inflammatory pathways. J Demnatol Sci 66 : 183-189, 2012

PubMed

11) Agostini L, Martinon F, Burns K, et al : NALP3 fonns an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20 : 319-325, 2004

 

12) Lamkanfi M, Dixit VM : Mechanisms and functions of inflammasomes. Cell 157 : 1013-1022, 2014

PubMed

13) Ter Haar N, Lachmann H, Ozen S, et al : Treatment of autoinflammatory diseases : results from the Eurofever Registry and a literature review. Ann Rheum Dis 72 : 678-685, 2013

 

14) Yokota S, Nishikomori R, Takada H, et al : Guidance on the use of canakinumab in patients with cryopyrin-associated periodic syndronie in Japan. Mod Rheum/Jpn Rheum Assoc 23 : 425-429, 2013

 

15) Pinney JH, Lachmann HJ : Systemic M amyloidosis. Sub-cellular Biochem 65 : 541-564, 2012

 

・ 自己炎症性疾患, サイト http://aid.kazusa.or.jp/2013/ (2015年8月24日アクセス)

 

・ infevers : The registry of Hereditary Auto-inflammatory Disorders Mutations http://fmf.igh.cnrs.fr/ISSAID/infevers/ (2015年8月24日アクセス)

 

・ 難病情報センター http://www.nanbyou.or.jp (2015年8月24日アクセス)

 

・ 小児慢性特定疾病情報センター http://www.shoumanjp (2015年8月24日アクセス)

 

P.775 掲載の参考文献

1) Al-Herz W, Bousfiha A, Casanova JL, et al : Primary immunodeficiency diseases : an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol 5 : 162, 2014

PubMed

2) Pettigrew HD, Teuber SS, Gershwin ME : Clinical significance of complement deficiencies. Ann NY Acad Sci 1173 : 108-123, 2009

PubMed

3) Rodriguez E, Rallapalli PM, Osborne AJ, et al : New functional and structural insights from updated mutational databases for complement factor H, factor I, membrane cofactor protein and C3. Biosci Rep 34 : 2014 doi : 10.1042/BSR2014 0117

 

4) Okura Y, Nawate M, Takahashi Y, et al : Rheumatoid factor-positive synovitis in a patient with C3 deficiency. Scand J Rheumatol 41 : 405-406, 2012

 

5) Okura Y, Kobayashi I, Yamada M, et al : Clinical characteristics and genotype-phenotype correlations in C3 deficiency. J Allergy Clin Immunol (in press)

 

6) Lewis LA, Ram S : Meningococcal disease and the complement system. Virulence 5 : 98-126, 2014

PubMed

7) 一般社団法人日本補体学会 : 遺伝性血管性浮腫 (HAE) のガイドライン改訂2014年度版 http://square.umin.ac.jp/compl/common/images/disease-information/hae/HAEGuideline2014.pdf (2015年8月26日アクセス)

 

8) 非典型溶血性尿毒症症候群診断基準作成委員会 : 非典型溶血性尿毒症症候群診断基準 http://www.jsn.or.jp/guideline/pdf/ahus2013.pdf (2015年8月26日アクセス)

 

9) 厚生労働省科学研究費補助金新型インフルエンザ等新興・再興感染症研究事業重症の腸管出血性大腸菌感染症の病原性因子及び診療の標準化に関する研究班溶血性尿毒症症候群の診断・治療ガイドライン作成班溶血性尿毒症症候群 (HUS) の診断・治療ガイドライン 2013 http://www.jsn.or.jp/academicinfo/report/hus2013book.pdf (2015年8月26日アクセス)

 

P.778 掲載の参考文献

1) Okkenhaug K, Vanhaesebroeck B : PI3K in lymphocyte development, Differentiation and activation. Nat Rev Immunol 3 : 317-330, 2003

PubMed

2) Angulo I, Vadas O, GarCon E et al : Phosphoinositide 3-kinase δ gene mutation predisposes to respiratory infection and airway damage. Science 342 : 866-871, 2013

 

3) Lucas CL, Kuehn HS, Zhao F, et al : Dominant-activating germline mutations in the gene encoding the PI (3) Kcatalytic subunit p 110 δ result in T cell senescence and human immunodeficieiicy. Nat lmmunol 15 : 88-97, 2014

 

4) Deau MC, Heurtier L, Frange P, et al : A human immunodeficiency caused by mutations in the PIK3R1 gene. J Clin Invest 124 : 3923-3928, 2014

 

5) Crank MC, Grossman JK, Moir S, et al : Mutations in PIK3CD can cause hyper IgM syndrome (HIGM) associated with increased cancer susceptibility. J Clin Immunol 34 : 272-276, 2014

PubMed

6) Kracker S, Curtis J, Ibrahim MA, et al : Occurrence of B-cell lymphomas in patients with activated phosphoinositide 3-kinase δ syndrome. J Allergy Clin Immunol 134 : 233-236, 2014

 

・ PIDJ Primary Immunodeficiency Database in Japan http://pidj.rcai.rikenjp/ (2015年8月26日アクセス)

 

・ APDSyndrome.org http://www.apdsyndrome.org/ (2015年8月26日アクセス)

 

P.784 掲載の参考文献

1) 峯岸克行 : 原発性免疫不全症の原因遺伝子探索の新展開. 医学のあゆみ 252 : 5-9. 2015

Medical*Online

2) Picard C, Fischer A : Contribution of high-throughput DNA sequencing to the study of primary immunodeficiencies. Eur J Immunol 44 : 2854-2861, 2014

 

3) Al-Herz W, Bousfiha A, Casanova JL, et al : Primary immunodeficiency diseases : an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Frontiers Immunol 5 : 162, 2014

 

4) Ivashkiv LB, Donlin LT : Regulation of type I interferon responses. Nature Rev Immunol 14 : 36-49, 2014

 

5) Rigby RE, Rehwinkel J : RNA degradation in antiviral immunity and autoimmunity. Trend Immunol 36 : 179-188, 2015

PubMed

6) Rice G, Patrick T, Parmar R, et al : Clinical and molecular phenotype of Aicardi-Goutieres syndrome. Am J Hum Genet 81 : 713-725, 2007

PubMed

7) 西小森隆太, 他 : リウマチ・膠原病疾患との鑑別が必要な免疫不全症. 小児内科 46 : 1522-1528, 2014

Medical*Online

8) Pendergraft WF 3rd, Means TK AGS, SLE, and RNASEH2 mutations : translating insights into therapeutic advances. J Clin Invest 125 : 102-104, 2015

PubMed

9) Abe J, Nakamura K, Nishikomori R, et al : A nationwide survey of Aicardi-Goutieres syndrome patients identifies a strong association between dominant TREX1 mutations and chilblain lesions : Japanese cohort study. Rheumatology (Oxford, England) 53 : 448-458. 2014

 

10) Glocker EO, Kotlarz D, Boztug K, et al : Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N Engl J Med 361 : 2033-2045, 2009

PubMed

11) Glocker EO, Kotlarz D, Klein C, et al : IL-10 and IL-10 receptor defects in humans. Ann NY Acad Sci 1246 : 102-107, 2011

PubMed

VII. アレルギー疾患

P.790 掲載の参考文献

1) Komata T, Soderstrom L, Borres MP, et al : The predictive relationship of food-specific serum IgE concentrations to challenge outcomes for egg and milk varies by patient age. J Allergy Clin Immunol 119 : 1272-1274, 2007

 

2) Komata T, Soderstrom L, Borres MP, et al : Usefulness of wheat and soybean specific IgE antibody titers for the diagnosis of food allergy. Alleregolo Int 58 : 599-603, 2009

PubMed

3) Ebisawa M, Shibata R, Sato S, et al : Clinical utility of IgE antibodies to ω-5 gliadin in the diagnosis of wheat allergy : a pediatric multicenter challenge study. Int Arch Allergy Immunol 158 : 71-76, 2012

 

4) Nicolaou N, Poorafshar M, Murray C, et al : Allergy or tolerance in children sensitized to peanut : prevalence and differentiation using component-resolved diagnostics. J Allergy Clin Immunol 125 : 191-197, 2010

 

5) 海老澤元宏, 伊藤浩明 : ピーナッツアレルギー診断におけるAra h 2特異的IgE抗体測定の意義. 日小児アレルギー会誌 27 : 621-628, 2013

Medical*Online

6) Asarnoj A, Nilsson C, Lidholm J, et al : Peanut component Ara h 8 sensitization and tolerance to peanut. J Allergy Clin Immunol 130 : 468-472, 2012

PubMed

7) Cabrera-Freitag P, Goikoetxea MJ, Beorlegui C, et al : Can component-based microarray replace fluorescent enzimoimmunoassay in the diagnosis of grass and cypress pollen allergy? Clin Exp Allergy 41 : 1440-1446, 2011

PubMed

8) 小田嶋博, 田場直彦, 藤澤隆夫, 他 : アラスタット3gAllergyの臨床的有用性に関する検討 (第2報) 多施設共同研究による評価 (小児科・皮膚科における検討). アレルギー・免疫 19 : 1985-2000, 2012

 

P.795 掲載の参考文献

1) 日本アレルギー学会 : アナフィラキシーガイドライン. 2014

 

2) 平田博国, 石井芳樹 : 昆虫および動物によるアナフィラキシー. アレルギー・免疫 20 : 1164-1175. 2013

 

3) Tokura Y, Tamura Y, Takigawa M, et al : Severe hypersensitivity to mosquito bites associated with natural killer cell lymphocytosis. Arch Dermatol 126 : 362-368

 

4) Hirata H, Asakura T, Arima M, et al : Efficacy and safety of rush immunotherapy in patients with Hymenoptera allergy in Japan. Asian Pac J Allergy Immunol 21 : 89-94. 2003

PubMed

P.798 掲載の参考文献

1) 赤澤晃, 松永佳世子 (監修) : ラテックスアレルギー安全対策ガイドライン 2013. 協和企画, 東京, 2013

 

2) Hamilton RG, Biagini RE, Krieg EF : Diagnostic performance of FDA-cleared serological assays for natural rubber latex specific IgE antibody. J Allergy Clin Inninunol 103 : 925-930, 1999

 

3) Banerjee B, Wang X, Kelly KJ : IgE from latex allergic patients binds to cloned and expressed B cell epitopes of prohevein. J Immunol 159 : 5724-5732, 1997

PubMed

4) 井上徳浩, 二村昌樹, 明石真幸, 他 : 当院におけるラテックスアレルギー患者の特徴と追跡調査. 日ラテックスアレルギー研究会誌 9 : 54-63, 2005

 

・ 日本ラテックスアレルギー研究会 http://latex.kenkyuukai.jp/about/ (2015年8月27日アクセス)

 

P.804 掲載の参考文献

1) 秀道広, 他 : 蕁麻疹診療ガイドライン. 日皮会誌 121 : 1339-1388, 2011

 

2) 亀好良一, 秀道広, 他 : 最新皮膚科学大系 3, 中山書店, 東京, pp 186-195, 2002

 

3) 細木美和 : 蕁麻疹はなぜかゆい? 秀道広 (編) : じんましん最前線, 1版, メディカルレビュー社, 東京, pp28-29, 2007

 

4) 平郡真記子 : 蕁麻疹の予後. アレルギー・免疫 20 : 264-271, 2013

 

・ 日本皮膚科学会 : 皮膚科Q&A 蕁麻疹 https://www.dermatol.or.jp/qa/qa9/ (2015年8月27日アクセス)

 

・ 日本皮膚科学会 : 蕁麻疹診療ガイドライン https://www.dermatol.or.jp/modules/guideline/index.php?content_id=2 (2015年8月27日アクセス)

 

P.809 掲載の参考文献

1) 濱崎雄平, 河野陽一, 海老澤元宏, 他 : 小児気管支喘息治療・管理ガイドライン 2012, 協和企画, 東京, 2011

 

2) Phelan PD, et al : The Melborne asthma study : 1964-1999. J Allergy Clin Immunol 109 : 189-194, 2002

 

3) Maekawa T, et al : Modified Pulmonary Index Score was sufficiently reliable to assess the severity of acute asthma exacerbations in children. Allergol Int 63 : 603-607, 2014

PubMed

4) Carroll CL, et al : A modified pulmonary index score with predictive value for pediatric asthma exacerbations. Ann Allergy Asthma Immunol 94 : 355-359, 2005

PubMed

5) Castro-Rodriguez JA, Holberg CJ, Wright AL, et al : A clinical index to define risk of asthma in young children with recurrent wheezing. Am J Respir Crit Care Med 162 (4 Pt 1) : 1403-1406, 2000

 

6) Okayama M, et al : Methacholine bronchial hyperreponsiveness in chronic sinusitis. Respiration 65 : 450-457, 1998

 

7) 大谷ゆう子, 他 : 小児慢性副鼻腔炎におけるマクロライド少量長期療法の検討. 日小児会誌 113 : 498-502, 2009

 

8) Sears MR, et al : A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 349 : 1414-1422, 2003

PubMed

P.814 掲載の参考文献

1) Williams H, Robertson C, Stewart A, et. al : Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 103 : 125-138, 1999

 

2) Silverberg JI, Hanifin J, Simpson EL : Climatic factors are associated with childhood eczeｍbirth offers effective atopic dermatitis prevention. J Allergy Clin Immunol 134 : 818-823, 2014

 

6) Horimukai K, Morita K, Narita M, et al : Application of moisturizer to neonates prevents development of atopic dermatitis. J Allergy Clin Immunol 134 : 824-830, e6, 2014

 

7) Kamata Y, Yamamoto M, Kawakami E et al : Bleomycin hydrolase is regulated biphasically in a differentiation-and cytokine-dependent manner : relevance to atopic dermatitis. J Biol Chem 286 : 8204-8212, 2011

 

8) Yoshida K, Kubo A, Fujita H, et al : Distinct behavior of human Langerhans cells and inflammatory dendritic epidermal cells at tight junctions in patients with atopic dermatitis. J Allergy Clin Immunol 134 : 856-864, 2014

PubMed

9) Wilson SR, et al : The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell 155 : 285-295, 2013

PubMed

10) Fukuie T, Nomura I, Horimukai K, et al : Proactive treatment appears to decrease serum immunoglobulin-E levels in patients with severe atopic dermatitis. Br J Dermatol 163 : 1127-1129, 2010

PubMed

・ 九州大学医学部皮膚科学教室 : アトピー性皮膚炎に関する情報 「アトピー性皮膚炎の標準治療」http://www.kyudai-derm.org/atopy_care/index.html (2015年8月28日アクセス)

 

P.820 掲載の参考文献

1) 馬場廣太郎. 中江公裕 : 鼻アレルギーの全国疫学調査2008 <1998年との比較> -耳鼻咽喉科医およびその家族を対象として. Prog Med 28 : 2001-2012, 2008

Medical*Online

2) 一般社団法人日本アレルギー学会 (編) : 第1章 アレルギー疾患総論. アレルギー総合ガイドライン 2013, 協和企画, 東京, pp1-12, 2013

 

3) 鼻アレルギー診療ガイドライン作成委員会 (編) : 第3章 発症のメカニズム. 鼻アレルギー診療ガイドライン-通年性鼻炎と花粉症. ライフ・サイエンス, 東京, pp 13-16, 2013

 

4) Okubo K, et al : A randomized double-blind comparative study of sublingual immunotherapy for cedar pollinosis. Allergol Int 58 : 265-275, 2008

 

5) 奥田稔 他 : アレルギー性鼻炎QOL調査票の開発. アレルギー 52 (補冊) : 1-87, 2003

 

6) 藤枝重治, 坂下雅文, 意元義政 : 好酸球性副鼻腔炎の疫学と診断Eosinophilic Chronic Rhinosinusitis. 耳鼻臨床 106 : 477-484, 2013

 

P.826 掲載の参考文献

1) 厚生労働科学研究班 (主任研究者 : 海老澤元宏) : 食物アレルギーの診療の手引き 2011 http://www.allergy.go.jp/allergy/guideline/05/05_2011.pdf (2015年8月28日アクセス)

 

2) 平成21年度日本保育保健協議会での全国調査

 

3) 日本学校保健会 : 平成25年度学校生活における健康管理に関する調査事業報告書

 

4) 文部科学省 : 平成26年度 今後の学校給食における食物アレルギー対応について http://www.mext.go.jp/b_menu/hakusho/nc/1345963.htm (2015年8月28日アクセス)

 

5) 東京都福祉保健局 : 平成21年度 アレルギー疾患に関する3歳児全都調査 http://www.metro.tokyo.jp/INET/CHOUSA/2010/04/DATA/60k4m103.pdf (2015年8月28日アクセス)

 

6) Akiyama H, Imai T, Ebisawa M : Japan food allergen labeling regulation-history and evaluation. Adv Food Nutr Res 62 : 139-171, 2011

PubMed

7) 平成21年度 新生児食物蛋白誘発胃腸炎 (N-FPIES) の疾患概念確立, 実態把握, 診断治療指針作成に関する研究

 

8) Morita E, et al : Food-dependent exercise-induced anaphylaxis-importance of omega-5 gliadin and HWM-glutenin as causative antigens for wheat-dependent exercise-induced anaphylaxis. Allegol Int 58 : 493-498, 2009

 

9) Lack G : Epidemiologic risks for food allergy. J Allergy Clin Immunol 121 : 1331-1336, 2008

PubMed

10) 池松かおり, 他 : 乳児期発症食物アレルギーに関する検討 (第2報). アレルギー 55 : 533-541. 2006

Medical*Online

11) Skolnick HS, et al : The natural history of peanut allergy. J Allergy Clin Immunol 107 : 367-374, 2001

PubMed

12) Komata T, et al : The predictive relationship of food-specific serum IgE concentrations to challenge outcomes for egg and milk varies by patient age. J Allergy Clin Immunol 119 : 1272-1274, 2007

 

13) Haneda Y, et al : Ovomucoids IgE is a better marker than egg white-specific IgE to diagnose boiled egg allergy. J Allergy Clin Immunol 129 : 1681-1682, 2012

 

14) 海老澤元宏. 伊藤浩明 : ピーナッツアレルギー診断におけるAra h 2特異的IgE抗体測定の意義. 日小児アレルギー会誌 27 : 621-628, 2013

Medical*Online

15) 今井孝成, 他 : 遷延する食物アレルギーの検討. アレルギー 56 : 1285-1292, 2007

Medical*Online

P.831 掲載の参考文献

1) Tejedor Alonso MA, Moro Moro M, Mugica Garcia MV, et al : Incidence of anaphylaxis in the city of Alcorcon (Spain) : a population based study. Clin Exp Allergy 42 : 578-589, 2012

 

2) 長野智那, 石黒精, 余谷暢之, 他 : 小児病院におけるアナフィラキシーと二相性反応. アレルギー 62 : 163-170, 2013

Medical*Online

3) Lee JK, Vadas P : Anaphylaxis : mechanisms and management, Clin Exp Allergy 41 : 923-938, 2011

PubMed

4) Resuscitation Council (UK), Anaphylaxis, Emergency treatment of anaphylactic reactions : Guidelines for healthcare providers http://www.resus.org.uk/pages/reaction.pdf (2015年8月28日アクセス)

 

5) 栗原和幸 : クローズアップ新しい子どもの病気 経皮感作と食物アレルギー. 小児内科 45 : 1137-1138, 2013

 

・ 日本アレルギー学会 : アナフィラキシーガイドライン http://www.jsaweb.jp/modules/journal/index.php?content_id=4 (2015年8月28日アクセス)

 

・ 財団法人日本学校保健会 : 学校のアレルギー疾患に対する取り組みガイドライン http://www.gakkohoken.jp/book/ebook/ebook_01/01.pdf (2015年8月28日アクセス)

 

・ 厚生労働省 : 保育所におけるアレルギー対応ガイドライン http://www.mhlw.go.jp/bunya/kodomo/pdf/hoiku03.pdf (2015年8月28日アクセス)

 

P.836 掲載の参考文献

1) 厚生労働省難治性疾患研究班作成 : 新生児-乳児消化管アレルギー診断治染指針 http://nrichd.ncchd.gojp/imal/FPIES/icho/pdf/fpies.pdf (2015年8月28日アクセス)

 

1) Nomura I, Morita H, Hosokawa S, et al : Four distinct subtypes of non-IgE-mediated gastrointestinal food allergies in neonates and infants, distinguished by their initial symptoms. J Allergy Clin Immunol 127 : 685-688, e8, 2011

 

2) Nowak-Wegrzyn A, Katz Y, Mehr SS, et al : Non-IgE-mediated gastrointestinal food allergy. J Allergy Clin Immunol 135 : 1114-1124, 2015

PubMed

2) 厚生労働省. 難病情報センターホームページ, 好酸球性消化管疾患 (新生児-乳児食物蛋白誘発胃腸炎) http://www.nanbyou.or.jp/entry/3931 (2015年8月28日アクセス)

 

3) Berin MC : Immunopathophysiology of food protein-induced enterocolitis syndrome. J Allergy Clin Immunol 135 : 1108-1113, 2015

PubMed

4) Kimura M, Oh S, Narabayashi S, et al : Usefulness of lymphocyte stimulation test for the diagnosis of intestinal cow's milk allergy in infants. Int Arch Allergy Immunol 157 : 58-64, 2012

PubMed

5) Morita H, Nomura I, Orihara K, et al : Antigen-specific T-cell responses in patients with non-IgE-mediated gastrointestinal food allergy are predominantly skewed to T (H) 2. J Allergy Clin Immunol 131 : 590-592, e1-6, 2013

 

P.841 掲載の参考文献

1) Ebihara N, Funaki T, Takai S, et al : Tear chymase in vernal keratoconjunctivitis. Curr Eye Res 28 : 417-420, 2004

PubMed

2) Ebihara N, Okumura K, Nakayasu K, et al : High level of FcεRI-bindable IgE in the tear fluid and increase IgE-saturated cells in the giant papillae of vernal keratocorkjunctivitis patients. Jpn J Ophthalmol 46 : 357-363, 2002

 

3) de Klerk TA, Sharma V, Arkwright PD, et al : Severe vernal keratoconjunctivitis successfully treated with subcutaneous omalizumab. J AAPOS 17 : 305-306, 2013

PubMed

4) Ebihara N, Yokoyaina T, Kimura T, et al : Anti VLA-4 monoclonal antibody inhibits eosinophil infiltration in allergic conjunctivitis model of guinea pig. Curr Eye Res 19 : 20-25, 1999

 

5) Ohtomo K, Ebihara N, Matsuda A, et al : Role of TGF-β in tissue eosinophilia associated with vernal keratoconjunctivitis. Exp Eye Res 91 : 748-754, 2010

 

6) Matsuda A, Ebihara N, Yokoi N, et al : Functional roles of thymic stromal lyinphopoietin for chronic allergic keratoconjunctivitis. Invest Ophthalmol Vis Sci 51 : 151-155, 2010

PubMed

7) Matsuda A, Okayama Y, Terai N, et al : The role of interleukin-33 in chronic allergic conjunctivitis. Invest Ophthalmol Vis Sci 50 : 4646-4652, 2009

PubMed

8) Asada Y, Nakae S, Ishida W, et al : Roles of epithelial cell-derived type 2-initiating cytokines in experimental allergic conjunctivitis. Invest Ophthalmol Vis Sci 56 : 5194-5202, 2015

PubMed

VIII. リウマチ性疾患とその周辺疾患

P.849 掲載の参考文献

1) Chang C : Cutting edge issues in rheumatic fever. Clinc Rev Allerg Immumol 42 : 213-237, 2012

 

2) Alsaeid K, Cassidy JT : Acute rhematic fever and poststreptococcal reactive arthritis. Text Book of Pediatric Rheumatology, 6th ed, Saunders, Philadelphia, pp600-614, 2010

 

3) Chakravarty SD, Zabriskie JB, Gibofsky A : Acute rhematic fever and streptococci : the quintessential pathogenic trigger of autoimmunity. Clin Rheumatol 33 : 893-901, 2014

 

4) Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki disease of the Council on Cardiovascular Disease in the Young of the American Heart Association : Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. JAMA 268 : 2069-2073, 1992

 

5) 重盛朋子, 伊藤保彦 : リウマチ熱. 小児内科 44 (増刊) : 266-267, 2012

 

6) Cilliers AM : Rhematic fever and its management. BMJ 333 : 1153-1156, 2006

 

7) Working Group on Pediatric Acute Rheumatic Fever and Cardiology Chapter of Indian Academy of Pediatrics : Guidelines on Pediatric Acute Rheumatic Fever and Rheumatic Heart Disease. Indian Pediatrics 45 : 565-573, 2008

 

8) Ahmed S, Ayob EM, Scornik JC, et al : Poststreptococcal reactive arthritis : clinical characteristics and association with HLA-DR alleles. Arthritis Rheum 41 : 1096-1102, 1998

 

9) Ayoub EM, Ahmed S : Update on complication on Group A streptococcal infections. Curr Probl Pediatr 27 : 90-101, 1997

 

10) Barash J : Rhematic fever and post-Group A streptococcal arthritis in children. Curr Infect Dis Rep 15 : 263-268, 2013

 

P.855 掲載の参考文献

1) 横田俊平, 森雅亮, 今川智之, 他 : 若年性特発性関節炎 初期診療の手引き (2007年). 日小児会誌 111 : 1103-1112. 2007

 

2) 日本骨代謝学会ステロイド性骨粗鬆症の管理と治療ガイドライン改訂委員会 : ステロイド骨粗鬆症の管理と治療ガイドライン2014年改訂版, 大阪大学出版会, 大阪, pp41-48, 2014

 

3) Kobayashi I, Mori M, Yamaguchi K, et al : Pediatric Rheumatology Association of Japan recommendation for vaccination in pediatric rheumatic diseases. Mod Rheumatol 25 : 335-343, 2015

PubMed

4) Heijstek MW, Ott de Bruin LM, Bijl M, et al : EULAR recommendations for vaccination in paediatric patients with rheumatic diseases. Ann Rheum Dis 70 : 1704-1712, 2011

PubMed

5) Cassidy JT, Petty RE : Chronic arthritis, polyarthritis, oligoarthritis, systemic arthritis. In Cassidy JT, Petty RE, Laxer RM, et al (eds) : Textbook of Pediatric Rheumatology, 5th ed, Elsevier Saunders, Philadelphia, pp206-303, 2005

 

6) Benedetti FD, Massa M, Pignatti P, et al : Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest 93 : 2114-2119, 1994

 

・ 日本小児リウマチ学会 http://plaza.umin.ac.jp/~praj/ (2015年8月31日アクセス)

 

P.861 掲載の参考文献

1) Takei S, et al : Clinical features of Japanese children and adolescents with systemic lupus erythematosus : results of 1980-1994 survey. Acta Paediatr Jpn 39 : 250-256, 1997

PubMed

2) 橋本博史 : 全身性エリテマトーデス臨床マニュアル. 1版, 日本医事新報社, 東京, pp 22-49, 2012

 

3) Mohan C, Putterman C : Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat Rev Nephrol 11 : 329-341, 2015

PubMed

4) Buoncompagni A : Childhood systemic lupus erythematosus : a review of 30 cases. Clin Exp Rheumatol 9 : 425-430, 1991

PubMed

5) Weening JJ, D'Agati VD, Schwartz MM, et al : The classification of glomerulonephritis in systemic lupus erythematosus revised. J Am Soc Nephrol 15 : 241-250, 2004

PubMed

6) 森雅亮 : 小児SLE. 炎症と免疫 20 : 90-95, 2012

Medical*Online

7) Bombardier C, Gladman DD, Urowitz MB, et al : Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35 : 630-640, 1992

 

8) 渡邊言夫 : 厚生省心身障害研究報告書. 昭和60年度研究業績集, 厚生省, p31, 1986

 

9) Hechberg MC : Updating the Anierican College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40 : 1725, 1997

 

10) 黒澤るみ子, 他 : 小児期発症全身性エリテマトーデス38例の臨床的特徴と診断における問題点. 日小児会誌 110 : 398-405, 2006

 

11) 黒澤るみ子, 他 : 小児期発症SLEの治療法の変遷とその効果についての検討-経静脈的シクロフォスファミド・パルス療法の有効性について. リウマチ 43 : 932-937, 2003

 

12) Martin F, et al : Side-effects of intravenous cyclophosphamide pulse therapy. Lupus 6 : 254-257, 1997

PubMed

P.869 掲載の参考文献

1) Rider LG, Lindsley CB, Cassidy JT : Juvenile dermatomyositis. In Petty RE, et al (eds) : Textbook of Pediatric Rheumatology, 6th ed, WB Saunders, Philadelphia, pp375-413, 2011

 

2) Ernste FC, Reed AM : Recent advances in juvenile idiopathic inflammatory myopathies. Curr Opin Rheumatol 26 : 671-678, 2014

PubMed

3) Bohan A, Peter JB : Polymyositis and dermatomyositis. N Engl J Med 292 : 344-347, 1975

PubMed

4) Banker BQ, Victor M : Dermatomyositis (systemic angiopathy) of childhood. Medicine (Baltimore) 45 : 261-289, 1966

PubMed

5) Kobayashi S, Higuchi K, Takami H, et al : Characteristics ofjuvenile dermatomyositis in Japan. Acta Pediatr Jpn 39 : 257-262, 1997

 

6) Feldman BM, Rider LG, Reed AM, et al : Juvenile dermatomyositis and other idiopathic inflammatory myopathies of childhood. Lancet 371 : 2201-2212, 2008

PubMed

7) Tomono N, Mori M, Nakajima S, et al : HLA-DRB1*15021 is the predominant allele in Japanese patients with juvenile dermatomyositis. J Rheumatol 31 : 1847-1850, 2004

PubMed

8) Ye Y, Zyl BV, Varsani H, et al : Maternal microchimerism in muscle biopsies from children with juvenile dermatomyositis. Rheumatology 51 : 987-991, 2012

 

9) Kobayashi I, OkUra Y, Yamada M, et al : Anti-melanoma differentiation-associated gene 5 antibody is a diagnostic and predictive marker for interstitial lung diseases associated with juvenile dermatomyositis. J Pediatr 158 : 675-677, 2011

PubMed

10) Kobayashi N, Takezaki S, Kobayashi I, et al : Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis. Rheumatology 54 : 784-791, 2015

PubMed

11) Hoogendiik J, et al : 119th ENMC international workshop : trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands. Neuromuscle Disord 14 : 337-345, 2004

 

12) Martin N, Li CK, Wedderburn LR : Juvenile demiatomyositis : new insights and new treatment strategies. Ther Adv Musculoskel Dis 4 : 41-50, 2012

 

13) Kobayashi I, Yamada M, Takahashi Y, et al : Interstitial lung disease associated with juvenile dermatomyositis ; clinical features and efficacy of cyclosporine A. Rheumatology 43 : 371-374, 2003

 

14) Riley P, et al : Intravenous cyclophosphalnide pulse therapy in juvenile dermatomyositis. A review of efficacy and safety. Rheumatology 43 : 491-496, 2004

PubMed

15) Rider LG, Werth VP, Huber AM, et al : Measures of adult and juvenile dermatomyositis, polymyositis, and inclusion body myositis. Arthritis Care Res 63 (S11) : S118-157, 2011

 

16) Mathiesen P, Hegaard H, Herlin T, et al : Long-term outcome in patients with juvenile demmatomyositis : a cross-sectional follow-up study. Scand J Rheumatol 41 : 50-58, 2012

PubMed

P.874 掲載の参考文献

1) Zulian F, Vallongo C, Woo P, et al : Localized scleroderma in childhood is not just a skin disease. Arthritis Rheum 52 : 2873-2881, 2005

 

2) Herrick AL, Lunt M, Whidby N, et al : Observational study of treatment outcome in early diffuse cutaneous systemic sclerosis. J Rheumatol 37 : 116-124, 2010

PubMed

3) Sung JJ, Chen TS, Gilliam AC, et al : Clinicohistopathological correlations in juvenile localized scleroderma : studies on a subset of children with hypopigmented juvenile localized scleroderma due to loss of epidermal melanocytes. J Am Acad Dermatol 65 : 364-373, 2011

PubMed

4) Zulian E Woo P, Athreya BH, et al : The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis. Arthritis Rheum 57 : 203-212, 2007

 

5) Weibel L, Laguda B, Atherton D, et al : Misdiagnosis and delay in referral of children with localized scleroderma. Br J Dermatol 165 : 1308-1313, 2011

PubMed

6) Li SC, Torok KS, Pope E, et al : Development of consensus treatment plans for juvenile localized scleroderma : a roadmap toward comparative effectiveness studies in juvenile localized scleroderma. Arthritis Care Res (Hoboken) 64 : 1175-1185, 2012

PubMed

7) Kelsey CE, Torok KS : The Localized Scleroderma Cutaneous Assessmellt Tool : responsiveness to change in a pediatric clinical population. J Am Acad Dennatol 69 : 214-220, 2013

 

8) 佐藤伸一, 藤本学, 桑名正隆, 他 : 日本皮膚科学会ガイドライン 全身性強皮症診療ガイドライン. 日皮会誌 122 : 1293-1345. 2012

 

9) Foeldvari I, Wierk A : Healthy children have a significantly increased skin score assessed with the modified Rodnan skin score. Rheumatology (Oxford) 45 : 76-78, 2006

PubMed

10) La Torre F, Martini G, Russo R, et al : A preliminaly disease severity score for juveilile systemic sclerosis. Arthritis Rheum 64 : 4143-4150, 2012

 

・ 難病情報センター : 全身性強皮症 http://www.nanbyou.or.jp/entry/3694 (2015年8月31日アクセス)

 

・ PRINTO : 強皮症 http://www.printo.it/pediatric-rheumatology/information/Japan/4.htm (2015年8月31日アクセス)

 

・ 小児慢性特定疾病情報センター : 強皮症 http://www.shouman.jp/details/6_4_13.html (2015年8月31日アクセス)

 

P.878 掲載の参考文献

1) Suzuki H, Kiryluk K, Novak J, et al : The pathophysiology of IgA nephropathy. J Am Soc Nephrol 22 : 1795-1803, 2011

PubMed

2) Suzuki H, Fan R, Zhang Z, et al : Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 119 : 1668-1677, 2009

PubMed

3) Kawana S, Nishiyama S : Serum SC5b-9 (terminal complement complex) level, a sensitive indicator of disease activity in patients with Henoch-Schonlein purpura. Dermatology 184 : 171-176, 1992

 

4) 後藤芳充, 上村治. 安藤恒三郎, 他 : アレルギー性紫斑病及び紫斑病性腎炎と好中球エラスターゼ. 日小児会誌 100 : 1221-1226, 1996

 

5) 川上民裕 : IgA血管炎 (Henoch-Schonlein). 尾崎承一 (編) : 血管炎の診断と治療-新分類CHCC2012に沿って, 別冊・医学のあゆみ. 医歯薬出版, 東京, pp72-77, 2014

 

6) Nagamori T, Oka H, Koyano S, et al : Construction of a scoring system for predicting the risk of severe gastrointestinal involvement in Henoch-Schonlein Purpura. SpringerPlus 3 : 171, 2014

PubMed

7) Jennette JC, et al : Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37 : 187-192, 1994

PubMed

8) Ozen S, et al : EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis 65 : 936-941, 2006

PubMed

9) 藤田直也, 上村治, 後藤芳充, 他 : アレルギー性紫斑病におけるウリナスタチンの腎炎発症予防効果. 日小児会誌 100 : 1482-1486, 1996

 

10) 藤永周一郎, 平野大志 : 血管性紫斑病, Modern Physician 31 : 233-234, 2011

 

P.884 掲載の参考文献

1) 中村好 : 疫学調査 : 年次推移, 地域特性, 中山書店, 東京, 2008

 

2) 中村好 : 諸外国の川崎病 : 疫学的特徴, 中山書店, 東京, 2008

 

3) 上原里 : 疫学調査から見た遺伝背景. 中山書店, 東京, 2008

 

4) Onouchi Y : Genetics of Kawasaki disease : What we know and don't know. Circ J 76 : 1581-1586, 2012

 

5) 横田俊, 菊地雅, 野澤智, 他 : 炎症性サイトカインからみた炎症病態の考え方と治療法の最近の動向 川崎病, 全身型若年性特発性関節炎, クリオピリン関連周期性発熱症候群に対するサイトカイン遮断療法の効果について. 日小児会誌 116 : 1829-1841, 2012

 

6) 清水忠 : 全身性若年性特発性冠せ炎に合併するマクロファージ活性化症候群-サイトカインプロファイリングから-. 小児感染免疫 22 : 52-58, 2010

 

7) 厚生労働省川崎病研究班 : 川崎病 (MCLS, 小児急性熱性皮膚粘膜リンパ節症候群) 診断の手引き (改訂5版). 日小児会誌 106 : 836-837. 2002

 

8) Terai M, Yasukawa K, Narumoto S, et al : Vascular endothelial growth factor in acute Kawasaki disease. Am J Cardiol 83 : 337-339, 1999

PubMed

9) Hirose S, Hamashima Y : Morphological observations on the vasculitis in the mucocutaneous lymph node syndrome. A skin biopsy study of 27 patients. Eur J Pediatr 129 : 17-27, 1978

PubMed

10) Jibiki T, Terai M, Kohno Y : High concentrations of interleukin-8 and monocyte chemoattractant protein-1 in urine of patients with acute Kawasaki disease. Eur J Pediatr 163 : 749-750, 2004

PubMed

11) 佐地勉, 鮎澤衛, 三浦大, 他 :日本小児循環器学会学術委員会 : 日本小児循環器学会研究委員会研究課題「川崎病急性期治療のガイドライン」(平成24年改訂版). 日本循環器会誌 28 : s1-28, 2012

 

12) 日本循環器学会学術委員会合同研究班 : 川崎病心臓血管後遺症の診断と治療に関するガイドライン (2013年改訂版) http://www.j-circ.or.jp/guideline/pdf/JCS2013_ogawas_h.pdf (2015年8月31日アクセス)

 

13) Kobayaslli T, Saji T, Otani T, et al : Efficacy of immunoglobulin plus prednisolone for prevention of corollary artery abnormalities in severe Kawasaki disease (raise study) : A randomised, open-label, blinded-endpoints trial. Lancet 379 : 1613-1620, 2012

 

14) Kobayashi T, Inoue Y, Takeuchi K, et al : Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 113 : 2606-2612, 2006

PubMed

15) Egami K, Muta H, Ishii M, et al : Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 149 : 237-240, 2006

PubMed

16) Sano T, Kurotobi S, Matsuzaki K, et al : Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr 166 : 131-137, 2007

PubMed

P.889 掲載の参考文献

1) Bastuji-Garin S, Rzany B, Roujeau JC, et al : Clinical classification of cases of toxic epidenmal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129 : 92-96, 1993

PubMed

2) Takahashi R, Sato Y, Shiohara T, et al : Pathological role of regulatory T cells in the initiation and maintenance of eczema herpeticum lesions. J Immunol 192 : 969-978, 2014

PubMed

3) Prindaville B, Newell BD, Horii KA, et al : Mycoplasma pneumonia-associat, ed mucocutaneous disease in children : dilemmas in classification. Pediatr Dermatol 31 : 670-675, 2014

 

4) Canavan TN, Mathes EF, Shinkai K, et al : Mycoplasma pneumoniae-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and eiythema mukiforme : a systematic review. J Am Acad Dermatol 72 : 239-245, 2015

PubMed

5) Chung WH, Shih SR, Hung SI : Clinicopathologic analysis of coxsackieviurs a6 new variant induced widespread mucocutaneous bullous reactions mimicking severe cutaneous adverse reactions. J Infect Dis 208 : 1968-1978, 2013

 

6) Dinulos JG : What's new with common, uncommon and rare rashes in childhood. Curr Opin Pediatr 27 : 261-266, 2015

 

7) Atanaskovic-Markovic M, Medio B, Nestorovic B, et al : Stevens-Johnson syndrome and toxic epidermal necrolysis in children. Pediatr Allergy Immunol 24 : 645-649, 2013

 

8) Ahluwalia J, Wan J, Yan AC, et al : Mycoplasma-associated Stevens-Johnson syndrome in children : retrospective review of patients managed with or without intravenous immunogolobulin, systemic corticosteroids, or combination of therapies. Pediatr Dermatol 31 : 664-669, 2014

PubMed

9) Chen J, Wang B, Xu H, et al : High-dose intravenous immunoglobulin's in the treatment of Stevens-Johnson syndrome and toxic epidemal necrolysis in Chinese patients : a retrospectiv study of 82 cases. Eur J Dermatol 20 : 743-747, 2010

 

10) Yang Y, Xu J, Zhu X, et al : Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrolne : a retrospective comparative study in China. Int J Dermatol 48 : 1122-1128, 2009

 

P.894 掲載の参考文献

1) 堀田哲也 : 抗リン脂質抗体症候群の臨床と基礎研究の進歩. 日臨免疫会誌 35 : 481-494, 2012

 

2) Giannakopoulos B, Krilis SA : The pathogenesis of antiphospholipid syndrome. N Engl J Med 368 : 1033-1044, 2013

PubMed

3) Miyakis S, Lockshin MD, Atsumi T, et al : International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4 : 295-306, 2006

 

4) Cervera R, Piette JC, Font J, et al : Antiphospholipid syndrome : clinical and immunological manifestations and patterns of expression in a cohort of 1,000 patients. Arthritis Rheum 46 : 1019-1027, 2002

 

5) Avcin T : Antiphospholipid syndromein children. Curr Opin Rheumatol 20 : 595-600, 2008

 

6) Avcin T, Cimaz R, Silverman ED, et al : Pediatric antiphospholipid syndrome : Clinical and immunological features of 121 patients in an interbational registry. Pediatrics 122 : e1100-1107, 2008

 

7) Erkan D, Aguiar CL, Andrade D, et al : 14th International Congress on Antiphospholipid Antibodies Task Force Report on antiphospholipid syndrome treatment trends. Autoimmun Rev 13 : 685-696, 2014

PubMed

8) Wahl DG, Bounameaux H, de Moerloose P, et al : Prophylactic antithroinbotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies : do the benefits outweigh the risks? Adecision analysis. Arch Intern Med 160 : 2042-2048, 2000

PubMed

9) Berman H, Rodriguez-Pinto I, Cervera R : Pediatric catastrophic antiphospholipid syndrome : descriptive analysis of 45 patients from the "CAPS Registry". Autoimmun Rev 13 : 157-162, 2014

PubMed

P.898 掲載の参考文献

1) Aringer M, Smolen JS : Mixed comective tissue disease : what is behind the curtain? Best Pract Res Clin Rheumatol 21 : 1037-1049, 2007

PubMed

2) 川端仁人 : 混合性結合組織病. 最新医学 68 : 1254-1264, 2013

 

3) 三森経世 : 混合性結合組織病. 内科 113 : 1344-1346, 2014

 

4) 三森経世, 桑名正隆, 岡野裕, 他 : 抗UIRNP抗体産生および混合性結合組織病に関する免疫遺伝学要因. 厚生省特定疾患/皮膚・結合組織疾患調査研究班混合性結合組織病分科会研究報告書, 平成9年度, pp29-33, 1998

 

5) Hoffman RW, Maldonado ME : Immune pathogenesis of mixed connective tissue disease : a short analytical review. Clin Immunol 128 : 8-17, 2008

 

6) Szodoray P, Hajas A, Kardos L, et al : Distinct phenotypes in mixed connective tissue disease : subgroups and survival. Lupus 21 : 1412-1422, 2012

PubMed

7) 横田俊平, 今川智之, 森雅亮, 他 : 小児期発症混合性結合組織病-全国調査の結果から. 日内会誌 85 : 1217-1222, 1996

 

8) 横田俊平 : MCTD. 小児科 40 : 1399-1408, 1999

 

9) 吉田俊治, 深谷修作, 京晋吾, ほか : 混合性結合組織病 (MCTD) の肺動脈性肺高血圧症 (PAH) 診断の手引き改訂について. 厚生労働省難治性疾患克服研究事業混合性結合組織病調査研究班平成22年度報告書, pp7-13, 2011

 

10) Tani C, Carli L, Vagnani S, et al : The diagnosis and classification of mixed connective tissue disease. J Autoimmun 48-49 : 46-49, 2014

 

P.904 掲載の参考文献

1) 武井修治, 加藤忠明 : 小児慢性特定疾患治療研究事業 (小慢) のデータベースを利用した稀少膠原病の検討-小児シェーグレン症候群. 平成18年度厚生労働省科学研究費補助全分担研究報告書. pp20-23. 2007

 

2) 冨板美奈子, 河野陽一 : 小児のシェーグレン症候群. 日本シェーグレン症候群学会 (編) : シェーグレン症候群の診断と治療マニュアル, 改訂2版, 診断と治療社, 東京, pp 184-194, 2014

 

3) Inoue H, Tsubota K, Ono M, et al : Possible involvement of EBV-mediated α-fodrin cleavage for organ-specific autoantigen in Sjogren's syndrome. J Immunol 166 : 5801-5809, 2001

 

4) Terada K, Katamine S, Eguchi K, et al : Prevalence of serum and salivary antibodies of to HTLV-1 in Sjogren's syndrome. Lancet 344 : 1116-1119, 1994

PubMed

5) Gottenberg JE, Cagnard N, Lucches C, et al : Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome. PNAS 103 : 2770-2775, 2006

 

6) 冨板美奈子, 平野清美, 齋藤公幸, 他 : 小児Sjogren症候群患者の口唇小唾液腺組織におけるアポトーシス. 小児科臨床 57 : 1083-1090, 2004

Medical*Online

7) Yoshimoto K, Fujimoto T, Itaya-Hironaka A, et al : Involvement of autoimmunity to REG, a regeneration factor, in patients with primary Sjogren's syndrome. Clin Exp Immunol 174 : 1-9, 2013

PubMed

8) Nakamura Y, Wakamatsu E, Matsumoto I, et al : High prevalence of autoantibodies to muscarinic-3 acetylcholine receptor in patients with juvenile-onset Sjpgren syndrome. Ann Rheum Dis 67 : 136-137, 2008

PubMed

9) Tomiita M, Ueda T, Nagata H, et al : Usefulness of magnetic resonance sialography in patients with juvenile Sjogren's syndrome. Clin Exp Rheum 23 : 540-544, 2005

 

10) Shiboski SC, et al : American College of Rheumatology classification criteria for Sjogren's syndrome : A data-driven, expert consensus approach in the SICCA cohort. Arthritis Care Res 64 : 475-487, 2012

PubMed

11) Nakayamada S, Fujimoto T, Nomonmura A, et al : Usefulness of initial histological features for stratifying Sjogren's syndrome responders to mizoribine therapy. Rheumatology 48 : 1279-1282, 2009

PubMed

・ 小児慢性特定疾病情報センター http://www.shouman.jp (2015年9月1日アクセス)

 

・ 難病情報センター http://www.nanbyou.or.jp (2015年9月1日アクセス)

 

・ 日本シェーグレン症候群学会 http://sjogren.jp (2015年9月1日アクセス)

 

・ SS-info. net (シェーグレン症候群情報サイト) http://www.ss-info.net (2015年9月1日アクセス)

 

P.910 掲載の参考文献

1) Cho SB, Cho S, Bang D : New insight in the clinical understanding of Behcet's disease. Yonsei Med J 53 : 35-42, 2012

PubMed

2) Zouboulis CC, May T : Pathogenesis of Adamantiades-Behcet's disease. Med Microbiol Immunol 192 : 149-155, 2003

PubMed

3) Fresko I, Stuebiger N, Tascilar K : Behcet's syndrome, polychondritis and eye symptom in rheumatic diseases. EULAR Textbook on Rheumatic Diseases, pp689-701, EULAR, 2012

 

4) Mizuki N, Meguro A, Ota M, et al : Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet's disease susceptibility loci. Nature Genet 42 : 703-707, 2010

PubMed

5) Remmers EF, Cosan E Kirino Y, et al : Genome-wide association studies identifies varients in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet's disease. Nature Genet 42 : 698-702, 2010

 

6) Mazzoccoli G, Matarangolo A, Rubino R, et al : Behcet syndrome from pathogenesis to novel therapies. Clin Exp Med, 2014 doi : 10.1007/s10238-014-0328-z

 

7) International Team for the Revision of International Criteria for Behcet's Disease (ITR-ICBD) The International Criteria for Behcet's Disease (ICBD) : a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28 : 338-347, 2014

 

8) Kone-Paut I, Dace-Bello M, Shahram F, et al : Registries in rheumatological and musculoskeletal conditions. Pediateric Behcet's disease : an international cohort study of 110 patients : one-year follow-up data. Rheumatology 50 : 184-188, 2010

 

P.914 掲載の参考文献

1) Gattomo M, Piccini A, Lasiglie D, et al : The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 58 : 1505-1515, 2008

 

2) Shimizu M, Yokoyama T, Yamada K, et al : Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis. Rheumatology (Oxford) 49 : 1645-1653, 2010

PubMed

3) Shimizu M, Nakagishi Y, Yachie A : Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles. Cytokine 61 : 345-348, 2013

PubMed

4) Wada T, Kanegane H, Ohta K, et al : Sustained elevation of serum interleukin-18 and its association with hemophagocytic lymphohistiocytosis in XIAP deficiency. Cytokine 65 : 74-78, 2014

PubMed

5) Canna SW, de Jesus AA, Gouni S, et al : An activating mRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome. Nat Genet 46 : 1140-1146, 2014

 

6) Hazen MM, Woodward AL, Hofmann I, et al : Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis. Arthritis Rheum 58 : 567-570, 2008

 

7) 横田俊平, 武井修治 : 若年性特発性関節炎-トシリズマブ治療の理論と実際 2009. メディカルレビュー社, 東京, pp 17-23. 2009

 

8) Ravelli A, Magni-Manzoni S, Pistorio A, et al : Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 146 : 598-604, 2005

PubMed

9) Miyazono A, Abe J, Ogura M, et al : Successful remission induced by plasma exchange combined with leukocytapheresis against refractory systemic juvenile idiopathic arthritis. Eur J Pediatr 173 : 1557-1560, 2014

PubMed

10) Sawhney S, Woo P, Murray KJ : Macrophage activation syndrome : a potentially fatal complication of rheumatic disorders. Arch Dis Child 85 : 421-426, 2001

PubMed

P.918 掲載の参考文献

1) Moriwaki R, Numano F : Takayasu arteritis : follow-up studies for 20 years. Heart Vessels Suppl 7 : 138-145, 1992

PubMed

2) Takamura C, Ohhigashi H, Ebana Y, et al : A new HLA risk allele in Japanese patients with Takayasu arteritis. Circulation J 76 : 1697-1702, 2012

PubMed

3) Seko Y, Minota S, Kawasaki A, et al : Perforin-secreting killer cell infiltration and expression of a 65-kD heat-shock protein in aortic tissue of patients with Takayasu's arteritis. J Clin Invest 93 : 750-758, 1994

PubMed

4) BrunnerJ, Feldman BM, Tyrrell PN, et al : Takayasu arteritis in children and adolescents. Rheumatology (Oxford) 49 : 1806-1814, 2010

 

5) Dagna L, Salvo E Tiraboschi M, et al : Pentraxin-3 as a marker of disease activity in Takayasu alteritis. Ann Intern Med 155 : 425-433, 2011

 

6) Andrews J, Mason JC : Takayasu's arteritis-recent advances in imaging offer promise. Rheumatology (Oxford) 46 : 6-15, 2007

PubMed

7) Molloy ES, Langford CA, Claek TM, et al : Anti-tumor necrosis in patients with refractory Takayasu arteritis : long-term follow-up. Ann Rheumat Dis 67 : 1567-1569, 2008

 

8) Abisror N, Mekinian A, Lavigne C, et al : Tocilizumab in refractory Takayasu arteritis : a case series and updated literature review. Autoimmun Rev 12 : 1143-1149, 2013

PubMed

9) Direskeneli H, Aydin SZ, Merkel PA : Assessment of disease activity and progression in Takayasu's arteritis. Clin Exp Rheumatol 29 : 86-91, 2011

 

10) Szugye HS, Zeft AS, Spalding SJ : Takayasu arteritis in the pediatric population : a contemporary United States-Based Single Center Cohort. Pediatr Rheumatol Online J 12 : 12-21, 2014

PubMed

・ 血管炎症候群の診療ガイドライン, 循環器病の診断と治療に関するガイドライン (2006-2007年度合同研究班報告), pp 1260-1275, 2008 http://www.j-circ.or.jp/guideline/pdf/JCS2008_ozaki_h.pdf (2015年9月1日アクセス)

 

P.922 掲載の参考文献

1) Buyon JP, Hiebert R, Copel J, et al : Autoimmune-associated congenital heart block : demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 31 : 1658-1666, 1998

PubMed

2) Julkunen H, Eronen M : The rate of recurrence of isolated congenital heart block : a population-based study. Arthritis Rheum 44 : 487-488, 2001

PubMed

3) 厚生労働科学研究費補助金 成育疾患克服等次世代育成基盤研究事業 自己抗体陽性女性の妊娠管理指針の作成及び新生児ループスの発症リスクの軽減に関する研究. 2013年3月 http://www.aiiku.or.jp/~doc/houkoku/h24/19007A010.pdf (2015年9月1日アクセス)

 

4) Clancy RM, Backer CB, Yin X, et al : Cytokine polymorphisms and histologic expression in autopsy studies : contribution of TNF-alpha and TGF-beta 1 to the pathogenesis of autoimmune-associated congenital heart block. J Immunol 171 : 3253-3261, 2003

 

5) Briassouli P, Halushka MK, Reed JH, et al : A central role of plasmin in cardiac injury initiated by fetal exposure to maternal anti-Ro autoantibodies. Rheumatology (Oxford) 52 : 1448-1453, 2013

PubMed

6) Izmirly PM, Buyon JP, Saxena A : Neonatal lupus : advances in understanding pathogenesis and identifying treatments of cardiac disease. Curr Opin Rheumatol 24 : 466-472, 2012

PubMed

7) Alvarez D, Briassouli P, Clancy RM, et al : A novel role of endothelin-1 in linking Toll-like receptor 7-mediated inflammation to fibrosis in congentital healt block. J Biol Chem 286 : 30444-30454, 2011

 

8) Anami A, Fukushima K, Takasaki Y, et al : The predictive value of anti-SS-A antibodies titration in pregnant women with fetal congenital heart block. Mod Rheumatol 23 : 653-658, 201 : 3

 

9) Izmirly PM, Kim MY, Llanos C, et al : Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine. Ann Rheum Dis 69 : 1827-1830, 2010

PubMed

10) Friedman DM, Kim MY, Copel JA, et al : Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study. Am J Cardiol 103 : 1102-1106, 2009

PubMed

P.926 掲載の参考文献

1) 宮前多佳子, 菊地雅子, 原拓麿, 他 : 本邦における小児線維筋痛症の実態. 日小児会誌 113 : 503-507, 2009

 

2) 宮前多佳子, 菊地雅子. 原拓麿, 他 : 小児期に発症した線維筋痛症の臨床的特徴と性格傾向. 日小児会誌 114 : 1856-1860, 2010

 

3) 横田俊平, 梅林宏明, 宮前多佳子, 他 : 小児期の線維筋痛症3症例の経験. 日小児会誌 111 : 462-468, 2007

 

4) Gracely RH, Petzke E Wolf JM, et al : Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 46 : 1333-1343, 2002

 

5) Yunus MB : Role of central sensitization in symptoms beyond muscle pain, and the evaluation of a patient with widespread pain. Best Pract Res Clin Rheumatol 21 : 481-497, 2007

PubMed

6) Kashikar-Zuck S, Ting TV : Juvenile fibromyalgia : currellt status of research and future developments. Nat Rev Rheumatol 10 : 89-96, 2014

PubMed

7) Wolfe E Smythe HA, Yums MB, et al : The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33 : 160-172, 1990

 

8) Wolfe F, Clauw DJ, Fitzcharles MA, et al : The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 62 : 600-610, 2010

PubMed

9) 日本線維筋痛症学会 (編) : 線維筋痛症診療ガイドライン 2013. 日本医事新報社, 東京, p. 7, 2013

 

10) Yokota S, Kikuchi M, Miyamae T : Juvenile fibromyalgia : Guidance for mallagement. Pediatr Int 55 : 403-409, 2013

PubMed

IX. 中毒

P.934 掲載の参考文献

1) 公益財団法人日本中毒情報センター : 中毒情報センターから 2013年受信報告. 中毒研究 27 : 241-273, 2014

 

2) 今田優子, 波多野弥生 : 中毒初級講座 [第11回] 小児の中毒事故. 中毒研究 25 : 70-75, 2012

 

3) 消費者庁消費者安全調査委員会 : 消費者安全法第31条第3項に基づく経過報告 子どもによる医薬品誤飲事故 http://www.caa.go.jp/csic/action/pdf/7_houkoku_honbun.pdf (2015年9月2日アクセス)

 

4) Mowry JB, Spyker DA, Cantilena LR Jr, et al : 2012 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS) : 30th Annual Report. J Toxicol Clin Toxicol 51 : 949-1229, 2013

 

5) The American Association of Poison Control Centers Alerts http://www.aapcc.org/alerts/ (2015年9月2日アクセス)

 

6) 波多野弥生, 黒木由美子, 遠藤容子, 他 : 洗濯用パック型洗剤による小児の事故 日本中毒情報センターの受信状況について. 中毒研究 27 : 320-322, 2014

 

7) 公益財団法人日本中毒情報センター : 情報提供資料 (報道・一般向け) 「パック型洗剤による事故に注意しましょう! 」 (2015年3月2日 http://www.j-poison-ic.or.jp/homepage.nsf (2015年9月2日アクセス)

 

8) 日本小児科学会 こどもの生活環境改善委員会 : Injury Alert (傷害速報) No. 050「新しいタイプの洗剤 (1回分パックタイプ洗濯用液体洗剤) の誤飲 (1), (2), (3) 」 http://www.jpeds.or.jp/modules/injuryalert/ (2015年9月2日アクセス)

 

9) Mowry JB, Spyker DA, Cantilena LR Jr, et al : 2013 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS) : 31st Annual Report. J Toxicol Clin Toxicol 52 : 1032-1283, 2014

 

10) 厚生労働省 医薬食品局監視指導・麻薬対策課 : 報道関係者各位「ニコチンを含む電子タバコへの注意を呼び掛け 都道府県には販売業者などへの監視指導の徹底を依頼」 (平成22年8月18日) http://www.mhlw.go.jp/stf/houdou/2r98520000001v0j.html (2015年9月2日アクセス)

 

P.942 掲載の参考文献

1) Crawford R, Campbell DG, Ross J : Carbon monoxide poisoning in the home : recognition and treatment. BMJ 301 : 977-979, 1990

PubMed

2) Kim JK, Coe CJ : Clinical study on carbon monoxide intoxication in children. Yonsei Med J 28 : 266-273, 1987

PubMed

3) 下田春海, 遠藤広子, 川崎平八郎 : 小児の急性一酸化炭素中毒症-成人例との比較を中心に. 小児科 32 : 191-199, 1991

 

4) Pepe G, Castelli M, Nazerian P, et al : Delayed neuropsychological sequelae after carbon monoxide poisoning : predictive risk factors in the Emergency Department. A retrospective study. Scand J Trauma Resusc Emerg Med 19 : 16, 2011

 

5) 清野慶子, 林田昌子, 伊関憲 : 長時間の曝露による一酸化炭素中毒の遅発性脳症をMRIで評価した1例. 中毒研究 26 : 54-60, 2013

 

6) Iseki K, Ozawa A, Seino K, et al : The suicide pandemic of hydorogen sulfide poisoning in Japan. Asia Pac J Med Toxicol 3 : 13-17, 2014

 

P.948 掲載の参考文献

2) Dart RC, Erdman AR, Olson KR, et al : Acetaminophen poisoning : an evidence-based consensus guideline for out-of-hospital management. Clin Toxicol 44 : 1-18, 2006

PubMed

3) American Academy of Pediatrics, Committee on Drugs : Acetaminophen toxicity in children. Pediatrics 108 : 1020-1024, 2011

 

4) 福本真理子 : 中毒医療ガイドライン 医薬品 アセトアミノフェン. 日本中毒学会 (編) : 急性中毒標準診療ガイド. じほう, 東京, pp 106-125, 2008

 

5) Smilkstein MJ, Knapp GL, Kulig KW : Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose : analysis of the National Multicenter Study (176-1985). N Engl J Med 319 : 1557-1562, 1988

 

6) Hall AH, Smolinske SC, Conrad FL : Ibupurofen overdose : 126 cases. Ann Emerg Med 15 : 1308-1313, 1986

PubMed

7) Perry SJ, Streete PJ, Volans GN : Ibuprofen overdose : the first two years of over-the-counter sales. Hum Toxicol 6 : 173-178, 1987

PubMed

8) 0ker EE, Hermann L, Baum CR, et al : Serious toxicity in a young child due to ibupurofen. Acad Emerg Med 7 : 821-823, 2000

 

9) Chyka PA, Erdman AR, Chistiarlson G, et al : Salicylate poisoning : An evidence-based consensus guideline for out-of-hospital management. Clin Toxicol 45 : 95-131, 2007

PubMed

10) Lugassy DM : Salicylates. In Flomenbaum NE (ed) : Goldfrand's Toxicologic Emergencies, 10th ed, McGraw-Hill, New York, pp516-527, 2015

 

日本中毒情報センター : 2014年受信報告. 中毒研究 28 : 273-305, 2015

 

・ 公益財団法人日本中毒情報センター http://www.j-poison-ic.or,jp/homepage.nsf (2015年9月2日アクセス)

 

P.953 掲載の参考文献

1) 谷川攻一 : 中毒の標準的治療. 前川和彦, 相川直樹 (編) : 今日の救急治療指針, 2版, 医学書院, 東京, pp706-709. 2012

 

2) 日本中毒学会 : 急性中毒の標準治療 http://jsct.umin.jp/page037.html (2015年9月2日アクセス)

 

3) Jacobs F, Brivet FG : Conventional hemodialysis significantly lowers toxic level s of phenobarbital. Nephrol Dial Transplant 19 : 1663-1664, 2004

 

4) Sen S, Ratnaraj N, Davies NA, et al : Treatment of phenytoin toxicity by the molecular absorbents recirculating system (MARS). Epilepsia 44 : 265-267, 2003

 

5) 鈴木薫, 井尻好雄, 西田勇彦, 他 : Carbamazepine 大量服用により中毒を起こした一症例. TDM研究 21 : 213-214, 2004

 

6) Schuerer DJ, Brophy PD, Maxvold VJ, et al : High efficiency dialysis for carbamazepine overdose. J Toxicol Clin Toxicol 28 : 321-323, 2000

 

7) Ram Prabahar M, Raja Karthik K, Singh M, et al : Successful treatment of carbalnazepine poisoning with hemodialysis : A case report and review of the literature. Hemodial Int 15 : 407-411, 2011

PubMed

8) Schlafke D, Kloock R : Carbamazepine poisoning. Anaesthesiol Reanim 16 : 220-224, 1991

PubMed

9) Auinger K, Muller V, Rudiger A, et al : Valproric acid intoxication imitating brain death. Am J Emerg Med 27 : 1177. e5-6, 2009

 

10) 富永綾, 伊関憲, 小澤昌子, 他 : 血液透析で治療したバルプロ酸大量内服の1症例. 中毒研究 27 : 45-46, 2014

 

P.958 掲載の参考文献

1) Fredholm BB, Ijzerman AP, Jacobson KA, et al : International union ofPharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacological Rev 53 : 527-552, 2001

 

2) Fukuda M, Suzuki Y, Hino H, et al : Adenosine A1 receptor blockage mediates theophylline-associated seizures. Epilepsia 51 : 483-487, 2010

PubMed

3) Shinohara M, Saitoh M, Nishizawa D, et al : ADORA2A polymorphism predisposes children to encephalopathy with febrile status epilepticus. Neurology 23 : 1571-1576, 2013

 

4) 小田島安平, 中野裕史, 加藤哲司 : テオフィリン投与中の痙攣症例に関する臨床的検討. アレルギー 55 : 1295-1303, 2006

Medical*Online

5) 水口雅 : テオフィリンの神経毒性 : けいれんの遷延・重症化とけいれん重積型急性脳症. 日小児会誌 111 : 140. 2007

 

6) 塩見正司 : テオフィリン関連けいれん. 小児内科 41 : 519-523, 2009

Medical*Online

7) 大澤真木子 : けいれん重積の治療. 脳と発達 39 : 185-192, 2007

Medical*Online

8) 厚生労働省 : 重症副作用疾患別対応マニュアル 小児の急性脳症, 平成23年3月 http://www.pmda.go.jp/files/000144308.pdf (2015年9月2日アクセス)

 

9) 松岡典子, 森川清子, 横路征太郎, 他 : テオフィリン治療中に生じた痙攣重積状態の臨床的検討. 日小児会誌 110 : 1234-1241, 2006

 

10) 阿部裕樹, 吉川秀人. 山崎佐和子, 他 : Theophylline関連けいれんに対する初期治療効果の検討. 日小児会誌 107 : 1356-1360, 2003

 

P.963 掲載の参考文献

1) 佐野晴洋 : 金属による職業病 9-I 総論. 藤原元典, 渡辺厳一, 高桑栄松 (監修) : 総合衛生公衆衛生学, 下巻, 改訂2版, 南江堂, 東京, pp924-930, 1985

 

2) 和田攻 : 17. 鉛. 金属とヒト-エコトキシコロジーと臨床, 朝倉書店, 東京, pp236-245, 1985

 

3) 角田正史 : 12章 中毒・環境要因による疾患 2 金属. 門脇孝, 永井良三 (編) : カラー版 内科学. 西村書店, 東京, pp515-518, 2012

 

4) 山田至康 : 重金属 (鉛. 水銀, ヒ素). 小児内科 41 (増刊) : 1283-1286, 2010

 

5) 諏訪園靖, 能川浩二 : 中毒 (鉛, 水銀, ヒ素). 小児内科 35 (増刊) : 1321-1325, 2003

 

6) CDC http://www.cdc.gov/nceh/lead/publications/books/plpyc/contents.html (2015年9月15日アクセス)

 

7) 臼杵扶佐子 : 水銀に関する水俣条約の調印. 医学のあゆみ 251 : 1078-1079, 2014

Medical*Online

8) 環境省 : 水銀に関する水俣条約の概要 https://www.env.go.jp/chemi/tmms/convention.html (2015年9月2日アクセス)

 

9) Sakurai T : Biomethylation of arsenic is essentially detoxicating event. J Health Sci 49 : 171-178, 2003

 

10) 千代孝夫 : ヒ素中毒. 山口徹, 北原光夫 (編) : 今日の治療指針 2015年版, 医学書院, 東京, pp 139-140, 2015

 

P.968 掲載の参考文献

1) 日本中毒情報センター : 2013年受信報告 http://www.j-poison-ic.or.jp/homepage.nsf (2015年9月2日アクセス)

 

2) 環境省環境リスク評価室 : 化学物質の環境リスク評価, 第1巻, 平成14年3月 http://www.env.go.jp/chemi/report/h14-05/ (2015年9月2日アクセス)

 

3) 西勝英 (監) : 2 有機溶媒・有機物質. 薬・毒物中毒救急マニュアル, 医薬ジャーナル社, 大阪, pp348-353, 2003

 

4) 相馬一亥 (監) : 1 石油製品. 2 シンナー・トルエン・キシレン. 臨牀中毒学. 1版. 医学書院, 東京, pp2-11, 2009

 

5) 内藤裕史 : 9章 化学用品. 工業用品, I 炭化水素および芳香族化合物. 中毒百科-事例・病態・治療. 改訂第2版, 南江堂, 東京, pp314-321, 2001

 

6) 竹内康浩 : 有機溶剤中毒. 綜合臨牀 48 : 2550-2553, 1999

Medical*Online

7) 市原学 : 有機溶剤中毒と尿検査. 綜合臨牀 58 : 1269-1271, 2009

Medical*Online

8) 市原学, 竹内康浩 : 有機溶剤中毒. 綜合臨牀 51 (増刊) : 1846-1851, 2002

Medical*Online

9) Anas N, Namasonthi V, Ginsburg CM : Criteria for hospitalizing children who have ingested products containing hydrocarbons. JAMA 246 : 840-843, 1981

PubMed

10) Machado B, Cross K, Snodgrass WR : Accidental hydrocarbon ingestion cases telephoned to a regional poison center. Ann Emerg Med 17 : 804-807, 1988

PubMed

P.976 掲載の参考文献

1) 佐竹元吉 :日本の有毒植物, Gakkenフィールドベスト図鑑vol. 16, 学研教育出版, 東京, 2012

 

2) 指田豊, 中山秀夫 : 植物による食中毒と皮膚のかぶれ, 少年写真新聞社, 2000

 

3) 難波恒雄. 御影雅幸 : 毒のある植物, 保育社, 1983

 

4) 小西天二, 磯田進, 邑田裕子. 矢原正治 : 薬用植物ガイド, トンボ出版, 2010

 

・ 公益財団法人日本中毒情報センター http://www.j-poison-ic.or.jp/homepage.nsf (2015年7月22日アクセス)

 

・ 厚生労働省 : 自然毒のリスクプロファイル http://www.mhlw.go.jp/stf/seisakunitsuite/bunya/kenkou_iryou/shokuhin/syokuchu/poison/index.html (2015年7月22日アクセス)

 

・ 農林水産省 : 食品中のソラニンやチャコニンに関する情報 http://www.maff.go.jp/j/syouan/seisaku/solanine/ http://www.maff.gojp/j/syouan/seisaku/solanine/syousai/ (2015年7月22日アクセス)

 

P.981 掲載の参考文献

1) Hifumi T, Sakai A, Kondo Y, et al : Venomous snake bites : clinical diagnosis and treatment. J Intensive Care 3 : 16, 2015

PubMed

2) Dee Hodge III : Section III : Medical Emergencies, Chapter 3, Bites and Stings. In Textbook of Pediatric Emergency Medicine, 6th ed, pp677-685, 2010

 

3) Gold BS, Dalt RC, Barish RA : Bites of venomous snakes. N Engl J Med 347 : 347-256, 2002

 

4) 宮城良充 : ヘビ毒, ハチ毒. 小児内科 41 (増刊) : 1296-1300, 2009

 

5) Hifumi T, Yamamoto A, Morokuma K, et al : Clinical efficacy of antivenom and cepharantine for the treatment of Mamushi bites in tertiary care centers in Japan. Jpn J Infect Dis 66 : 26-31, 2013

 

6) 平田博国, 林ゆめ子, 福田健 :日本におけるハチ毒アレルギーの現状とその対応. アレルギア 36 : 27-34, 2007

 

7) 石地尚興 : ハチアレルギーの診断と治療. アレルギーの臨床 357 : 222-225, 2007

 

8) Mueller UR : Insect Sting Allergy : Clinical Picture, Diagnosis, and Treatment, Gustav Fischer, New York, 1990

 

P.985 掲載の参考文献

1) 厚生労働省 : 職場のあんぜんサイト GHS対応モデルラベル・モデルSDS情報 http://anzeninfo.mhlw.go.jp/anzen_pg/GHS_MSD_FND.aspx (2015年9月2日アクセス)

 

2) 日本中毒学会 (編) : 急性中毒標準診療ガイド, じほう. 東京, 2008

 

3) 上條吉人 (著), 相馬一亥 (監修) : 臨床中毒学, 医学書院, 東京, 2009

 

4) 内藤裕史 (著) : 薬物乱用・中毒百科-覚醒剤から咳止めまで, 丸善, 東京, 2011

 

P.990 掲載の参考文献

1) 日本中毒情報センター : 中毒情報データベース http://wwwj-poison-ic.or.jp/homepage.nsf (2015年9月2日アクセス)

 

2) 上條吉人 : アルコールおよびグリコール類. 相馬一亥 (監) : 臨床中毒学. 初版, 医学書院. 東京. pp331-349, 2009

 

3) 栗原伸公 : アルコール中毒. 小児科臨床 65 : 1517-1522, 2012

Medical*Online

4) McCormick T, Levine M, Knox O, et al : Ethanol ingestion in two infants under 2 months old : a previously unreported cause of ALTE. Pediatrics 131 : e604-607, 2013

 

5) 佐久間一基. 荒川武蔵. 広瀬保夫, 他 : メタノール, エタノール, ギ酸の血中濃度を経時的に分析したメタノール中毒の2例. 中毒研究 23 : 232-237, 2010

 

6) Kruse JA : Methallol and ethylene glycol intoxication. Crit Care Clin 28 : 661-711, 2012

PubMed

7) 武川薬品工業株式会社 : ホメピゾール点滴静注1.5g「タケダ」医薬品インタビューフォーム http://www.takedamed.com/content/medicine/pdf/interview/if-fomepizole.pdf (2015年9月2日アクセス)

 

8) Brent J : Fomepizole for ethylene glycol and methanol poisoning. N Engl J Med 360 : 2216-2223, 2009

PubMed

9) Cheri TH, Kuo CH, Huang CT, et al : Use of fomepizole in pediatric methanol exposure : the first case report in Taiwan and a literature review. Pediatr Neonatol 2013 Dec 10 pii : S1875-9572 (13) 00192-7 doi : 10.1016/j. pedneo. 2013. 08. 009 [Epub ahead of print]

 

10) Roberts DM, Yates C, Megarbane B, et al : Recommendations for the role of extracorporeal treatments in the management of acute methanol poisoning : a systematic review and consensus statement. Crit Care Med 43 : 461-472, 2015

PubMed

P.995 掲載の参考文献

1) 厚生労働省化学物質安全対策室 : 家庭用品等に係る健康被害病院モニター報告 (平成24年度) http://www.mhlw.go.jp/stf/houdou/0000042457.html (2015年9月2日アクセス)

 

2) 日本小児科学会こどもの生活環境改善委員会 : タバコの誤飲に対する処置について. 日小児会誌 102 : 613, 1998

 

3) 福本真理子, 小鴨晃, 久保博昭 : 紙巻きたばこの各溶液へのニコチン浸出率. 中毒研究 10 : 433-434, 1997

 

4) 内藤裕史 : ニコチンおよびクロロニコチニル系殺虫剤 (付タバコ). 中毒百科-事例・病態・治療. 改訂2版, 南江堂, 東京, pp261-264, 2001

 

5) 奥村徹, 有吉孝一, 人見知洋, 他 : タバコ誤食「タバコを食べたみたいなんです」治療 90 : 2663-2666, 2008

 

6) 星野恭子, 松裏裕行, 有本潔. 他 : タバコ誤飲におけるニコチン, コチニンの血中濃度について. 日小児会誌 100 : 1387-1391, 1996

 

7) Slnolinske SC, Spoerke DG, Spiller SK, et al : Cigarette and nicotine chewing gum toxicity in children. Hum Toxicol 7 : 27-31, 1988

 

8) 日本中毒学会学術委員会 : 急性中毒の標準治療, 日本中毒学会が推奨する標準治療の解説, (1) 胃洗浄 http://jsct.umin.jp/page027.html (2015年9月2日アクセス)

 

9) Krenzelok E, Vale A : Position statement : gut decontamination. American Academy of Clinical Toxicology : European Association of Poisons Centres and Clinical Toxicologists. J Toxicol Clin Toxicol 35 : 695-786, 1997

PubMed

P.1000 掲載の参考文献

1) Litovitz T, Whitaker N, Clark L, et al : Emerging battery-ingestion hazard : clinical implications. Pediatrics 125 : 1168-1177, 2010

PubMed

2) 中島健太郎 : 乳幼児診療の基本手技 異物誤飲への対応, 小児科 52 : 785-788, 2011

 

3) Karaman A, Karaman I, Erdogan D, et al : Perforation of Meckel's diverticulum by a button battery : report of a case. Surg Today 37 : 1115-1116, 2007

PubMed

4) Tanaka J, Yamashita M, Yamashita M, et al : Esophageal electrochemical burns due to button type lithium batteries in dogs. Vet Hum Toxicol 40 : 193-196, 1998

PubMed

5) 山本健太, 岩田晶子, 都間佑介, 他 : コイン型リチウム電池誤飲により食道潰瘍を来した2例 後遺症を残さなかった1例と後遺症を残した1例. 小児科臨床 63 : 1667-1673, 2010

Medical*Online

6) 畑田智子, 大浜用克, 新開真人, 他 : マグネットチューブで摘出できないボタン電池. こども医療センター医学誌 37 : 67-71, 2008

 

7) Thabet MH, basha WM, Askar S : Button battery foreign bodies in children : hazards, management, and recommendations. Biomed Res Int : 846091, 2013

PubMed

8) 須田博子, 岡島英明, 寺倉宏嗣. 他 : コイン型リチウム電池による食道異物. 小児外科 40 : 1221-1224, 2008

Medical*Online

9) National Capital Poison Center. NBIH Button Battery Ingestion Triage and Treatment Guideline. http://www.poison.org/battery/guideline.asp (2015年9月3日アクセス)

 

・ 日本小児外科学会ホームページ : リチウム電池に関する警告 http://www.jsps.gr.jp/general/attension/litillmu-battery (2015年9月3日アクセス)

 

・ 消費者庁・独立行政法人国民生活センター : 「乳幼児 (特に1歳以下) のボタン電池の誤飲に注意! -重症化することを知らない保護者が6割も!!」 (平成26年6月18日付) http://www.caa.go.jp/safety/pdf/140618kouhyou_1.pdf (2015年9月3日アクセス)

 

X. 事故

P.1009 掲載の参考文献

1) 日本小児科学会ホームページ : Injury Alert (傷害速報) https://www.jpeds.or.jp/modules/injury-alert/ (2015年9月3日アクセス)

 

2) Davis RM, Pless B : BMJ bans accidents. BMJ 322 : 1320-1321, 2001

PubMed

3) United States Consumer Product Safety Commission http://www.cpsc.gov (2015年9月3日アクセス)

 

4) 日本小児科学会こどもの生活環境改善委員会 : Injury Alert (傷害速報) Follow-up報告 No. 3. 日小児会誌 116 : 1309-1310, 2012

 

5) 日本小児科学会こどもの生活環境改善委員会 : Injury Alert (傷害速報) Follow-up報告 No. 6. 日小児会誌 119 : 109-113, 2015

 

6) 日本小児科学会こどもの生活環境改善委員会 : Injury Alert (傷害速報) No. 31 フード付きパーカーによる溢頸. 日小児会誌 116 : 1036-1037, 2012

 

7) 山中龍宏 : 子どもの安全とアロマザリング. 根ヶ山光一, 柏木惠子 (編著) : ヒトの子育ての進化と文化. 有斐閣, 東京, pp203-225, 2010

 

8) 岸部峻, 他 : 小児科医自身は「子供の傷害予防」をどう考えているのか? : アンケート調査研究. 日小児会誌 119 : 374, 2015

 

P.1012 掲載の参考文献

1) Committee on Trauma Research, Commission on Life Sciences, National Research Council and Institute of Medicine : Injury in America : a continuing public health problem. National Academic Press, Washington DC 1985

 

2) National Highway Traffic Safety Administration : Traffic Safety Facts : Occupant Protection. 2008 Data. http://www-nrd.nhtsa.dot.gov/Pubs/811160.pdf (2015年10月7日アクセス)

 

3) Centers for Disease Control and Prevention : The effectiveness of universal school-based programs for the prevention of violent and aggressive behavior : Areport on recommendations of the Task Force on Community Preventive Services. MMWR Recomm Rep 56 (RR-7) : 1-12, 2007

 

4) The Guide to Community Preventive Services : Reducing alcohol-impaired driving : ignition interlocks. http://www.thecommunityguide.org/mvoi/AID/ignitioninterlocks.html (2015年9月24日アクセス)

 

5) Stevens JA : ACDC Compendium of Effective Fall Interventions : What Works for Community-Dwelling Older Adults, 2nd ed, Centers for Disease Control and Prevention, National Center for Injury Prevention and Control, Atlama, 2010 http://www.cdc.gov/HomeandRecreationalSafety/pdfrCDC_Falls_Compendium_lowres.pdf (2015年9月24日アクセス)

 

6) 反町吉秀 : WHO推奨セーフコミュニティ活動の国際的展開, 評価と今後-効果的かつ持続可能な発展のために. 日本セーフティプロモーション学会誌 7 : 11-19, 2014

 

P.1016 掲載の参考文献

1) 山中巧, 原田敦子, 山崎麻美 : 小児軽症頭部外傷における頭蓋骨骨折例と頭蓋内出血例の検討. 小児の脳神経 39 : 262-268. 2014

Medical*Online

2) 小野純一, 山浦晶 : 頭部外傷データバンクにおける小児頭部外傷の分析. 小児の脳神経 33 : 390-395, 2008

Medical*Online

3) 西本博 : 小児頭部外傷の特異性. 山崎麻美, 坂本博昭 (編) : 小児脳神経外科学. 金芳堂, 京都, pp679-681, 2009

 

4) 末廣栄一, 鈴木倫保 : 神経集中治療における頭蓋内圧モニターの有用性, revist. No Shinkei Geka 42 : 195-204, 2014

 

5) 重症頭部外傷治療・管理のガイドライン作成委員会 (編) : 重症頭部外傷治療・管理のガイドライン第3版, 医学書院, 2013

 

6) Boake C, McCauley SR, Levin HS, et al : Diagnostic criteria for postconcussional syndrome after mild to moderate traumatic brain injury. J Neuropsychiatry Clin Neurosci 17 : 350-356, 2005

PubMed

7) Pigula FA, Wald SL, Shackford SR, et al : The effect of hypotension and hypoxia on children with severe head injuries. J Pediatr Surg 28 : 310-314, 1993

PubMed

8) Kuppermann N, Holmes JF, Dayan PS, et al : PECARN : Identification of children at very low risk of clinically-important brain injuries after head trauma : a prospective cohort study. Lancet 374 : 1160-1170, 2009

PubMed

9) Chambers IR, Jones PA, Lo TY, et al : Critical thresholds of intracranial pressure and cerebral perfusion pressure related to age in paediatric head injury. J Neurol Neurosurg Psychiatry 77 : 234-240, 2006

PubMed

10) Pang D : Spinal cord injury without radiographic abnormality in children, 2 decades later. Neurosurgery 55 : 1325-1343, 2004

PubMed

P.1020 掲載の参考文献

1) 畠山理, 日隈智憲, 尾藤祐子, 他 : 小児気道異物小児外科から 当科における気道異物症例40例の検討. 日気食会報 53 : 406-411. 2002

 

2) 香取幸夫. 川瀬哲明, 小林俊光 : 小児気管・気管支異物の診断と治療. 小児耳 26 : 67-74, 2005

 

3) 市丸智浩, 樋口収. 足立雄一, 他 : 小児における気管・気管支異物の全国調査結果-予防策の推進にむけて. 日小児呼吸器会誌 19 : 85-89, 2008

Medical*Online

4) 工藤典代 : 小児の気道・食道異物. 日気食会報 61 : 438-444, 2010

 

5) 橘一也, 木内恵子, 竹内宗之 : 小児の気道管理-困難気道への対処-気道異物症例の周術期管理. 日臨麻会誌 31 : 946-951, 2011

 

6) 岡川信一郎, 山内淑行, 佐藤昇一, 他 : ラリンゲルマスクを用いた気道異物に対する内視鏡治療. 日呼吸会誌 36 : 601-606, 1998

 

7) 足立雄一, 樋口収, 市丸智浩, 他 : 小児における気道異物事故予防にむけて. 外来小児 17 : 81-85, 2014

Medical*Online

・ 日本小児呼吸器学会, 日本小児救急医学会 : 小児の気道異物事故予防ならびに対応 (2013年8月) http://jspp1969.umin.jp/ind_img/cc03.pdf (2015年9月2日アクセス)

 

P.1026 掲載の参考文献

1) 大津一弘, 古田靖彦, 塩田仁彦 : 小児消化管異物216例の検討. 日臨外会誌 61 : 1698-1703. 2000

 

2) Hammond P, Jaffray B, Hamilton L : Tracheoesophageal fistula secondary to disk battery ingestion : a case report of gastric interposition and tracheal patch. J Pediatr Surg 42 : E39-41, 2007

 

3) Cevizci MN, Demir M, Demir B, et al : Migration of ingested sewing needle from within sigmoid colon to outside of the lumen. Pak J Med Sci 30 : 1422-1424, 2014

PubMed

4) Agbo C, Lee L, Chiang V, et al : Magnet-related injury rates in children : a single hospital experience. J Pediatr Gastroenterol Nutr 57 : 14-17, 2013

PubMed

5) Kircher MF, Milla S, Callahan MJ : Ingestion of magnetic foreign bodies causing multiple bowel perforations. Pediatr Radiol 37 : 933-936, 2007

PubMed

6) Romine M, Ham PB 3rd, Yon JR, et al : Multiple magnet ingestion in children. Am Surg 80 : e189-191, 2014

PubMed

7) Kramer RE, Lerner DG, Lin T, et al : Management of ingested foreign bodies in children : A clinical report of the NASPGHAN Endoscopy Committee. J Pediatr Gastroenterol Nutr 60 : 562-574, 2015.

 

8) Karthikeyan VS, Aiisari MG, Suresh R, et al : Spontaneous passage of long, sharp gastrointestinal foreign body in a child. BMJ Case Rep, 2015 doi : 10.1136/bcr-2014-206542

 

9) Pinto A, Lanza C, Pinto F, et al : Role of plain radiography in the assessment of ingested foreign bodies in the pediatric patients. Semin Ultrasound CT MR 36 : 21-27, 2014

PubMed

10) Fuentes S, Cano I, Benavent MI, et al : Severe esophageal injuries caused by accidental button battery ingestion in children, J Emerg Trauma Shock 7 : 316-321, 2014

 

・ 日本小児外科学会 : 異物の誤嚥・誤飲 http://www.jsps.gr.jp/general/disease/gi/bp8ck2 (2015年9月2日アクセス)

 

・ 独立行政法人国民生活センター : 命を落とすこともある! 子どもの誤飲事故 (平成17年4月6日) http://www.kokusen.go.jp/pdf/n-20050406_2.pdf (2015年9月2日アクセス)

 

P.1031 掲載の参考文献

1) 国民生活センター : 危害情報からみた子どものやけど, pp 1-5, 2003

 

2) 高橋宏樹 : 虐待. 救急医学 38 : 1336-1341, 2014

 

3) 日本熱傷学会用語委員会 (編) : 熱傷用語集, 日本熱傷学会, 2009

 

4) 福屋安彦 : 小児熱傷の問題点. 救急医学 38 : 1331-1335, 2014

 

5) 創傷・熱傷ガイドライン委員会報告 : 熱傷診療ガイドライン. 日皮会誌 121 : 3279-3306, 2011

 

6) 菅又章 : 小児熱傷. 木所昭夫 (編) : 熱傷治療マニュアル, 中外医学社, 東京, pp290-298, 2007

 

P.1037 掲載の参考文献

1) ゴードン・G・ギースブレヒト. ジェームス・A・ウイルカースン〔栗栖茜 (訳) 〕 : 低体温症と凍傷, 海山社, 東京, pp15-79, 2014

 

2) West JB, Schoene RB, Luks A, et al : High Altitude Medicine and Physiology, CRC Press, FL, USA, pp346-372, 2013

 

3) Hallam MJ, Cubison T, Dheansa B, et al : Managing frostbite. BMJ 341 : c5864, 2010 doi : 10.1136/bmj. c5864

 

4) Southard A, Niermeyer S, Yaron M : Language used in Lake Louise Scoring System underestimates symptoms of acute mountain sickness in 4-11-year-old children. High Altitude Med Biol 8 : 124-131, 2007

PubMed

5) 前川喜平, 長田実, 森虎 : 新生児期における急性東証-アイスパックによる. 小児科診察 32 : 59-62, 1969

 

6) 山本利春 : 凍傷への注意, アイシングの方法. クーリングダウン時のアイシング. Sportsmedicine Quarterly 21 : 13-21, 1997

 

7) 北愛里紗, 四ツ柳高敏, 斎藤有 : 低体温症に用いたアイスパックによって発生した耳介凍傷の一例. 形成外科 57 : 799-803, 2014

 

8) 三上剛人 : 凍傷. 臨床看護 37 (臨時増刊) : 573-575, 2011

 

9) 加藤博孝 : 低体温症・凍傷, 救急医学 34 : 848-850, 2010

 

10) 坂本静男 : 凍傷. 臨床スポーツ医学 15 : 232-233, 1998

 

・ Medline Plus : Extracorporeal membrane oxygenation http://www.nlm.nih.gov/medlineplus/ency/article/007234.htm (2015年9月3日アクセス)

 

・ 日本呼吸療法医学 : ECMOプロジェクト http://square.umin.ac.jp/jrcm/contents/ecmo/ (2015年9月3日アクセス)

 

・ メルクマニュアル : 寒冷傷害 http://merckmanual.jp/mmpej/sec21/ch319/ch319a.html (2015年9月3日アクセス)

 

P.1043 掲載の参考文献

1) 日本救急医学会回 (編) : 熱中症-日本を襲う熱波の恐怖. へるす出版, 東京, 2011

 

2) 日本救急医学会 : 熱中症診療ガイドライン 2015 http://www.jaam.jp/html/info/2015/pdf/info-20150413.pdf (2015年9月3日アクセス)

 

3) 安岡正蔵, 赤居正美, 有賀徹, 他 : 熱中症 (暑熱障害) I～III度分類の提案 : 熱中症新分類の臨床的意義. 救急医学 23 : 1119-1123, 1999

 

4) 三宅康史, 横田裕行, 奥寺敬, 他 : 熱中症の実態調査-日本救急医学会Heatstroke STUDY2012最終報告. 日救急医会誌 25 : 846-62, 2014

 

5) 環境省 : 有賀徹, 石川広, 井上芳光, 他 : 熱中症環境保健マニュアル http://www.env.go.jp/chemi/heat_stroke/manual/full.pdf (2015年9月3日アクセス)

 

6) 公益財団法人日本体育協会 : スポーツ活動中の熱中症予防ガイドブック http://www.japan-sports.or.jp/publish/tabid/776/Default.aspx#guide01 (2015年9月3日アクセス)

 

7) Squre DL : Heat illness. Peditr Clin North Am 37 : 1085-1108, 1990

 

8) Eichner ER : Genetic and other determinants of sweat sodium. Curr Sports Med 7 : S36-40, 2008

 

9) Committee on Sports Medicine and Fitness : Climatic heat stress and exercising child and adolescent. Pediatrics 106 : 158-159, 2000

PubMed

10) 奥寺敬 : 救急・災害医療における経口補水療法の可能性. 地域救急災害医療研究 6 : 6-7, 2007

Medical*Online

11) Meyer F, Bar-Or O, MacDougall D, et al : Sweat ellectrolyte loss during exercise in the heat : effects of gender and maturation. Med Sci Sports Exerc 24 : 776-781, 1992

PubMed

P.1048 掲載の参考文献

1) Szpilman D, Bierens JJLM, Handley AJ, et al : Drowning. N Engl J Med 366 : 2102-2110, 2012

PubMed

2) 長村敏生 : 事故予防と安全対策. 小児科診療 77 : 1165-1170, 2014

Medical*Online

3) Biagas K : Drowning and near drowning : submersion injuries. In Nichols DG, et al (eds) : Rogers' Textbook of Pediatric Intensive Care, 4th ed, Wolters Kluwer/Lippincott Williams & Wilkins, pp408-413, 2008

 

4) Bell GS, Gaitatzis A, Bell CL, et al : Drowning in people with epilepsy : how great is the risk? Neurology 71 : 578-582, 2008

PubMed

5) Iris AH, Berg RA, Bierens J, et al : Recommended guidelines for uniform reporting of date from drowning : "the Utstein Style". Circulation 108 : 2565-2574, 2003

 

6) 我那覇仁 : 溺水. 小児内科 43 : 123-125, 2011

Medical*Online

7) Vebema AM, Groothoff JW, Bierells JJLM : The role of bystanders during rescue and resuscitation of drowning victims. Resuscitation 81 : 434-439, 2010

 

8) Vanden Hoek TL, Morrison LJ, Shuster M, et al : Part 12 : Cardiac arrest in special situations : 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 122 : S829-861, 2010

PubMed

9) Kallas HJ : 溺死と溺水. 衛藤義勝 (監修) : ネルソン小児科学, 17版, エルゼビア・ジャパン, 東京, pp332-342. 2005

 

10) 我那覇仁 : 溺水の蘇生. 小児科 50 : 175-181, 2009

 

P.1055 掲載の参考文献

1) 日本スポーツ振興センター, 文部科学省委託事業 スポーツ事故防止対策推進事業「学校でのスポーツ事故を防ぐために」成果報告書, 2015 https://www.jpnsport.go.jp/anzen/tabid/1746/Default.aspx (2015年9月3日アクセス)

 

2) 全日本柔道連盟 : 柔道の安全指導, 第三版. 2011 http://www.judo.or.jp/wp-content/uploads/2013/08/print-shidou.pdf (2015年9月3日アクセス)

 

3) 日本体育協会 : スポーツ活動中の熱中症予防ガイドブック, 2013 http://www.japan-sports.or.jp/medicine/tabid/523/Default.aspx (2015年9月3日アクセス)

 

4) Hemenway D : While We Were Sleeping-Success Stories in Injury and Violence Prevention, University of California Press, 2010

 

5) 環境省 : 熱中症予防情報サイト http://www.wbgt.env.go.jp/ (2015年9月3日アクセス)

 

6) Rodriguez JO, Lavina AM, Agarwal A : Prevention and treatment of common eye injuries in sports. Am Fam Physician 67 : 1481-1488, 2013

 

7) チャイルドSCAT3 http://www.fajiwaraqol.com/concussion/child_scat3_ja.pdf (2015年9月3日アクセス)

 

8) SCAT3 http://www.fujiwaraqol.com/concussion/scat3_ja.pdf (2015年9月3日アクセス)

 

・ 文部科学省委託事業, スポーツ事故防止対策推進事業「学校でのスポーツ事故を防ぐために」https://www.jpnsport.go.jp/anzen/tabid/1746/Default.aspx (2015年9月3日アクセス)